amiodarone has been researched along with Tachycardia in 525 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Tachycardia: Abnormally rapid heartbeat, usually with a HEART RATE above 100 beats per minute for adults. Tachycardia accompanied by disturbance in the cardiac depolarization (cardiac arrhythmia) is called tachyarrhythmia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Short-term oral amiodarone treatment following ablation for paroxysmal or persistent AF did not significantly reduce recurrence of atrial tachyarrhythmias at the 6-month follow-up, but it more than halved atrial arrhythmia related hospitalization and cardioversion rates during the blanking period." | 9.19 | Recurrence of arrhythmia following short-term oral AMIOdarone after CATheter ablation for atrial fibrillation: a double-blind, randomized, placebo-controlled study (AMIO-CAT trial). ( Chen, X; Darkner, S; Hansen, J; Johannessen, A; Nielsen, JB; Pehrson, S; Svendsen, JH, 2014) |
| " amiodarone in the therapy of atrial tachyarrhythmias in critically ill patients." | 9.08 | Parenteral magnesium sulfate versus amiodarone in the therapy of atrial tachyarrhythmias: a prospective, randomized study. ( Cunningham, DN; Gallagher, J; Leppard, P; Moran, JL; Peake, SL; Salagaras, M, 1995) |
| "The incidence of clinically significant tachycardia was reduced by amiodarone." | 9.07 | Amiodarone prophylaxis for tachycardias after coronary artery surgery: a randomised, double blind, placebo controlled trial. ( Butler, J; Harriss, DR; Sinclair, M; Westaby, S, 1993) |
| "The Canadian Amiodarone Myocardial Infarction Trial (CAMIAT) is a multicenter, triple-blind, randomized, placebo-controlled trial." | 9.07 | Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT): rationale and protocol. CAMIAT Investigators. ( Cairns, JA; Connolly, SJ; Gent, M; Roberts, R, 1993) |
| "The efficacy and the safety of amiodarone therapy in 82 patients with recurrent tachyarrhythmias, refractory to conventional antiarrhythmics, were evaluated by a multicenter trial." | 9.07 | Efficacy and safety of amiodarone in treatment of refractory atrial and ventricular tachyarrhythmias. ( Kato, K, 1992) |
| "Amiodarone is very effective in suppressing refractory nonsustained ventricular tachycardia." | 9.07 | The efficacy of amiodarone in the treatment of refractory nonsustained ventricular tachycardia. ( Ballas, SL; Veltri, EP, 1991) |
| "To assess the most appropriate method of administering amiodarone and predicting its efficacy (empiric vs guided by Holter or by ventricular stimulation), 19 patients with sustained ventricular tachycardia or ventricular fibrillation underwent a "parallel study"." | 9.07 | [Treatment of malignant ventricular tachyarrhythmia with amiodarone: comparison of empirical administration and administration guided by Holter or ventricular stimulation. Results of the parallel test]. ( Bonso, A; D'Este, D; Delise, P; Di Pede, F; Gasparini, G; Piccolo, E; Raviele, A; Zanocco, A, 1991) |
| "High-dose intravenous amiodarone was given to 35 patients with recurrent life-threatening ventricular tachycardia (VT) refractory to conventional antiarrhythmic agents." | 9.06 | Efficacy and tolerance of high-dose intravenous amiodarone for recurrent, refractory ventricular tachycardia. ( Esterbrooks, DJ; Hee, TT; Hilleman, DE; Mohiuddin, SM; Mooss, AN; Rovang, KS; Sketch, MH, 1990) |
| "The interaction between the efficacy and tolerance of amiodarone and the degree of left ventricular (LV) dysfunction was assessed in 126 patients with sustained ventricular tachyarrhythmias." | 9.06 | Development of congestive heart failure and alterations in left ventricular function in patients with sustained ventricular tachyarrhythmias treated with amiodarone. ( Brady, P; De Paola, AA; Greenspan, AM; Horowitz, LN; Kay, HR; Morganroth, J; Spielman, SR, 1987) |
| "Induction of rapid ventricular tachycardia or fibrillation during therapy with amiodarone is associated with an increased risk of sudden death." | 9.06 | Amiodarone versus amiodarone and a type IA agent for treatment of patients with rapid ventricular tachycardia. ( Buxton, AE; Flores, BT; Josephson, ME; Marchlinski, FE; Miller, JM; Vassallo, JA, 1986) |
| "We examined the chronic electrophysiologic, systemic, and pharmacologic effects of chronic oral amiodarone therapy in 24 patients with refractory ventricular tachycardia and organic heart disease." | 9.05 | Chronic effects of amiodarone in patients with refractory ventricular tachycardia. ( Cappello, G; Rothbart, ST; Saksena, S, 1983) |
| "The role of provocation tests for the assessment of amiodarone therapy in patients with ventricular tachycardia remains a subject of controversy: recent studies seem to show that the ability to initiate VT in patients on amiodarone is compatible with a good long-term result." | 9.05 | [Value of provocation tests in the evaluation of the treatment of ventricular tachycardias with amiodarone]. ( Bounhoure, JP; Calazel, J; Cassagneau, B; Fauvel, JM; Marin, T; Massabuau, P; Narula, OS; Puel, J; Tournadre, P, 1984) |
| "Thirty-three patients with recurrent drug-refractory ventricular tachycardia were treated with oral amiodarone during an average period of 6." | 9.05 | Antiarrhythmic efficacy of amiodarone in recurrent ventricular tachycardia evaluated by multiple electrophysiological and ambulatory ECG recordings. ( Griffin, J; Mason, J; Peters, F; Rasmussen, K; Ross, D; Winkle, R, 1982) |
| "Amiodarone, a benzofuranic iodine-rich pan-anti-arrhythmic drug, induces amiodarone-induced thyrotoxicosis (AIT) in 7-15% of patients." | 9.01 | Issues in amiodarone-induced thyrotoxicosis: Update and review of the literature. ( Batisse-Lignier, M; Benichou, T; Dallel, S; Desbiez, F; Maqdasy, S; Montanier, N; Roche, B; Tauveron, I, 2019) |
| "The objective of this review is to explore and challenge the superiority of amiodarone for rate control in Wolff-Parkinson-White syndrome and concomitant atrial fibrillation (WPW-AF)." | 8.86 | Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation. ( Langdorf, MI; Lotfipour, S; Simonian, SM; Wall, C, 2010) |
| "A case of the use of amiodarone in pregnancy is reported and the literature on this subject reviewed." | 8.77 | Amiodarone in pregnancy. Case report and review of the literature. ( Foster, CJ; Love, HG, 1988) |
| "Amiodarone may be considered for patients with junctional ectopic tachycardia refractory to treatment with sedation, analgesia, cooling, and electrolyte replacements." | 8.31 | Hemodynamic profile effects of PM101 amiodarone formulation in patients with post-operative tachyarrhythmias. ( Besunder, J; Breedlove, K; Brown, M; Clark, J; DeCoy, M; Gothard, D; Nofziger, R; Page-Goertz, C; Raimer, P; Ruggles, C; Stewart, R, 2023) |
| "Amiodarone is the gold-standard medication to control heart rate in critically ill patients with atrial tachyarrhythmias (ATs); however, effective doses and covariates influencing its efficacy remain unknown." | 7.83 | Modeling of Amiodarone Effect on Heart Rate Control in Critically Ill Patients with Atrial Tachyarrhythmias. ( Aissaoui, N; Alazard, M; El-Aissaoui, M; Faisy, C; Funck-Brentano, C; Hulot, JS; Le-Heuzey, JY; Salem, JE; Urien, S, 2016) |
| "In a 10-year prospective observational study, 71 of 2651 patients (2885 procedures, 2106 bypass procedures) received amiodarone for newly detected postoperative atrial (n = 70) or ventricular (n = 7) tachyarrhythmia: early treatment (initiation within 60 minutes of arrhythmia detection) and late treatment (after that)." | 7.74 | Impact of early and standardized treatment with amiodarone on therapeutic success and outcome in pediatric patients with postoperative tachyarrhythmia. ( Camphausen, CK; Haas, NA, 2008) |
| "Special attention should be paid to patients on treatment with amiodarone and/or a diagnosis of atrial fibrillation as they may have an increased risk of fracture." | 7.74 | Fracture risk in patients treated with amiodarone or digoxin for cardiac arrhythmias: a nation-wide case-control study. ( Mosekilde, L; Rejnmark, L; Vestergaard, P, 2007) |
| "Amiodarone, a class III antiarrhythmic drug, is one of the most effective drugs used in the treatment of ventricular and paroxysmal supraventricular tachyarrhythmia." | 7.74 | Acute pancreatitis and amiodarone: a case report. ( Chen, CY; Chen, YY; Leung, KK, 2007) |
| "Amiodarone-induced thyrotoxicosis (AIT) with features consistent with both AIT type I (in which thyroid antibodies and nodular goiter are present) and AIT type II (which is not responsive to thionamide therapy and eventually leads to permanent hypothyroidism)." | 7.74 | Treatment of amiodarone-associated thyrotoxicosis. ( Franklyn, JA; Gammage, MD, 2007) |
| "Although there are two types of amiodarone-induced thyrotoxicosis (AIT), only type II AIT has been seen at our institution in Japan so far." | 7.73 | Mild and short recurrence of type II amiodarone-induced thyrotoxicosis in three patients receiving amiodarone continuously for more than 10 years. ( Hagiwara, N; Kasanuki, H; Matsuda, N; Onoda, N; Sato, K; Shiga, T; Takano, K, 2006) |
| "Amiodarone may still be safely prescribed for Chinese patients who have baseline liver dysfunction." | 7.73 | Prevalence of amiodarone-related hepatotoxicity in 720 Chinese patients with or without baseline liver dysfunction. ( Chan, WW; Fung, JW; Ho, SS; Hui, HH; Kum, LC; Sanderson, JE; Wong, GW; Yu, CM, 2006) |
| "Amiodarone is an effective anti-arrhythmic agent for the treatment of supraventricular and ventricular tachycardias." | 7.72 | Efficacy and safety of intravenous amiodarone for incessant tachycardias in infants. ( Bauersfeld, U; Burri, S; Hug, MI, 2003) |
| "Fetuses with incessant tachycardia and either hydrops fetalis (n=24) or ventricular dysfunction (n=2) for whom digoxin monotherapy and secondary antiarrhythmic agents (n=13) were not effective were treated transplacentally with a loading dose of oral amiodarone for 2 to 7 days, followed by daily maintenance therapy for <1 to 15 weeks." | 7.72 | Amiodarone therapy for drug-refractory fetal tachycardia. ( Cuneo, BF; Deal, BJ; Feinkind, L; Gotteiner, NL; Hussey, M; McGregor, SN; Meijboom, EJ; Michon, MM; Oudijk, MA; Parilla, BV; Strasburger, JF, 2004) |
| "Intravenous amiodarone is found to be an effective and safe antiarrhythmic agent for children with acute life-threatening and chronic tachyarrhythmias and depressed left ventricular systolic functions." | 7.70 | Effectiveness and safety of intravenous amiodarone in drug-resistant tachyarrhythmias of children. ( Celiker, A; Ceviz, N; Ozme, S, 1998) |
| "Two patients with amiodarone-induced thyrotoxicosis were treated successfully with potassium perchlorate and carbimazole while treatment with amiodarone was continued." | 7.69 | Two cases of amiodarone-induced thyrotoxicosis successfully treated with a short course of antithyroid drugs while amiodarone was continued. ( Düren, DR; Trip, MD; Wiersinga, WM, 1994) |
| "To compare the efficacy and safety of intravenous (IV) amiodarone and procainamide for the treatment of atrial tachyarrhythmias (AT) in the critically ill." | 7.68 | Management of atrial tachyarrhythmias in the critically ill: a comparison of intravenous procainamide and amiodarone. ( Chapman, MJ; Cunningham, DN; Moran, JL; O'Fathartaigh, MS; Peisach, AR, 1993) |
| "Intravenous amiodarone was administered in 1-mg/kg body weight aliquots followed by continuous infusion to patients with potentially life-threatening tachyarrhythmias that had not been abolished by standard therapies." | 7.68 | Intravenous amiodarone for life-threatening tachyarrhythmias in children and young adults. ( Denfield, SW; Fenrich, AL; Friedman, RA; Knilans, TK; Marlow, D; Perry, JC, 1993) |
| "In 15 patients with recurrent ventricular tachycardia, the hemodynamic effects of amiodarone were evaluated under oral loading (1000 mg/day for 14-16 days) and during chronic treatment (600 mg/day for a further 10 weeks)." | 7.68 | Hemodynamic effects of amiodarone during acute and chronic treatment in patients with recurrent sustained ventricular tachycardia. ( Jung, W; Lüderitz, B; Manz, M, 1992) |
| "105 sequential patients with ventricular arrhythmias in a basal ECG-H recording, that were evaluated within 1 year with a new recording on amiodarone or propafenone, without major clinical events or therapeutic changes between the two recordings." | 7.68 | [Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia]. ( Adragão, P; Bonhorst, D; Seabra-Gomes, R; Ventosa, A, 1990) |
| "A group of 34 consecutive patients with coronary artery disease (n = 29) or dilated cardiomyopathy (n = 5) (3 women, 31 men, age 38-80 yr) who had severely impaired left ventricular function (left ventricular ejection fraction less than or equal to 40%) and high-grade ventricular ectopic activity (sustained or nonsustained ventricular tachycardia or ventricular fibrillation) were treated with amiodarone (mean dose: 206 mg/d) and followed for 1-117 (mean: 49) months." | 7.68 | Long-term treatment of ventricular tachycardia with amiodarone in presence of severe left ventricular dysfunction. ( Burckhardt, D; Hoffmann, A; Pfisterer, M; Robertson, A, 1991) |
| "To clarify the risk-benefit ratio involved in association of antiarrhythmic drugs, a combined therapy of amiodarone and propafenone was tested by means of continuous electrocardiographic monitoring, analysis of levels of the drug in the plasma and programmed electrical stimulation in a selected group of 10 patients who had left ventricular dysfunction and spontaneous relapses of sustained ventricular tachycardia despite treatment with amiodarone." | 7.68 | The use of associated propafenone in patients with amiodarone-resistant ventricular tachycardia. ( Camerini, F; Chersevani, D; Dreas, L; Humar, F; Maras, P; Morgera, T, 1991) |
| "Antiarrhythmic and electrophysiological effects of three class I antiarrhythmic agents, one from each subclass A, B, and C, were assessed in single use and in combination with amiodarone in patients with inducible, sustained ventricular tachycardia that was not suppressed by monotherapy with these agents." | 7.68 | A prospective comparison of class IA, B, and C antiarrhythmic agents in combination with amiodarone in patients with inducible, sustained ventricular tachycardia. ( Kadish, A; Morady, F; Toivonen, L, 1991) |
| "Directed surgical intervention in patients with ventricular tachyarrhythmias who have experienced failure of amiodarone therapy is a common clinical scenario." | 7.68 | Amiodarone-related postoperative adult respiratory distress syndrome. ( Greenspon, AJ; Hurley, W; Kidwell, GA; Mannion, J, 1991) |
| "Intravenous amiodarone was administered to 22 patients with recurrent ventricular tachycardia failing an average of 3." | 7.68 | Intravenous amiodarone for short-term treatment of refractory ventricular tachycardia or fibrillation. ( DonMichael, TA; Ismail, Y; Nalos, PC; Nyitray, W; Pappas, JM, 1991) |
| " Recently, amiodarone has been shown to be rapidly effective in suppressing sustained, incessant ventricular tachycardia and ventricular fibrillation in this setting." | 7.68 | Amiodarone versus bretylium for suppression of reperfusion arrhythmias in dogs. ( Horrigan, TP; Mostow, ND; Noon, DL; Rosalion, A; Snow, NJ, 1991) |
| "The results of electrophysiologic testing after short-term and long-term treatment with amiodarone were compared in 71 patients with ventricular tachycardia." | 7.68 | Comparison of the results of electrophysiologic testing after short-term and long-term treatment with amiodarone in patients with ventricular tachycardia. ( Calkins, H; deBuitleir, M; Kadish, AH; Morady, F; Rosenheck, S; Schmaltz, S; Sousa, J, 1991) |
| "The long-term follow-up of 52 pts (36 M, 16 F, mean age: 62 years) with sustained ventricular tachyarrhythmias (SVT) was analyzed to assess the efficacy and feasibility of empiric amiodarone treatment." | 7.68 | [Empiric treatment with amiodarone in patients with sustained ventricular tachyarrhythmia. Results of a long-term follow-up]. ( Bonso, A; Caprioglio, F; D'Este, D; Delise, P; Di Pede, F; Gasparini, G; Piccolo, E; Raviele, A; Zanocco, A, 1990) |
| "To shorten the delay in the onset of antiarrhythmic effect when using amiodarone for the conversion of refractory atrial tachyarrhythmias to sinus rhythm, 19 patients were given oral amiodarone according to a high-dose loading protocol." | 7.68 | Rapid control of refractory atrial tachyarrhythmias with high-dose oral amiodarone. ( Mostow, ND; Noon, D; Rakita, L; Vrobel, TR, 1990) |
| "To evaluate the efficacy and safety of long-term empiric amiodarone therapy in patients with recurrent Sustained Ventricular Tachycardia (SVT) and Chronic Chagasic Myocarditis (CCM)." | 7.68 | [Empiric therapy with amiodarone in patients with chronic Chagas cardiomyopathy and sustained ventricular tachycardia]. ( Bellotti, G; Lee, JH; Pileggi, F; Scanavacca, MI; Sosa, EA, 1990) |
| "Our experience with amiodarone therapy in 145 consecutively referred patients with medically refractory sustained ventricular tachycardia and/or fibrillation treated for at least 3 years was reviewed." | 7.68 | Benefit and risks of long-term amiodarone therapy for sustained ventricular tachycardia/fibrillation: minimum of three-year follow-up in 145 patients. ( Gang, ES; Mandel, WJ; Myers, M; Nalos, PC; Oseran, DS; Peter, T; Weiss, D, 1990) |
| "Amiodarone in a low dose (200 mg/day) was administered alone or in combination with other type I antiarrhythmic drugs as a first-line agent in 33 patients with ventricular tachycardia (VT) (n = 24) or ventricular fibrillation (VF) (n = 9) secondary to coronary artery disease with healed myocardial infarction." | 7.68 | Long-term follow-up of postmyocardial infarction patients with ventricular tachycardia or ventricular fibrillation treated with amiodarone. ( Kusniec, J; Mager, A; Sclarovsky, S; Strasberg, B; Zlotikamien, B, 1990) |
| "We undertook this study to determine if the cycle-length response of ventricular tachycardia (VT) to procainamide and amiodarone is similar in the individual patient." | 7.68 | Cycle-length response of ventricular tachycardia associated with coronary artery disease to procainamide and amiodarone. ( Buxton, AE; Josephson, ME; Marchlinski, FE; Vaitkus, PT, 1990) |
| "We report the case of a patient who developed a life-threatening polymorphous ventricular tachycardia ( PVT ) after six weeks of treatment with amiodarone." | 7.67 | Polymorphous ventricular tachycardia associated with a marked prolongation of the Q-T interval induced by amiodarone. ( Bhandari, AK; Quock, C; Sung, RJ, 1984) |
| "Using His bundle electrograms and programmed ventricular stimulation, the effects of chronic amiodarone treatment on induction, morphology, and the rate of ventricular tachycardia (VT) were studied in 17 consecutive patients treated with amiodarone for control of recurrent sustained VT or ventricular fibrillation." | 7.67 | Effect of amiodarone on electric induction, morphology, and rate of ventricular tachycardia and its relation to clinical efficacy. ( Jivrajka, V; Kuo, CS; Reddy, CP, 1984) |
| ") amiodarone infusion (10 to 20 mg/kg/day for 4 to 7 days) followed by chronic oral amiodarone therapy (400 to 800 mg/day for 24 to 53 days) were evaluated in 17 patients with refractory sustained ventricular tachycardia (VT) or ventricular fibrillation." | 7.67 | Clinical efficacy and electropharmacology of continuous intravenous amiodarone infusion and chronic oral amiodarone in refractory ventricular tachycardia. ( Cappello, G; Rothbart, ST; Saksena, S; Shah, Y, 1984) |
| " amiodarone in patients with reentrant supraventricular tachycardia (SVT) can predict the efficacy of long-term oral therapy with this drug." | 7.67 | Effects of amiodarone on supraventricular tachycardia involving bypass tracts. ( Alboni, P; Baggioni, F; Masoni, A; Pirani, R; Scarfo, S; Shantha, N; Tomasi, AM, 1984) |
| "Electrophysiologic studies were performed in nine patients with reentrant paroxysmal supraventricular tachycardia (PSVT) during a control period and following 5 mg/kg body weight of intravenous amiodarone (Cordarone, Labaz) administered as a slow continuous infusion over 15 to 20 minutes." | 7.67 | Electrophysiologic effects and mechanisms of termination of supraventricular tachycardia by intravenous amiodarone. ( El-Sherif, N; Gomes, JA; Hariman, RJ; Kang, PS; Lyons, J, 1984) |
| "We studied the effects of intravenous amiodarone administration (5 mg/kg) on reproducible repetitive ventricular responses and ventricular tachycardia (VT) induced by programmed electrical stimulation of the heart in 32 patients." | 7.67 | Effects of intravenous amiodarone in patients with inducible repetitive ventricular responses and ventricular tachycardia. ( El-Sherif, N; Gomes, JA; Hariman, RJ; Kang, PS, 1984) |
| "The determinants of long-term clinical outcome were studied in 42 patients with recurrent ventricular tachycardia (VT) or ventricular fibrillation (VF) who were treated with amiodarone as the sole antiarrhythmic agent." | 7.67 | Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone. ( DiMarco, JP; Garan, H; Grant, G; Malacoff, RF; McGovern, B; Ruskin, JN; Sellers, TD, 1984) |
| " To determine their relative antiarrhythmic efficacy, amiodarone and its desethyl metabolite, desethylamiodarone, were administered to mongrel dogs with ventricular tachycardia 24 hr after ligation of the left anterior descending coronary artery." | 7.67 | The antiarrhythmic efficacy of amiodarone and desethylamiodarone, alone and in combination, in dogs with acute myocardial infarction. ( Davies, M; Nattel, S; Quantz, M, 1988) |
| "To determine whether the slow onset of action of amiodarone might result in a delayed effect on the inducibility of sustained ventricular arrhythmias, 45 patients with ischemic heart disease and inducible sustained monomorphic ventricular tachycardia were prospectively studied." | 7.67 | Cumulative effects of amiodarone on inducibility of ventricular tachycardia: implications for electrophysiological testing. ( Beckman, KJ; Hargis, J; Krafchek, J; Lin, HT; Magro, SA; Nielsen, AP; Wyndham, CR, 1988) |
| "Because of its presumed unique efficacy, amiodarone (AM) is often used to treat patients whose sustained ventricular tachyarrhythmias (VT/VF) appear to be drug-refractory." | 7.67 | Empiric amiodarone versus "ineffective" drug therapy in patients with refractory ventricular tachyarrhythmias. ( Elson, JJ; Fiedler, SB; Fogoros, RN, 1988) |
| "Verapamil is a calcium channel blocker ideally suited for the treatment of A-V nodal reciprocating supraventricular tachycardia." | 7.67 | [Idiopathic recurrent ventricular tachycardia: role of verapamil in its treatment]. ( Arriagada, C; Fajuri, A; González, R; Marchesse, M; Serrat, H, 1989) |
| "The clinical efficacy of intravenous amiodarone in terminating sustained ventricular tachycardia and in preventing recurrences of ventricular tachycardia and ventricular fibrillation was evaluated in 26 patients." | 7.67 | Clinical efficacy of intravenous amiodarone in the short term treatment of recurrent sustained ventricular tachycardia and ventricular fibrillation. ( Harringer, W; Herbinger, W; Kerschner, K; Leisch, F; Schützenberger, W, 1989) |
| "Amiodarone was used in 86 patients with ventricular tachycardia (VT) (67 patients) or ventricular fibrillation (19 patients) secondary to coronary artery disease." | 7.67 | Prognostic value of early electrophysiologic studies for ventricular tachycardia recurrence in patients with coronary artery disease treated with amiodarone. ( Estes, NA; Manolis, AS; Uricchio, F, 1989) |
| "Treatment of amiodarone-induced thyrotoxicosis (AIT) with thionamide, lithium or radioactive iodine is ineffective." | 7.67 | Dexamethasone treatment of amiodarone-induced thyrotoxicosis (AIT) with or without persistent administration of the drug. ( Bernard, R; Bonnyns, M; Bourdoux, P; Demaret, B; Renard, M; Sterling, I, 1989) |
| "Amiodarone, a iodine-rich drug widely used in the treatment of tachyarrhythmias, represents one of the most common sources of iodine-induced thyrotoxicosis." | 7.67 | Amiodarone: a common source of iodine-induced thyrotoxicosis. ( Aghini-Lombardi, F; Bartalena, L; Braverman, L; Mariotti, S; Martino, E; Pinchera, A, 1987) |
| "The electrophysiologic effects and antiarrhythmic efficacy of flecainide were evaluated by electrophysiologic study (EPS) in 20 patients with ventricular tachycardia (VT) refractory to an average 2." | 7.67 | Clinical and electrophysiologic effects of flecainide in patients with refractory ventricular tachycardia. ( Capparelli, EV; Chow, MS; Kluger, J; Regnier, JC, 1988) |
| "A 42-year old man with non-obstructive myocardiopathy complicated by paroxysmal atrial fibrillation treated with amiodarone (200 mg per day) received flecainide in daily doses of 400 mg for undocumented palpitations." | 7.67 | [Bundle branch reentry tachycardia: a possible mechanism of flecainide proarrhythmia effect]. ( Berland, J; Cribier, A; Letac, B; Saoudi, N, 1988) |
| "The antiarrhythmic efficacy and safety of intravenous amiodarone were evaluated in 13 patients with recurrent sustained ventricular tachycardia." | 7.67 | Efficacy of intravenous amiodarone as short-term treatment for refractory ventricular tachycardia. ( Klein, RC; Machell, C; Rushforth, N; Standefur, J, 1988) |
| "Induction of ventricular tachycardia (VT) at electrophysiologic study in patients taking amiodarone poorly predicts recurrence of VT." | 7.67 | Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrop ( Chang, MS; Fineberg, N; Heger, JJ; Kammerling, JM; Klein, LS; Miles, WM; Prystowsky, EN; Zipes, DP, 1988) |
| "The prognostic value of 3 previously reported programmed stimulation efficacy criteria was studied in 70 patients taking amiodarone for sustained ventricular tachycardia (VT)." | 7.67 | Prognostic value of the changes in the mode of ventricular tachycardia induction during therapy with amiodarone or amiodarone and a class 1A antiarrhythmic agent. ( Felder, SD; Figura, I; Fisher, JD; Johnston, DR; Kim, SG; Mercando, AD, 1987) |
| "Thirty-three patients with clinically recurrent ventricular tachyarrhythmias were treated with amiodarone (200 to 600 mg/day) during a mean follow-up period of 23." | 7.67 | Amiodarone in patients with recurrent sustained ventricular tachyarrhythmias: results of programmed electrical stimulation and long-term clinical outcome in chronic treatment. ( Brachmann, J; Kübler, W; Rizos, I; Schmitt, C; Senges, J; Waldecker, B, 1987) |
| "Fifty-four patients with a previous myocardial infarction and drug-refractory symptomatic ventricular tachycardia (VT) were treated with amiodarone on a long-term basis (range 6 to 54 months, mean 26) irrespective of the results of programmed ventricular stimulation, which was performed after high-dose oral amiodarone loading for more than 4 weeks." | 7.67 | Electrophysiologic predictors of long-term clinical outcome with amiodarone for refractory ventricular tachycardia secondary to coronary artery disease. ( Alpert, JS; Bishop, RL; Gold, RL; Haffajee, CI; Yazaki, Y, 1987) |
| "The value of serial electropharmacologic testing during long-term oral amiodarone therapy for prediction of long-term drug efficacy as well as characteristics of arrhythmia recurrence is controversial." | 7.67 | Predictors of efficacy of amiodarone and characteristics of recurrence of arrhythmia in patients with sustained ventricular tachycardia and coronary artery disease. ( DiMarco, JP; Haines, DE; Lerman, BB; Zhu, J, 1987) |
| "Oral amiodarone was administered to 30 children (aged one week to 14 years) for treatment of resistant or life threatening tachycardias." | 7.67 | Intravenous and oral amiodarone for arrhythmias in children. ( Bucknall, CA; Curry, PV; Holt, DW; Keeton, BR; Sutherland, GR; Tynan, MJ, 1986) |
| "We recently reported a retrospective experience with serial Holter monitoring as a guide to therapy in patients with sustained ventricular tachycardia treated with amiodarone." | 7.67 | The use of ambulatory monitoring in the prognostic evaluation of patients with sustained ventricular tachycardia treated with amiodarone. ( Griffith, LS; Guarnieri, T; Platia, EV; Reid, PR; Veltri, EP, 1986) |
| "We describe the appearance of long QT interval and polymorphous ventricular tachycardia in a patient treated with amiodarone who presented with hypokalemia secondary to chronic diuretic therapy." | 7.67 | Amiodarone and hypokalemia. A dangerous combination. ( Corres Peiretti, MA; Moro, C; Romero, J, 1986) |
| "The value of two reported and two new ambulatory electrocardiographic (Holter) criteria was studied in 80 patients taking amiodarone for refractory recurrent sustained ventricular tachycardia." | 7.67 | Value of Holter monitoring in predicting long-term efficacy and inefficacy of amiodarone used alone and in combination with class 1A antiarrhythmic agents in patients with ventricular tachycardia. ( Felder, SD; Figura, I; Fisher, JD; Johnston, DR; Kim, SG; Waspe, LE, 1987) |
| "Several studies have reported upon the inducibility of ventricular tachycardia (VT) with programmed ventricular stimulation (PVS) during chronic amiodarone therapy; however, few studies have systematically described and compared the morphology, duration, and cycle length of VT induced by PVS before and after amiodarone." | 7.67 | Effects of chronic amiodarone therapy on ventricular tachycardia induced by programmed ventricular stimulation. ( Annesley, T; Baerman, JM; de Buitleir, M; DiCarlo, LA; Morady, F; Schurig, L, 1987) |
| "We examined the value of clinical variables, chronic 24-hour ambulatory ECG monitoring, and chronic electrophysiologic (EP) testing in 49 patients with recurrent and refractory sustained ventricular tachycardia (VT) and ventricular fibrillation (VF) treated with chronic oral amiodarone in order to develop a prospective approach to the management of these patients." | 7.67 | Management of refractory sustained ventricular tachycardia with amiodarone: a reappraisal. ( Lavery, D; Saksena, S, 1987) |
| "The values of two Holter ambulatory electrocardiographic monitoring criteria and one programmed stimulation efficacy criterion reported to be predictive of the efficacy of amiodarone were compared in 70 patients taking amiodarone for sustained ventricular tachyarrhythmias." | 7.67 | Comparison of programmed stimulation and Holter monitoring for predicting long-term efficacy and inefficacy of amiodarone used alone or in combination with a class 1A antiarrhythmic agent in patients with ventricular tachyarrhythmia. ( Felder, SD; Figura, I; Fisher, JD; Johnston, DR; Kim, SG; Waspe, LE, 1987) |
| "During treatment with amiodarone, digoxin and nadolol, asystole occurred repeatedly in a patient with chronic persistent automatic atrial tachycardia." | 7.67 | Asystole during treatment with amiodarone in a patient with persistent atrial tachycardia. ( Kuo, CS; Paciotti, MV; Reddy, CP, 1985) |
| "Forty-two patients with refractory, recurrent life-threatening ventricular tachycardia and spontaneous ventricular tachycardia (greater than or equal to 3 beats, heart rate greater than 100 beats/min) on baseline 24 hour Holter recording were treated with amiodarone." | 7.67 | Amiodarone in the treatment of life-threatening ventricular tachycardia: role of Holter monitoring in predicting long-term clinical efficacy. ( Griffith, LS; Platia, EV; Reid, PR; Veltri, EP, 1985) |
| "Ventricular tachycardia induced by programmed electrical stimulation during amiodarone therapy often does not preclude a good clinical response." | 7.67 | Amiodarone: risk factors for recurrence of symptomatic ventricular tachycardia identified at electrophysiologic study. ( Duncan, G; Fineberg, NS; Heger, JJ; Naccarelli, GV; Prystowsky, EN; Zipes, DP, 1985) |
| "The effects of isoproterenol on induction of circus movement tachycardia were studied in 21 patients with an accessory atrioventricular pathway." | 7.67 | Effects of isoproterenol and amiodarone and the role of exercise in initiation of circus movement tachycardia in the accessory atrioventricular pathway. ( Brugada, P; Facchini, M; Wellens, HJ, 1986) |
| "Over a 10-year period 130 patients with drug-resistant cardiac arrhythmias associated mainly with coronary artery disease and its complications were treated with amiodarone." | 7.67 | Amiodarone for refractory cardiac arrhythmias: 10-year study. ( Eydt, JN; Leak, D, 1986) |
| "The prognostic implications of changes in ventricular ectopic activity on serial 24 hour ambulatory electrocardiographic (Holter) recordings were prospectively evaluated in 107 patients with a history of sustained ventricular tachyarrhythmias treated with amiodarone for at least 30 days." | 7.67 | Utility of ambulatory electrocardiographic monitoring for predicting recurrence of sustained ventricular tachyarrhythmias in patients receiving amiodarone. ( Brady, PM; Greenspan, AM; Horowitz, LN; Kay, HR; Rae, AP; Sokoloff, NM; Spielman, SR, 1986) |
| "The prognostic importance of electrophysiologic studies in patients with sustained ventricular tachyarrhythmias treated with amiodarone was prospectively studied in 100 consecutive patients." | 7.67 | Usefulness of electrophysiologic testing in evaluation of amiodarone therapy for sustained ventricular tachyarrhythmias associated with coronary heart disease. ( Greenspan, AM; Horowitz, LN; Kay, HR; Morganroth, J; Rae, AP; Rotmensch, H; Segal, BL; Sokoloff, NM; Spielman, SR; Webb, CR, 1985) |
| "Multivariate analysis of 11 clinical variables was performed in 104 patients with sustained, symptomatic ventricular tachycardia (VT) or ventricular fibrillation treated with amiodarone to determine variables predictive of subsequent cardiac arrest or sudden death." | 7.67 | Cardiac arrest and sudden death in patients treated with amiodarone for sustained ventricular tachycardia or ventricular fibrillation: risk stratification based on clinical variables. ( Davis, JC; DiCarlo, LA; Evans-Bell, T; Malone, P; Morady, F; Sauve, MJ; Scheinman, MM; Winston, SA, 1985) |
| "Thirteen patients with refractory, recurrent, life-threatening ventricular tachycardia (VT) underwent electrophysiologic testing before and after long-term amiodarone therapy." | 7.67 | Results of late programmed electrical stimulation and long-term electrophysiologic effects of amiodarone therapy in patients with refractory ventricular tachycardia. ( Griffith, LS; Platia, EV; Reid, PR; Veltri, EP, 1985) |
| "In 65 patients a single oral dose of amiodarone (30 mg/kg) produced an antiarrhythmic effect on supraventricular or ventricular arrhythmias within 3 to 8 hours and lasted for 17 to 19 hours." | 7.67 | Suppression of arrhythmias within hours after a single oral dose of amiodarone and relation to plasma and myocardial concentrations. ( Cheymol, G; Coumel, P; Escoubet, B; Jaillon, P; Lagier, G; Leclercq, JF; Maison-Blanche, P; Menasche, P; Piwnica, A; Poirier, JM, 1985) |
| "A dose-dependent cutaneous leukocytoclastic vasculitis developed in a 34 year old man who was given amiodarone for supraventricular tachycardias resistant to other drugs." | 7.67 | Amiodarone-induced vasculitis and polyserositis. ( Bircher, J; Stäubli, M; Zimmermann, A, 1985) |
| "A patient with sinuatrial disease and implanted pacemaker was treated with amiodarone (maximum dose 1000 mg, maintenance dose 800 mg daily) for 10 months, for control of supraventricular tachyarrhythmias." | 7.67 | Pneumonitis with pleural and pericardial effusion and neuropathy during amiodarone therapy. ( Clarke, B; Honey, M; Ward, DE, 1985) |
| "Recently a unique clinical entity has been suggested in subjects without apparent heart disease presenting with recurrent ventricular tachycardia (VT) characterized by RBBB + LAH electrocardiographic pattern, relatively slow rate, induction by atrial stimulation, and interruption by verapamil." | 7.67 | [Idiopathic ventricular tachycardia responsive to verapamil. Presentation of 3 cases and review of the literature]. ( Bonso, A; D'Este, D; Delise, P; Di Pede, F; Piccolo, E; Raviele, A, 1985) |
| "We report two patients who developed symptomatic life-threatening ventricular tachyarrhythmias with changing QRS axes (resembling torsades de pointes), during treatment of their supraventricular tachycardias with oral amiodarone." | 7.67 | Life-threatening ventricular arrhythmias provoked by amiodarone treatment. ( Eydt, J; Kumana, CR; Tanser, P, 1985) |
| "The clinical significance of sustained nonclinical ventricular tachycardia (VT) induced during electrophysiologic studies was studied in 10 amiodarone-treated patients." | 7.67 | Clinical significance of nonclinical ventricular tachycardia induced in amiodarone-treated patients. ( Belhassen, B; Keren, G; Laniado, S; Shapira, I, 1985) |
| "In 23 patients with symptomatic severe supraventricular and ventricular tachyarrhythmias the effectiveness and the side effects of a long-term therapy with the class III antiarrhythmic drug Amiodarone (Cordarone) in a dosage of 100-800 mg/die in monotherapy and combination therapy were investigated." | 7.67 | [Long-term therapy with amiodarone in tachyarrhythmias--report on various experiences with special reference to its side effects]. ( Assmann, I, 1985) |
| "The effect of amiodarone on survival was assessed in patients with hypertrophic cardiomyopathy and ventricular tachycardia in a drug trial with historical controls." | 7.67 | Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. ( Goodwin, JF; Krikler, DM; McKenna, WJ; Oakley, CM, 1985) |
| "The role that the new antiarrhythmic agents, such as verapamil and amiodarone, might play in the therapeutic strategy of tachycardia-induced fetal heart failure remains to be determined." | 7.67 | Transplacental treatment of tachycardia-induced fetal heart failure with verapamil and amiodarone: a case report. ( Duperron, L; Gauthier, R; Grignon, A; LeLorier, J; Lemay, M; Rey, E, 1985) |
| "Intravenous amiodarone has a clear anti-arrhythmic effect on induced sustained ventricular tachycardia (VT) in pigs with subacute myocardial infarction." | 7.67 | [Effect of amiodarone on stimulatory convertibility and degeneration into ventricular fibrillation of induced ventricular tachycardias in the pig]. ( Gertsch, M; Hottinger, S; Leupi, F; Mettler, D, 1985) |
| "Fifty-eight patients with symptomatic ventricular tachycardia (VT) or ventricular fibrillation (VF) were treated with amiodarone." | 7.66 | Amiodarone in the management of patients with ventricular tachycardia and ventricular fibrillation. ( Hess, DS; Morady, F; Scheinman, MM, 1983) |
| "Amiodarone was used in 40 patients with life-threatening or refractory tachyarrhythmias." | 7.66 | Amiodarone therapy for life threatening or refractory cardiac arrhythmias. ( Anderson, ST; Currie, PJ; Federman, J; Harper, RW; Johns, JA; Pitt, A, 1983) |
| "The antiarrhythmic effects of amiodarone hydrochloride 200 to 600 mg/daily were studied in 25 patients with ventricular tachycardia (VT)." | 7.66 | Long term-treatment of ventricular tachycardia in ambulatory patients with amiodarone. ( Buceta, JE; Dreyer, MP; Milei, J; Piñeiro, DJ; Vazquez Blanco, M, 1983) |
| "Amiodarone was administered to 154 patients who had sustained, symptomatic ventricular tachycardia (VT) (n = 118) or a cardiac arrest (n = 36) and who were refractory to conventional antiarrhythmic drugs." | 7.66 | Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation. ( Bhandari, A; Keung, E; Malone, P; Morady, F; Sauve, MJ; Scheinman, MM; Schwartz, AB; Shen, EN; Sung, RJ, 1983) |
| "Oral amiodarone was administered to ten children aged 3 months to 15 years who had recurrent SVT associated with the Wolff-Parkinson-White syndrome." | 7.66 | Amiodarone in control of sustained tachyarrhythmias in children with Wolff-Parkinson-White syndrome. ( Barzilay, Z; Feigl, A; Frand, M; Shahar, E, 1983) |
| "Twenty-three patients with sustained, recurrent, symptomatic ventricular tachycardia were treated with oral amiodarone." | 7.66 | Long-term management of sustained, recurrent, symptomatic ventricular tachycardia with amiodarone. ( Girotti, LA; Kaski, JC; Messuti, H; Rosenbaum, MB; Rutitzky, B, 1981) |
| "Ninety-six patients with life-threatening ventricular arrhythmias refractory to two or more conventional agents were treated with amiodarone and followed for 6 to 40 months (mean, 15 months)." | 7.66 | Amiodarone in refractory life-threatening ventricular arrhythmias. ( Cannom, DS; Feld, G; Hendrickson, J; Intarachot, V; Lopez, B; Nademanee, K; Singh, BN; Weiss, JL, 1983) |
| "Five cases of amiodarone-induced polymorphous ventricular tachycardia (torsade de pointes) are presented." | 7.66 | Amiodarone-induced polymorphous ventricular tachycardia. ( Agmon, J; Arditti, A; Kracoff, O; Lewin, RF; Sclarovsky, S; Strasberg, B, 1983) |
| "Ninety-six patients with recurrent, drug-refractory tachyarrhythmias were treated with amiodarone for 8." | 7.66 | Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias. ( Anderson, KP; Fogoros, RN; Mason, JW; Swerdlow, CD; Winkle, RA, 1983) |
| "A patient with sustained ventricular tachycardia was operated on after an unsuccessful trial of amiodarone." | 7.66 | Should oral amiodarone be used for sustained ventricular tachycardia in patients requiring open-heart surgery? ( Landymore, R; MacKinnon, G; Marble, A, 1983) |
| "Amiodarone was used in 30 patients with tachyarrhythmias refractory to treatment with several antiarrhythmic agents." | 7.66 | Amiodarone in long term management of refractory cardiac tachyarrhythmias. ( Lowe, JB; Lubbe, WF; Mercer, CJ; Roche, AH, 1981) |
| "A 44-year-old woman is described in whom amiodarone, disopyramide, and quinidine, administered alone separately, induced atypical ventricular tachycardia (AVT, torsade de pointes)." | 7.66 | Atypical ventricular tachycardia (torsade de pointes) induced by amiodarone: arrhythmia previously induced by quinidine and disopyramide. ( Benhorin, J; Gottlieb, S; Keren, A; Stern, S; Tzivoni, D, 1982) |
| "Six patients treated with a combination of amiodarone and class I antiarrhythmic agents for a minor arrhythmia developed atypical ventricular tachycardia "en torsades de pointe"." | 7.66 | [Harmful interactions of amiodarone and class I anti-arrhythmia agents]. ( Kappenberger, L; Steinbrunn, W; Tartini, R, 1982) |
| "Amiodarone was utilized in 70 patients with symptomatic, sustained refractory tachyarrhythmias." | 7.66 | Amiodarone therapy in symptomatic, sustained refractory atrial and ventricular tachyarrhythmias. ( Lown, B; Podrid, PJ, 1981) |
| "Amiodarone, 600 mg orally daily, was used in an attempt to control supraventricular tachyarrhythmias in a patient with the sick sinus syndrome." | 7.66 | Amiodarone-induced ventricular fibrillation. ( Adgey, AA; Geddes, JS; Khan, MM; Logan, KR; McComb, JM, 1980) |
| "A combined mexiletine and amiodarone treatment was applied in nine cases with recurrent refractory ventricular tachycardia." | 7.66 | Combined mexiletine and amiodarone treatment of refractory recurrent ventricular tachycardia. ( Demoulin, JC; Kulbertus, HE; Legrand, V; Mary-Rabine, L; Waleffe, A, 1980) |
| "Amiodarone hydrochloride was used to treat 19 patients with symptomatic arrhythmias refractory to quinidine sulfate, procainamide hydrochloride, disopyramide phosphate, antazoline hydrochloride, lidocaine hydrochloride, bretylium tosylate, propranolol hydrochloride, phenytoin sodium, and practotol acetanilide given to the limit of tolerance." | 7.66 | Control of refractory cardiac arrhythmias with amiodarone. ( Eydt, JN; Leak, D, 1979) |
| "Five patients with the bradycardia-tachycardia syndrome have been treated successfully with the antiarrhythmic agent amiodarone." | 7.66 | Use of amiodarone in bradycardia-tachycardia syndrome. ( Brown, AK; Newton, P; Primhak, RA, 1978) |
| "The effect of amiodarone in the Wolff-Parkinson-White syndrome was studied with programmed electrical stimulation of the heart in 15 patients." | 7.65 | Effect of amiodarone in the Wolff-Parkinson-White syndrome. ( Bär, FW; Dohmen, HJ; Düren, DR; Durrer, D; Lie, KI; Wellens, HJ; Wesdorp, JC, 1976) |
| "A double-blind, randomized, multicenter, dose-response study of the safety and efficacy of IV amiodarone was conducted in 61 children (30 days to 14." | 6.71 | Intravenous amiodarone for incessant tachyarrhythmias in children: a randomized, double-blind, antiarrhythmic drug trial. ( Acevedo, V; Brown, S; Burriss, SW; Cargo, P; Etheridge, SP; Graepel, J; Koskelo, EK; Marantz, P; Perry, JC; Saul, JP; Scott, WA; Triedman, JK; Wang, R, 2005) |
| "Patients who had cardiac arrest with ventricular fibrillation (or pulseless ventricular tachycardia) and who had not been resuscitated after receiving three or more precordial shocks were randomly assigned to receive 300 mg of intravenous amiodarone (246 patients) or placebo (258 patients)." | 6.69 | Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. ( Cobb, LA; Copass, MK; Cummins, RO; Doherty, AM; Fahrenbruch, CE; Hallstrom, AP; Kudenchuk, PJ; Murray, WA; Olsufka, M; Walsh, T, 1999) |
| "Amiodarone is an iodine-rich drug used to treat cardiac dysrhythmias." | 6.42 | Amiodarone-induced neonatal hypothyroidism: a unique form of transient early-onset hypothyroidism. ( Backeljauw, PF; Jackson, WA; Lomenick, JP, 2004) |
| " It has an apparent elimination half-life of 15-45 days, which presents unique dosing problems." | 6.36 | Amiodarone for tachyarrhythmias: pharmacology, kinetics, and efficacy. ( Asdourian, GK; Canada, AT; Haffajee, CI; Johnson, B; Lesko, LJ, 1983) |
| "Amiodarone dose was associated to HR decrease but not to MAP or plasma lactate increase." | 5.46 | Effectiveness of heart rate control on hemodynamics in critically ill patients with atrial tachyarrhythmias managed by amiodarone. ( Aissaoui, N; Dureau, P; El-Aissaoui, M; Faisy, C; Funck-Brentano, C; Hulot, JS; Salem, JE; Urien, S, 2017) |
| "Congestive heart failure was diagnosed in 6 patients (ejection fraction < 25%) and hypertensive heart failure in 3 patients (ejection infarction > 55%)." | 5.31 | [Control of tachycardia with intravenous amiodarone in acute left heart failure]. ( Arabadzisz, H; Beck, K; Marosi, A; Tomcsányi, J; Zsoldos, A, 2001) |
| "To date, there have been three cases of pulmonary fibrosis in patients receiving mexiletine spontaneously reported to the manufacturer." | 5.28 | Possible association of pulmonary fibrosis with mexiletine. ( Bero, CJ; Rihn, TL, 1991) |
| " The Authors evaluated the prophylactic efficacy of the chronic administration of amiodarone (A) on this arrhythmia and simultaneously the trend of ventricular extrasystole during the antiarrhythmic treatment." | 5.28 | [Amiodarone prophylaxis of ventricular tachycardia in ischemic cardiopathy]. ( Bernasconi, M; Cirino, D; Marzegalli, M; Pogna, M; Potenza, S, 1989) |
| " In 1, with recurrence of MAT, the same intravenous dosage was repeated for 2 consecutive days, with final achievement of stable sinus rhythm." | 5.28 | The effective treatment of multifocal atrial tachycardia with amiodarone. ( Chronopoulos, G; Cokkinos, DV; Halal, G; Ioannou, N; Kouvaras, G, 1989) |
| "Amiodarone was discontinued because of side effects in 14%, 26% and 37% of patients after 1, 3 and 5 years, respectively." | 5.28 | Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation. ( Goldberg, H; Griffin, JC; Helmy, I; Herre, JM; Langberg, JJ; Malone, P; Sauve, MJ; Scheinman, MM, 1989) |
| "Propafenone was less effective (mean effect 3." | 5.27 | European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias. ( Assayag, P; Coumel, P; Leclercq, JF, 1984) |
| "TWelve patients had overt congestive heart failure." | 5.27 | Intravenous amiodarone in the acute treatment of recurrent symptomatic ventricular tachycardia. ( DiCarlo, L; Morady, F; Scheinman, MM; Shapiro, W; Shen, E; Sung, RJ, 1983) |
| "Thus, the safety of amiodarone in the WPW syndrome should be established by electrophysiologic studies and induction of AF, because amiodarone is not protective in all patients with WPW." | 5.27 | Efficacy of amiodarone in the Wolff-Parkinson-White syndrome with rapid ventricular response via accessory pathway during atrial fibrillation. ( Fromer, MA; Kappenberger, LJ; Shenasa, M; Steinbrunn, W, 1984) |
| "Amiodarone is a potent new antiarrhythmic drug that has multiple effects on thyroid function, including inhibition of extrathyroidal triiodothyronine production and rarely, iodine-induced hypothyroidism." | 5.27 | Myxedema coma during long-term amiodarone therapy. ( Cantley, LK; Dalldorf, FG; Foster, JR; Mazonson, PD; Utiger, RD; Williams, ML, 1984) |
| "Amiodarone is a new and powerful antiarrhythmic agent currently under investigation in North America." | 5.27 | Acute necrotizing pneumonitis and hyperglycemia after amiodarone therapy. Case report and review of amiodarone-associated pulmonary disease. ( Pollak, PT; Sami, M, 1984) |
| "The atrial tachyarrhythmias were successfully controlled in 45 of 54 patients (83%) during a mean follow-up of 10." | 5.27 | Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias. ( Alpert, JS; Asdourian, G; Canada, AT; Haffajee, CI; Lesko, LJ; Love, JC, 1983) |
| "Amiodarone was used in the treatment of 21 patients with supraventricular or ventricular arrhythmias which were refractory to conventional antiarrhythmic drugs, individually or in combination." | 5.27 | Amiodarone: an effective alternative for recalcitrant supraventricular and ventricular tachycardias. ( Best, JF; Dunn, M; Lynch, L; Rinkenberger, R, 1986) |
| "9 antiarrhythmic drugs, used alone or in combination, were managed by low doses of beta-blocker agents combined with oral amiodarone (Am), either after loading (1." | 5.27 | Efficacy and safety of low doses of beta-blocker agents combined with amiodarone in refractory ventricular tachycardia. ( Fontaine, G; Frank, R; Grosgogeat, Y; Tonet, J, 1988) |
| "Amiodarone was administered orally at a dose of 500 mg/m2/24 hrs for 5 to 15 days, and then 250 mg/m2/24 hrs for one month in the surgical patient and for 9 to 39 months in the four "idiopathic" cases." | 5.26 | [Treatment of ventricular tachycardia in infancy and childhood with amiodarone]. ( Batisse, A; Fermont, L; Kachaner, J; Sardet, A, 1982) |
| "Oral amiodarone was given to 135 children (mean age, 10." | 5.26 | Amiodarone in the treatment of cardiac arrhythmias in children: one hundred thirty-five cases. ( Coumel, P; Fidelle, J, 1980) |
| "Short-term oral amiodarone treatment following ablation for paroxysmal or persistent AF did not significantly reduce recurrence of atrial tachyarrhythmias at the 6-month follow-up, but it more than halved atrial arrhythmia related hospitalization and cardioversion rates during the blanking period." | 5.19 | Recurrence of arrhythmia following short-term oral AMIOdarone after CATheter ablation for atrial fibrillation: a double-blind, randomized, placebo-controlled study (AMIO-CAT trial). ( Chen, X; Darkner, S; Hansen, J; Johannessen, A; Nielsen, JB; Pehrson, S; Svendsen, JH, 2014) |
| "Amiodarone hydrochloride, which is used in life-threatening cardiac tachyarrhythmia, has been known to cause amiodarone induced pulmonary toxicity (AIPT) as a complication." | 5.10 | Technetium-99m-DTPA aerosol scintigraphy in amiodarone induced pulmonary toxicity in comparison with Ga-67 scintigraphy. ( Atasever, A; Bacakoglu, F; Burak, Z; Dirlik, A; Erinc, R; Nalbantgil, S; Ozcan, Z; Ozhan, M, 2002) |
| " amiodarone in the therapy of atrial tachyarrhythmias in critically ill patients." | 5.08 | Parenteral magnesium sulfate versus amiodarone in the therapy of atrial tachyarrhythmias: a prospective, randomized study. ( Cunningham, DN; Gallagher, J; Leppard, P; Moran, JL; Peake, SL; Salagaras, M, 1995) |
| "The incidence of clinically significant tachycardia was reduced by amiodarone." | 5.07 | Amiodarone prophylaxis for tachycardias after coronary artery surgery: a randomised, double blind, placebo controlled trial. ( Butler, J; Harriss, DR; Sinclair, M; Westaby, S, 1993) |
| "The Canadian Amiodarone Myocardial Infarction Trial (CAMIAT) is a multicenter, triple-blind, randomized, placebo-controlled trial." | 5.07 | Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT): rationale and protocol. CAMIAT Investigators. ( Cairns, JA; Connolly, SJ; Gent, M; Roberts, R, 1993) |
| "The efficacy and the safety of amiodarone therapy in 82 patients with recurrent tachyarrhythmias, refractory to conventional antiarrhythmics, were evaluated by a multicenter trial." | 5.07 | Efficacy and safety of amiodarone in treatment of refractory atrial and ventricular tachyarrhythmias. ( Kato, K, 1992) |
| "The effects of two regimens for the initiation of amiodarone therapy were compared in 92 patients with inducible sustained ventricular tachycardia (VT) at baseline electrophysiologic testing." | 5.07 | A comparison of standard and high-dose regimens for the initiation of amiodarone therapy. ( Kadish, A; Morady, F; Summitt, J, 1992) |
| "Amiodarone is very effective in suppressing refractory nonsustained ventricular tachycardia." | 5.07 | The efficacy of amiodarone in the treatment of refractory nonsustained ventricular tachycardia. ( Ballas, SL; Veltri, EP, 1991) |
| "The effects of long-term amiodarone therapy on the defibrillation thresholds and the rate of shocks were evaluated in 62 patients who had implantation of an automatic cardioverter-defibrillator (n = 53) or prophylactic implantation of patch electrodes (n = 9) who were survivors of sudden cardiac death (n = 34) or had refractory rapid ventricular tachycardia (n = 28)." | 5.07 | Effects of long-term amiodarone therapy on the defibrillation threshold and the rate of shocks of the implantable cardioverter-defibrillator. ( Chenarides, JG; Huang, SK; Okike, NO; Tan de Guzman, WL; Vander Salm, TJ, 1991) |
| "To assess the most appropriate method of administering amiodarone and predicting its efficacy (empiric vs guided by Holter or by ventricular stimulation), 19 patients with sustained ventricular tachycardia or ventricular fibrillation underwent a "parallel study"." | 5.07 | [Treatment of malignant ventricular tachyarrhythmia with amiodarone: comparison of empirical administration and administration guided by Holter or ventricular stimulation. Results of the parallel test]. ( Bonso, A; D'Este, D; Delise, P; Di Pede, F; Gasparini, G; Piccolo, E; Raviele, A; Zanocco, A, 1991) |
| "To examine the presence and time course of beta-adrenergic antagonism produced by amiodarone, the heart rate, QT interval and arrhythmia frequency in response to graded doses of isoproterenol were evaluated in eight patients treated with oral amiodarone for sustained ventricular tachycardia." | 5.06 | Magnitude and time course of beta-adrenergic antagonism during oral amiodarone therapy. ( Chen, RF; Kadish, AH; Morady, F; Schmaltz, S, 1990) |
| "High-dose intravenous amiodarone was given to 35 patients with recurrent life-threatening ventricular tachycardia (VT) refractory to conventional antiarrhythmic agents." | 5.06 | Efficacy and tolerance of high-dose intravenous amiodarone for recurrent, refractory ventricular tachycardia. ( Esterbrooks, DJ; Hee, TT; Hilleman, DE; Mohiuddin, SM; Mooss, AN; Rovang, KS; Sketch, MH, 1990) |
| "In a randomised cross-over study, six patients with recurrent sustained ventricular tachycardia (VT) were treated with 3 regimens--amiodarone, amiodarone plus metoprolol, and amiodarone plus xamoterol." | 5.06 | Adjuvant xamoterol or metoprolol in patients with malignant ventricular arrhythmia resistant to amiodarone. ( Camm, AJ; Griffith, M; Paul, V; Ward, DE, 1989) |
| "The interaction between the efficacy and tolerance of amiodarone and the degree of left ventricular (LV) dysfunction was assessed in 126 patients with sustained ventricular tachyarrhythmias." | 5.06 | Development of congestive heart failure and alterations in left ventricular function in patients with sustained ventricular tachyarrhythmias treated with amiodarone. ( Brady, P; De Paola, AA; Greenspan, AM; Horowitz, LN; Kay, HR; Morganroth, J; Spielman, SR, 1987) |
| "Induction of rapid ventricular tachycardia or fibrillation during therapy with amiodarone is associated with an increased risk of sudden death." | 5.06 | Amiodarone versus amiodarone and a type IA agent for treatment of patients with rapid ventricular tachycardia. ( Buxton, AE; Flores, BT; Josephson, ME; Marchlinski, FE; Miller, JM; Vassallo, JA, 1986) |
| "We examined the chronic electrophysiologic, systemic, and pharmacologic effects of chronic oral amiodarone therapy in 24 patients with refractory ventricular tachycardia and organic heart disease." | 5.05 | Chronic effects of amiodarone in patients with refractory ventricular tachycardia. ( Cappello, G; Rothbart, ST; Saksena, S, 1983) |
| "Oral long-term treatment with various antiarrhythmic drugs (aprindine, mexiletine, disopyramide, amiodarone) was assessed in 82 patients with recurrent tachycardias demonstrated in the ECG using programmed ventricular stimulation." | 5.05 | [Long-term drug therapy in ventricular cardiac arrhythmias. Is an improvement of the prognosis possible?]. ( Lüderitz, B; Manz, M; Steinbeck, G, 1983) |
| "The role of provocation tests for the assessment of amiodarone therapy in patients with ventricular tachycardia remains a subject of controversy: recent studies seem to show that the ability to initiate VT in patients on amiodarone is compatible with a good long-term result." | 5.05 | [Value of provocation tests in the evaluation of the treatment of ventricular tachycardias with amiodarone]. ( Bounhoure, JP; Calazel, J; Cassagneau, B; Fauvel, JM; Marin, T; Massabuau, P; Narula, OS; Puel, J; Tournadre, P, 1984) |
| "Thirty-three patients with recurrent drug-refractory ventricular tachycardia were treated with oral amiodarone during an average period of 6." | 5.05 | Antiarrhythmic efficacy of amiodarone in recurrent ventricular tachycardia evaluated by multiple electrophysiological and ambulatory ECG recordings. ( Griffin, J; Mason, J; Peters, F; Rasmussen, K; Ross, D; Winkle, R, 1982) |
| "Amiodarone, administered orally in doses of 200 to 600 mg/day, was remarkably effective in the treatment and prevention of a wide variety of atrial and ventricular arrhythmias." | 5.04 | Clinical efficacy of amiodarone as an antiarrhythmic agent. ( Chiale, PA; Elizari, MV; Halpern, MS; Lázzari, JO; Levi, RJ; Nau, GJ; Przybylski, J; Rosenbaum, MB, 1976) |
| "Amiodarone, a benzofuranic iodine-rich pan-anti-arrhythmic drug, induces amiodarone-induced thyrotoxicosis (AIT) in 7-15% of patients." | 5.01 | Issues in amiodarone-induced thyrotoxicosis: Update and review of the literature. ( Batisse-Lignier, M; Benichou, T; Dallel, S; Desbiez, F; Maqdasy, S; Montanier, N; Roche, B; Tauveron, I, 2019) |
| "The objective of this review is to explore and challenge the superiority of amiodarone for rate control in Wolff-Parkinson-White syndrome and concomitant atrial fibrillation (WPW-AF)." | 4.86 | Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation. ( Langdorf, MI; Lotfipour, S; Simonian, SM; Wall, C, 2010) |
| "Decades after its registration, amiodarone is still regarded as the most effective antiarrhythmic drug available for the treatment of tachyarrhythmias." | 4.86 | [Current role of amiodarone in antiarrhythmic therapy]. ( Sohns, C; Zabel, M, 2010) |
| "A case of the use of amiodarone in pregnancy is reported and the literature on this subject reviewed." | 4.77 | Amiodarone in pregnancy. Case report and review of the literature. ( Foster, CJ; Love, HG, 1988) |
| "Amiodarone is a new antiarrhythmic drug approved for therapy of life-threatening ventricular tachycardia and ventricular fibrillation refractory to previous antiarrhythmic therapy." | 4.77 | Practical follow-up guidelines for patients treated with amiodarone. ( Podrid, PJ, 1987) |
| "Atypical manifestations of pulmonary toxicity and previously unreported autonomic nervous system dysfunction complicating amiodarone therapy were observed in a patient being treated for sustained ventricular tachycardia." | 4.77 | Atypical pulmonary and neurologic complications of amiodarone in the same patient. Report of a case and review of the literature. ( Estes, NA; Mack, KD; Manolis, AS; Tordjman, T, 1987) |
| "Amiodarone, an investigational drug in the United States, has had considerable use in this country and worldwide in the treatment of cardiac arrhythmias." | 4.76 | Clinical use and pharmacology of amiodarone. ( Heger, JJ; Miles, WM; Prystowsky, EN; Zipes, DP, 1984) |
| "Amiodarone may be considered for patients with junctional ectopic tachycardia refractory to treatment with sedation, analgesia, cooling, and electrolyte replacements." | 4.31 | Hemodynamic profile effects of PM101 amiodarone formulation in patients with post-operative tachyarrhythmias. ( Besunder, J; Breedlove, K; Brown, M; Clark, J; DeCoy, M; Gothard, D; Nofziger, R; Page-Goertz, C; Raimer, P; Ruggles, C; Stewart, R, 2023) |
| "Providing IV and PO overlap of amiodarone for a median of 4 hours did not decrease the rate of early tachyarrhythmia recurrence." | 3.91 | Clinical effects of intravenous to oral amiodarone transition strategies in critically ill adult patients. ( Aberle, C; Altshuler, D; Arnouk, S; Merchan, C; Papadopoulos, J; Piper, GL, 2019) |
| "Amiodarone is the gold-standard medication to control heart rate in critically ill patients with atrial tachyarrhythmias (ATs); however, effective doses and covariates influencing its efficacy remain unknown." | 3.83 | Modeling of Amiodarone Effect on Heart Rate Control in Critically Ill Patients with Atrial Tachyarrhythmias. ( Aissaoui, N; Alazard, M; El-Aissaoui, M; Faisy, C; Funck-Brentano, C; Hulot, JS; Le-Heuzey, JY; Salem, JE; Urien, S, 2016) |
| "Tachyarrhythmia produced by isoprenaline (15 μmol/L) could be reversed by sophocarpine (300 μmol/L)." | 3.77 | Electrophysiological mechanisms of sophocarpine as a potential antiarrhythmic agent. ( Chen, YM; Li, CZ; Liu, YM; Wang, HW; Wang, W; Yang, ZF; Zhang, Y, 2011) |
| "In a 10-year prospective observational study, 71 of 2651 patients (2885 procedures, 2106 bypass procedures) received amiodarone for newly detected postoperative atrial (n = 70) or ventricular (n = 7) tachyarrhythmia: early treatment (initiation within 60 minutes of arrhythmia detection) and late treatment (after that)." | 3.74 | Impact of early and standardized treatment with amiodarone on therapeutic success and outcome in pediatric patients with postoperative tachyarrhythmia. ( Camphausen, CK; Haas, NA, 2008) |
| "Special attention should be paid to patients on treatment with amiodarone and/or a diagnosis of atrial fibrillation as they may have an increased risk of fracture." | 3.74 | Fracture risk in patients treated with amiodarone or digoxin for cardiac arrhythmias: a nation-wide case-control study. ( Mosekilde, L; Rejnmark, L; Vestergaard, P, 2007) |
| "Amiodarone, a class III antiarrhythmic drug, is one of the most effective drugs used in the treatment of ventricular and paroxysmal supraventricular tachyarrhythmia." | 3.74 | Acute pancreatitis and amiodarone: a case report. ( Chen, CY; Chen, YY; Leung, KK, 2007) |
| "Amiodarone-induced thyrotoxicosis (AIT) with features consistent with both AIT type I (in which thyroid antibodies and nodular goiter are present) and AIT type II (which is not responsive to thionamide therapy and eventually leads to permanent hypothyroidism)." | 3.74 | Treatment of amiodarone-associated thyrotoxicosis. ( Franklyn, JA; Gammage, MD, 2007) |
| "Although amiodarone significantly increases survival to hospital admission when used in resuscitation of out-of-hospital pulseless ventricular tachycardia and fibrillation, there are limited data on its utility for in-hospital arrests." | 3.73 | The use of amiodarone for in-hospital cardiac arrest at two tertiary care centres. ( Al-Hazmi, A; Martin, J; Pollak, PT; Wee, V; Zarnke, KB, 2006) |
| "Although there are two types of amiodarone-induced thyrotoxicosis (AIT), only type II AIT has been seen at our institution in Japan so far." | 3.73 | Mild and short recurrence of type II amiodarone-induced thyrotoxicosis in three patients receiving amiodarone continuously for more than 10 years. ( Hagiwara, N; Kasanuki, H; Matsuda, N; Onoda, N; Sato, K; Shiga, T; Takano, K, 2006) |
| "Amiodarone may still be safely prescribed for Chinese patients who have baseline liver dysfunction." | 3.73 | Prevalence of amiodarone-related hepatotoxicity in 720 Chinese patients with or without baseline liver dysfunction. ( Chan, WW; Fung, JW; Ho, SS; Hui, HH; Kum, LC; Sanderson, JE; Wong, GW; Yu, CM, 2006) |
| " Amiodarone is recommended for treatment of wide complex tachycardia, but its hemodynamic effects in wide complex tachycardia induced by tricyclic antidepressant poisoning are unknown." | 3.73 | Effects of amiodarone in a swine model of nortriptyline [corrected] toxicity. ( Barrueto, F; Brewer, K; Meggs, W; Meltzer, A; Murr, I, 2006) |
| "The basis of the unique effectiveness of amiodarone for atrial fibrillation (AF) is poorly understood." | 3.72 | Effects of antiarrhythmic drugs on fibrillation in the remodeled atrium: insights into the mechanism of the superior efficacy of amiodarone. ( Nattel, S; Schram, G; Shinagawa, K; Shiroshita-Takeshita, A, 2003) |
| "Amiodarone is an effective anti-arrhythmic agent for the treatment of supraventricular and ventricular tachycardias." | 3.72 | Efficacy and safety of intravenous amiodarone for incessant tachycardias in infants. ( Bauersfeld, U; Burri, S; Hug, MI, 2003) |
| "Fetuses with incessant tachycardia and either hydrops fetalis (n=24) or ventricular dysfunction (n=2) for whom digoxin monotherapy and secondary antiarrhythmic agents (n=13) were not effective were treated transplacentally with a loading dose of oral amiodarone for 2 to 7 days, followed by daily maintenance therapy for <1 to 15 weeks." | 3.72 | Amiodarone therapy for drug-refractory fetal tachycardia. ( Cuneo, BF; Deal, BJ; Feinkind, L; Gotteiner, NL; Hussey, M; McGregor, SN; Meijboom, EJ; Michon, MM; Oudijk, MA; Parilla, BV; Strasburger, JF, 2004) |
| "Intravenous amiodarone is found to be an effective and safe antiarrhythmic agent for children with acute life-threatening and chronic tachyarrhythmias and depressed left ventricular systolic functions." | 3.70 | Effectiveness and safety of intravenous amiodarone in drug-resistant tachyarrhythmias of children. ( Celiker, A; Ceviz, N; Ozme, S, 1998) |
| "Two patients with amiodarone-induced thyrotoxicosis were treated successfully with potassium perchlorate and carbimazole while treatment with amiodarone was continued." | 3.69 | Two cases of amiodarone-induced thyrotoxicosis successfully treated with a short course of antithyroid drugs while amiodarone was continued. ( Düren, DR; Trip, MD; Wiersinga, WM, 1994) |
| " 1 and 2, atrial fibrillation was treated with either quinidine or quinidine and sotalol in combination." | 3.69 | Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports. ( Faber, TS; Hohnloser, S; Just, H; Van de Loo, A; Zehender, M, 1994) |
| "Intravenous amiodarone is an effective treatment for supraventricular and ventricular tachyarrhythmias." | 3.69 | Acute pulmonary toxicity in an infant from intravenous amiodarone. ( Daniels, CJ; Franklin, WH; Hammond, S; Schutte, DA, 1997) |
| "To compare the efficacy and safety of intravenous (IV) amiodarone and procainamide for the treatment of atrial tachyarrhythmias (AT) in the critically ill." | 3.68 | Management of atrial tachyarrhythmias in the critically ill: a comparison of intravenous procainamide and amiodarone. ( Chapman, MJ; Cunningham, DN; Moran, JL; O'Fathartaigh, MS; Peisach, AR, 1993) |
| "Intravenous amiodarone was administered in 1-mg/kg body weight aliquots followed by continuous infusion to patients with potentially life-threatening tachyarrhythmias that had not been abolished by standard therapies." | 3.68 | Intravenous amiodarone for life-threatening tachyarrhythmias in children and young adults. ( Denfield, SW; Fenrich, AL; Friedman, RA; Knilans, TK; Marlow, D; Perry, JC, 1993) |
| " In patients refractory to amiodarone alone or to a combination with mexiletine, the combined treatment with amiodarone and class-I-C drugs such as flecainide and encainide prolongs the cycle length of ventricular tachycardia, but does not suppress induction of ventricular tachycardia during programmed stimulation." | 3.68 | [Combination anti-arrhythmic drug therapy]. ( Jung, W; Lüderitz, B; Manz, M, 1992) |
| "A potentially fatal arrhythmia was encountered in a patient with a previous myocardial infarction, who was resistant to treatment with lidocaine, amiodarone and electric defibrillation." | 3.68 | Stabilization of cardiac rhythm in subsequently fatal ventricular tachycardia and fibrillation by calcitonin gene-related peptide. ( Liu, J; Liu, XZ; Zhang, JF, 1992) |
| "A 55-year-old patient with inferior wall infarction was treated effectively for ventricular tachycardia with high-dose oral amiodarone loading regimen (5 g within 16 hours)." | 3.68 | Antiadrenergic cardiovascular adverse effects of high-dose amiodarone loading regimen. ( Frey, B; Schmidinger, H; Steurer, G, 1992) |
| "In 15 patients with recurrent ventricular tachycardia, the hemodynamic effects of amiodarone were evaluated under oral loading (1000 mg/day for 14-16 days) and during chronic treatment (600 mg/day for a further 10 weeks)." | 3.68 | Hemodynamic effects of amiodarone during acute and chronic treatment in patients with recurrent sustained ventricular tachycardia. ( Jung, W; Lüderitz, B; Manz, M, 1992) |
| "105 sequential patients with ventricular arrhythmias in a basal ECG-H recording, that were evaluated within 1 year with a new recording on amiodarone or propafenone, without major clinical events or therapeutic changes between the two recordings." | 3.68 | [Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia]. ( Adragão, P; Bonhorst, D; Seabra-Gomes, R; Ventosa, A, 1990) |
| "A group of 34 consecutive patients with coronary artery disease (n = 29) or dilated cardiomyopathy (n = 5) (3 women, 31 men, age 38-80 yr) who had severely impaired left ventricular function (left ventricular ejection fraction less than or equal to 40%) and high-grade ventricular ectopic activity (sustained or nonsustained ventricular tachycardia or ventricular fibrillation) were treated with amiodarone (mean dose: 206 mg/d) and followed for 1-117 (mean: 49) months." | 3.68 | Long-term treatment of ventricular tachycardia with amiodarone in presence of severe left ventricular dysfunction. ( Burckhardt, D; Hoffmann, A; Pfisterer, M; Robertson, A, 1991) |
| "To clarify the risk-benefit ratio involved in association of antiarrhythmic drugs, a combined therapy of amiodarone and propafenone was tested by means of continuous electrocardiographic monitoring, analysis of levels of the drug in the plasma and programmed electrical stimulation in a selected group of 10 patients who had left ventricular dysfunction and spontaneous relapses of sustained ventricular tachycardia despite treatment with amiodarone." | 3.68 | The use of associated propafenone in patients with amiodarone-resistant ventricular tachycardia. ( Camerini, F; Chersevani, D; Dreas, L; Humar, F; Maras, P; Morgera, T, 1991) |
| "Antiarrhythmic and electrophysiological effects of three class I antiarrhythmic agents, one from each subclass A, B, and C, were assessed in single use and in combination with amiodarone in patients with inducible, sustained ventricular tachycardia that was not suppressed by monotherapy with these agents." | 3.68 | A prospective comparison of class IA, B, and C antiarrhythmic agents in combination with amiodarone in patients with inducible, sustained ventricular tachycardia. ( Kadish, A; Morady, F; Toivonen, L, 1991) |
| "Directed surgical intervention in patients with ventricular tachyarrhythmias who have experienced failure of amiodarone therapy is a common clinical scenario." | 3.68 | Amiodarone-related postoperative adult respiratory distress syndrome. ( Greenspon, AJ; Hurley, W; Kidwell, GA; Mannion, J, 1991) |
| "Intravenous amiodarone was administered to 22 patients with recurrent ventricular tachycardia failing an average of 3." | 3.68 | Intravenous amiodarone for short-term treatment of refractory ventricular tachycardia or fibrillation. ( DonMichael, TA; Ismail, Y; Nalos, PC; Nyitray, W; Pappas, JM, 1991) |
| " Recently, amiodarone has been shown to be rapidly effective in suppressing sustained, incessant ventricular tachycardia and ventricular fibrillation in this setting." | 3.68 | Amiodarone versus bretylium for suppression of reperfusion arrhythmias in dogs. ( Horrigan, TP; Mostow, ND; Noon, DL; Rosalion, A; Snow, NJ, 1991) |
| "The results of electrophysiologic testing after short-term and long-term treatment with amiodarone were compared in 71 patients with ventricular tachycardia." | 3.68 | Comparison of the results of electrophysiologic testing after short-term and long-term treatment with amiodarone in patients with ventricular tachycardia. ( Calkins, H; deBuitleir, M; Kadish, AH; Morady, F; Rosenheck, S; Schmaltz, S; Sousa, J, 1991) |
| "The long-term follow-up of 52 pts (36 M, 16 F, mean age: 62 years) with sustained ventricular tachyarrhythmias (SVT) was analyzed to assess the efficacy and feasibility of empiric amiodarone treatment." | 3.68 | [Empiric treatment with amiodarone in patients with sustained ventricular tachyarrhythmia. Results of a long-term follow-up]. ( Bonso, A; Caprioglio, F; D'Este, D; Delise, P; Di Pede, F; Gasparini, G; Piccolo, E; Raviele, A; Zanocco, A, 1990) |
| "A patient with sustained monomorphic ventricular tachycardia developed a second tachycardia of incessant character with alternating RR-interval and alternating QRS-complexes after treatment with amiodarone." | 3.68 | [Tachycardia with wide ventricular complexes and alternating QRS complexes and RR intervals]. ( Clément, DL; François, B; Jordaens, L, 1990) |
| "To shorten the delay in the onset of antiarrhythmic effect when using amiodarone for the conversion of refractory atrial tachyarrhythmias to sinus rhythm, 19 patients were given oral amiodarone according to a high-dose loading protocol." | 3.68 | Rapid control of refractory atrial tachyarrhythmias with high-dose oral amiodarone. ( Mostow, ND; Noon, D; Rakita, L; Vrobel, TR, 1990) |
| "To evaluate the efficacy and safety of long-term empiric amiodarone therapy in patients with recurrent Sustained Ventricular Tachycardia (SVT) and Chronic Chagasic Myocarditis (CCM)." | 3.68 | [Empiric therapy with amiodarone in patients with chronic Chagas cardiomyopathy and sustained ventricular tachycardia]. ( Bellotti, G; Lee, JH; Pileggi, F; Scanavacca, MI; Sosa, EA, 1990) |
| "Our experience with amiodarone therapy in 145 consecutively referred patients with medically refractory sustained ventricular tachycardia and/or fibrillation treated for at least 3 years was reviewed." | 3.68 | Benefit and risks of long-term amiodarone therapy for sustained ventricular tachycardia/fibrillation: minimum of three-year follow-up in 145 patients. ( Gang, ES; Mandel, WJ; Myers, M; Nalos, PC; Oseran, DS; Peter, T; Weiss, D, 1990) |
| "Amiodarone in a low dose (200 mg/day) was administered alone or in combination with other type I antiarrhythmic drugs as a first-line agent in 33 patients with ventricular tachycardia (VT) (n = 24) or ventricular fibrillation (VF) (n = 9) secondary to coronary artery disease with healed myocardial infarction." | 3.68 | Long-term follow-up of postmyocardial infarction patients with ventricular tachycardia or ventricular fibrillation treated with amiodarone. ( Kusniec, J; Mager, A; Sclarovsky, S; Strasberg, B; Zlotikamien, B, 1990) |
| "We undertook this study to determine if the cycle-length response of ventricular tachycardia (VT) to procainamide and amiodarone is similar in the individual patient." | 3.68 | Cycle-length response of ventricular tachycardia associated with coronary artery disease to procainamide and amiodarone. ( Buxton, AE; Josephson, ME; Marchlinski, FE; Vaitkus, PT, 1990) |
| "We report the case of a patient who developed a life-threatening polymorphous ventricular tachycardia ( PVT ) after six weeks of treatment with amiodarone." | 3.67 | Polymorphous ventricular tachycardia associated with a marked prolongation of the Q-T interval induced by amiodarone. ( Bhandari, AK; Quock, C; Sung, RJ, 1984) |
| "Using His bundle electrograms and programmed ventricular stimulation, the effects of chronic amiodarone treatment on induction, morphology, and the rate of ventricular tachycardia (VT) were studied in 17 consecutive patients treated with amiodarone for control of recurrent sustained VT or ventricular fibrillation." | 3.67 | Effect of amiodarone on electric induction, morphology, and rate of ventricular tachycardia and its relation to clinical efficacy. ( Jivrajka, V; Kuo, CS; Reddy, CP, 1984) |
| ") amiodarone infusion (10 to 20 mg/kg/day for 4 to 7 days) followed by chronic oral amiodarone therapy (400 to 800 mg/day for 24 to 53 days) were evaluated in 17 patients with refractory sustained ventricular tachycardia (VT) or ventricular fibrillation." | 3.67 | Clinical efficacy and electropharmacology of continuous intravenous amiodarone infusion and chronic oral amiodarone in refractory ventricular tachycardia. ( Cappello, G; Rothbart, ST; Saksena, S; Shah, Y, 1984) |
| "The relationship of apparent steady-state serum concentrations of amiodarone and its metabolite, desethylamiodarone, to therapeutic and toxic effects was assessed in 127 patients who had treatment-resistant ventricular or supraventricular arrhythmias or were intolerant to other agents." | 3.67 | Steady-state serum amiodarone concentrations: relationships with antiarrhythmic efficacy and toxicity. ( Belhassen, B; Greenspan, AM; Greenspon, AJ; Horowitz, LN; Rotmensch, HH; Shoshani, D; Spielman, SR; Swanson, BN; Vlasses, PH, 1984) |
| "In 12 patients (nine with Wolff-Parkinson-White syndrome and three with ventricular tachycardia) the electrophysiologic effects of intravenous (5 mg/kg body weight in 1 min) and oral (total dose 9800 to 11,200 mg) amiodarone were studied with programmed stimulation of the heart." | 3.67 | A comparison of the electrophysiologic effects of intravenous and oral amiodarone in the same patient. ( Abdollah, H; Brugada, P; Dassen, WR; Wellens, HJ, 1984) |
| " amiodarone in patients with reentrant supraventricular tachycardia (SVT) can predict the efficacy of long-term oral therapy with this drug." | 3.67 | Effects of amiodarone on supraventricular tachycardia involving bypass tracts. ( Alboni, P; Baggioni, F; Masoni, A; Pirani, R; Scarfo, S; Shantha, N; Tomasi, AM, 1984) |
| "Electrophysiologic studies were performed in nine patients with reentrant paroxysmal supraventricular tachycardia (PSVT) during a control period and following 5 mg/kg body weight of intravenous amiodarone (Cordarone, Labaz) administered as a slow continuous infusion over 15 to 20 minutes." | 3.67 | Electrophysiologic effects and mechanisms of termination of supraventricular tachycardia by intravenous amiodarone. ( El-Sherif, N; Gomes, JA; Hariman, RJ; Kang, PS; Lyons, J, 1984) |
| "We studied the effects of intravenous amiodarone administration (5 mg/kg) on reproducible repetitive ventricular responses and ventricular tachycardia (VT) induced by programmed electrical stimulation of the heart in 32 patients." | 3.67 | Effects of intravenous amiodarone in patients with inducible repetitive ventricular responses and ventricular tachycardia. ( El-Sherif, N; Gomes, JA; Hariman, RJ; Kang, PS, 1984) |
| "The determinants of long-term clinical outcome were studied in 42 patients with recurrent ventricular tachycardia (VT) or ventricular fibrillation (VF) who were treated with amiodarone as the sole antiarrhythmic agent." | 3.67 | Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone. ( DiMarco, JP; Garan, H; Grant, G; Malacoff, RF; McGovern, B; Ruskin, JN; Sellers, TD, 1984) |
| "Recurrent atypical ventricular tachycardia, with a long QT interval, was documented in a 56-year-old patient 16 days after discontinuing amiodarone 200 mg and 400 mg on alternate days." | 3.67 | Torsade de pointes after amiodarone withdrawal; effects of mild hypokalaemia on repolarization. ( Forfar, JC; Gribbin, B, 1984) |
| " Individual differences between the longest and the shortest RV MAP durations indicate that: normally (40 subjects) ventricular repolarization is almost synchronous; QT prolongation due either to bradycardia or to amiodarone treatment (eight cases) may be the result of a uniform lengthening of ventricular repolarization, when ventricular arrhythmias are not present; in long QT syndromes (LQTSs) of differing etiology (10 cases), in which severe ventricular arrhythmias are present, marked individual differences in RV MAP duration are present and correspond with pathological asynchrony of ventricular repolarization." | 3.67 | Monophasic action potential studies in human subjects with prolonged ventricular repolarization and long QT syndromes. ( Bonatti, V; Botti, G; Rolli, A, 1985) |
| " To determine their relative antiarrhythmic efficacy, amiodarone and its desethyl metabolite, desethylamiodarone, were administered to mongrel dogs with ventricular tachycardia 24 hr after ligation of the left anterior descending coronary artery." | 3.67 | The antiarrhythmic efficacy of amiodarone and desethylamiodarone, alone and in combination, in dogs with acute myocardial infarction. ( Davies, M; Nattel, S; Quantz, M, 1988) |
| "To determine whether the slow onset of action of amiodarone might result in a delayed effect on the inducibility of sustained ventricular arrhythmias, 45 patients with ischemic heart disease and inducible sustained monomorphic ventricular tachycardia were prospectively studied." | 3.67 | Cumulative effects of amiodarone on inducibility of ventricular tachycardia: implications for electrophysiological testing. ( Beckman, KJ; Hargis, J; Krafchek, J; Lin, HT; Magro, SA; Nielsen, AP; Wyndham, CR, 1988) |
| "Because of its presumed unique efficacy, amiodarone (AM) is often used to treat patients whose sustained ventricular tachyarrhythmias (VT/VF) appear to be drug-refractory." | 3.67 | Empiric amiodarone versus "ineffective" drug therapy in patients with refractory ventricular tachyarrhythmias. ( Elson, JJ; Fiedler, SB; Fogoros, RN, 1988) |
| "Verapamil is a calcium channel blocker ideally suited for the treatment of A-V nodal reciprocating supraventricular tachycardia." | 3.67 | [Idiopathic recurrent ventricular tachycardia: role of verapamil in its treatment]. ( Arriagada, C; Fajuri, A; González, R; Marchesse, M; Serrat, H, 1989) |
| "The clinical efficacy of intravenous amiodarone in terminating sustained ventricular tachycardia and in preventing recurrences of ventricular tachycardia and ventricular fibrillation was evaluated in 26 patients." | 3.67 | Clinical efficacy of intravenous amiodarone in the short term treatment of recurrent sustained ventricular tachycardia and ventricular fibrillation. ( Harringer, W; Herbinger, W; Kerschner, K; Leisch, F; Schützenberger, W, 1989) |
| "Amiodarone was used in 86 patients with ventricular tachycardia (VT) (67 patients) or ventricular fibrillation (19 patients) secondary to coronary artery disease." | 3.67 | Prognostic value of early electrophysiologic studies for ventricular tachycardia recurrence in patients with coronary artery disease treated with amiodarone. ( Estes, NA; Manolis, AS; Uricchio, F, 1989) |
| "Treatment of amiodarone-induced thyrotoxicosis (AIT) with thionamide, lithium or radioactive iodine is ineffective." | 3.67 | Dexamethasone treatment of amiodarone-induced thyrotoxicosis (AIT) with or without persistent administration of the drug. ( Bernard, R; Bonnyns, M; Bourdoux, P; Demaret, B; Renard, M; Sterling, I, 1989) |
| "This study examined the effectiveness of intravenous amiodarone for rapid control and prevention of recurrent life-threatening ventricular tachyarrhythmias associated with cardiovascular collapse." | 3.67 | Intravenous amiodarone for the rapid treatment of life-threatening ventricular arrhythmias in critically ill patients with coronary artery disease. ( Almquist, A; Benditt, DG; Gobel, FL; Goldenberg, IF; Milstein, S; Ochi, RP; Pedersen, W; Pritzker, M, 1989) |
| "Amiodarone, a iodine-rich drug widely used in the treatment of tachyarrhythmias, represents one of the most common sources of iodine-induced thyrotoxicosis." | 3.67 | Amiodarone: a common source of iodine-induced thyrotoxicosis. ( Aghini-Lombardi, F; Bartalena, L; Braverman, L; Mariotti, S; Martino, E; Pinchera, A, 1987) |
| " Sustained rapid ventricular tachyarrhythmias requiring cardioversion for termination were induced by double right ventricular apical extrastimuli during control, and treatment with disopyramide, quinidine, and fluocortolone." | 3.67 | Failure of corticosteroid therapy to prevent induction of ventricular tachycardia in sarcoidosis. ( Belhassen, B; Laniado, S; Pines, A, 1989) |
| "One hundred two patients with recurrent, drug-refractory tachyarrhythmias were treated with amiodarone for nine +/- eight months (mean +/- SD) (range, one to 50 months)." | 3.67 | Unusual neurotoxicity associated with amiodarone therapy. ( Iyer, V; Meckler, RJ; Palakurthy, PR, 1987) |
| "The electrophysiologic effects and antiarrhythmic efficacy of flecainide were evaluated by electrophysiologic study (EPS) in 20 patients with ventricular tachycardia (VT) refractory to an average 2." | 3.67 | Clinical and electrophysiologic effects of flecainide in patients with refractory ventricular tachycardia. ( Capparelli, EV; Chow, MS; Kluger, J; Regnier, JC, 1988) |
| "A 42-year old man with non-obstructive myocardiopathy complicated by paroxysmal atrial fibrillation treated with amiodarone (200 mg per day) received flecainide in daily doses of 400 mg for undocumented palpitations." | 3.67 | [Bundle branch reentry tachycardia: a possible mechanism of flecainide proarrhythmia effect]. ( Berland, J; Cribier, A; Letac, B; Saoudi, N, 1988) |
| "In order to assess the long-term efficacy of amiodarone, we followed 187 survivors of cardiac arrest and 316 patients with nonsustained or sustained ventricular tachycardia and compared the results of amiodarone therapy with the results of conventional therapy." | 3.67 | Long-term results of amiodarone therapy. ( Herre, JM; Sauve, MJ; Scheinman, MM, 1987) |
| "Forty-two patients with a history of symptomatic ventricular tachycardia or cardiac arrest underwent electrophysiologic testing at control and early in the course of amiodarone therapy (mean 12 +/- 7 days)." | 3.67 | Amiodarone therapy: role of early and late electrophysiologic studies. ( Greenberg, RM; Greenspon, AJ; Jefferies, L; Rotmensch, HH; Volosin, KJ, 1988) |
| "The antiarrhythmic efficacy and safety of intravenous amiodarone were evaluated in 13 patients with recurrent sustained ventricular tachycardia." | 3.67 | Efficacy of intravenous amiodarone as short-term treatment for refractory ventricular tachycardia. ( Klein, RC; Machell, C; Rushforth, N; Standefur, J, 1988) |
| "Induction of ventricular tachycardia (VT) at electrophysiologic study in patients taking amiodarone poorly predicts recurrence of VT." | 3.67 | Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrop ( Chang, MS; Fineberg, N; Heger, JJ; Kammerling, JM; Klein, LS; Miles, WM; Prystowsky, EN; Zipes, DP, 1988) |
| "Although chronic therapy with amiodarone is an effective means of suppressing ventricular tachycardia, its long-term effects on ventricular function have not been evaluated." | 3.67 | Right and left ventricular function during chronic amiodarone therapy. ( Duff, HJ; Manyari, DE; Mitchell, LB; Sheldon, RS; Wyse, DG, 1988) |
| "The prognostic value of 3 previously reported programmed stimulation efficacy criteria was studied in 70 patients taking amiodarone for sustained ventricular tachycardia (VT)." | 3.67 | Prognostic value of the changes in the mode of ventricular tachycardia induction during therapy with amiodarone or amiodarone and a class 1A antiarrhythmic agent. ( Felder, SD; Figura, I; Fisher, JD; Johnston, DR; Kim, SG; Mercando, AD, 1987) |
| "Thirty-three patients with clinically recurrent ventricular tachyarrhythmias were treated with amiodarone (200 to 600 mg/day) during a mean follow-up period of 23." | 3.67 | Amiodarone in patients with recurrent sustained ventricular tachyarrhythmias: results of programmed electrical stimulation and long-term clinical outcome in chronic treatment. ( Brachmann, J; Kübler, W; Rizos, I; Schmitt, C; Senges, J; Waldecker, B, 1987) |
| "Fifty-four patients with a previous myocardial infarction and drug-refractory symptomatic ventricular tachycardia (VT) were treated with amiodarone on a long-term basis (range 6 to 54 months, mean 26) irrespective of the results of programmed ventricular stimulation, which was performed after high-dose oral amiodarone loading for more than 4 weeks." | 3.67 | Electrophysiologic predictors of long-term clinical outcome with amiodarone for refractory ventricular tachycardia secondary to coronary artery disease. ( Alpert, JS; Bishop, RL; Gold, RL; Haffajee, CI; Yazaki, Y, 1987) |
| "The value of serial electropharmacologic testing during long-term oral amiodarone therapy for prediction of long-term drug efficacy as well as characteristics of arrhythmia recurrence is controversial." | 3.67 | Predictors of efficacy of amiodarone and characteristics of recurrence of arrhythmia in patients with sustained ventricular tachycardia and coronary artery disease. ( DiMarco, JP; Haines, DE; Lerman, BB; Zhu, J, 1987) |
| "Thirty-eight patients with refractory supraventricular and ventricular tachyarrhythmias were administered a mean oral dosage of 400 mg amiodarone daily (200-600 mg)." | 3.67 | [Amiodarone therapy--behavior of serum and fatty tissue concentrations]. ( Bethge, KP; Bosse, K; Gonska, BD; Köbberling, J; Kreuzer, H; Quentin, CD; Wagner, H, 1986) |
| "Oral amiodarone was administered to 30 children (aged one week to 14 years) for treatment of resistant or life threatening tachycardias." | 3.67 | Intravenous and oral amiodarone for arrhythmias in children. ( Bucknall, CA; Curry, PV; Holt, DW; Keeton, BR; Sutherland, GR; Tynan, MJ, 1986) |
| "We recently reported a retrospective experience with serial Holter monitoring as a guide to therapy in patients with sustained ventricular tachycardia treated with amiodarone." | 3.67 | The use of ambulatory monitoring in the prognostic evaluation of patients with sustained ventricular tachycardia treated with amiodarone. ( Griffith, LS; Guarnieri, T; Platia, EV; Reid, PR; Veltri, EP, 1986) |
| "Twenty-nine patients with recurrent sustained ventricular tachycardia (VT) or cardiac arrest underwent baseline, early (after 2 weeks of therapy) and late (after 5 months, mean) electrophysiologic studies during oral amiodarone therapy." | 3.67 | Amiodarone: correlation of early and late electrophysiologic studies with outcome. ( Buxton, AE; Josephson, ME; Kadish, AH; Marchlinski, FE, 1986) |
| "We describe the appearance of long QT interval and polymorphous ventricular tachycardia in a patient treated with amiodarone who presented with hypokalemia secondary to chronic diuretic therapy." | 3.67 | Amiodarone and hypokalemia. A dangerous combination. ( Corres Peiretti, MA; Moro, C; Romero, J, 1986) |
| "The value of two reported and two new ambulatory electrocardiographic (Holter) criteria was studied in 80 patients taking amiodarone for refractory recurrent sustained ventricular tachycardia." | 3.67 | Value of Holter monitoring in predicting long-term efficacy and inefficacy of amiodarone used alone and in combination with class 1A antiarrhythmic agents in patients with ventricular tachycardia. ( Felder, SD; Figura, I; Fisher, JD; Johnston, DR; Kim, SG; Waspe, LE, 1987) |
| "Several studies have reported upon the inducibility of ventricular tachycardia (VT) with programmed ventricular stimulation (PVS) during chronic amiodarone therapy; however, few studies have systematically described and compared the morphology, duration, and cycle length of VT induced by PVS before and after amiodarone." | 3.67 | Effects of chronic amiodarone therapy on ventricular tachycardia induced by programmed ventricular stimulation. ( Annesley, T; Baerman, JM; de Buitleir, M; DiCarlo, LA; Morady, F; Schurig, L, 1987) |
| "We examined the value of clinical variables, chronic 24-hour ambulatory ECG monitoring, and chronic electrophysiologic (EP) testing in 49 patients with recurrent and refractory sustained ventricular tachycardia (VT) and ventricular fibrillation (VF) treated with chronic oral amiodarone in order to develop a prospective approach to the management of these patients." | 3.67 | Management of refractory sustained ventricular tachycardia with amiodarone: a reappraisal. ( Lavery, D; Saksena, S, 1987) |
| "The values of two Holter ambulatory electrocardiographic monitoring criteria and one programmed stimulation efficacy criterion reported to be predictive of the efficacy of amiodarone were compared in 70 patients taking amiodarone for sustained ventricular tachyarrhythmias." | 3.67 | Comparison of programmed stimulation and Holter monitoring for predicting long-term efficacy and inefficacy of amiodarone used alone or in combination with a class 1A antiarrhythmic agent in patients with ventricular tachyarrhythmia. ( Felder, SD; Figura, I; Fisher, JD; Johnston, DR; Kim, SG; Waspe, LE, 1987) |
| "During treatment with amiodarone, digoxin and nadolol, asystole occurred repeatedly in a patient with chronic persistent automatic atrial tachycardia." | 3.67 | Asystole during treatment with amiodarone in a patient with persistent atrial tachycardia. ( Kuo, CS; Paciotti, MV; Reddy, CP, 1985) |
| "Forty-two patients with refractory, recurrent life-threatening ventricular tachycardia and spontaneous ventricular tachycardia (greater than or equal to 3 beats, heart rate greater than 100 beats/min) on baseline 24 hour Holter recording were treated with amiodarone." | 3.67 | Amiodarone in the treatment of life-threatening ventricular tachycardia: role of Holter monitoring in predicting long-term clinical efficacy. ( Griffith, LS; Platia, EV; Reid, PR; Veltri, EP, 1985) |
| "Ventricular tachycardia induced by programmed electrical stimulation during amiodarone therapy often does not preclude a good clinical response." | 3.67 | Amiodarone: risk factors for recurrence of symptomatic ventricular tachycardia identified at electrophysiologic study. ( Duncan, G; Fineberg, NS; Heger, JJ; Naccarelli, GV; Prystowsky, EN; Zipes, DP, 1985) |
| "The effects of isoproterenol on induction of circus movement tachycardia were studied in 21 patients with an accessory atrioventricular pathway." | 3.67 | Effects of isoproterenol and amiodarone and the role of exercise in initiation of circus movement tachycardia in the accessory atrioventricular pathway. ( Brugada, P; Facchini, M; Wellens, HJ, 1986) |
| "Over a 10-year period 130 patients with drug-resistant cardiac arrhythmias associated mainly with coronary artery disease and its complications were treated with amiodarone." | 3.67 | Amiodarone for refractory cardiac arrhythmias: 10-year study. ( Eydt, JN; Leak, D, 1986) |
| "A 67 year old man with recurrent hypotensive ventricular tachycardia, amiodarone-induced bradyarrhythmias and severe cardiac dysfunction underwent simultaneous implantation of an automatic cardioverter/defibrillator and bipolar atrioventricular (AV) pacemaker." | 3.67 | Combined bipolar dual chamber pacing and automatic implantable cardioverter/defibrillator. ( Kim, SS; Kouchoukos, NT; Lal, R; Ruffy, R, 1986) |
| "The prognostic implications of changes in ventricular ectopic activity on serial 24 hour ambulatory electrocardiographic (Holter) recordings were prospectively evaluated in 107 patients with a history of sustained ventricular tachyarrhythmias treated with amiodarone for at least 30 days." | 3.67 | Utility of ambulatory electrocardiographic monitoring for predicting recurrence of sustained ventricular tachyarrhythmias in patients receiving amiodarone. ( Brady, PM; Greenspan, AM; Horowitz, LN; Kay, HR; Rae, AP; Sokoloff, NM; Spielman, SR, 1986) |
| "Amiodarone has proved very effective in the treatment of otherwise resistant cardiac tachyarrhythmias." | 3.67 | Hepatotoxicity of amiodarone. ( Rumessen, JJ, 1986) |
| "The prognostic importance of electrophysiologic studies in patients with sustained ventricular tachyarrhythmias treated with amiodarone was prospectively studied in 100 consecutive patients." | 3.67 | Usefulness of electrophysiologic testing in evaluation of amiodarone therapy for sustained ventricular tachyarrhythmias associated with coronary heart disease. ( Greenspan, AM; Horowitz, LN; Kay, HR; Morganroth, J; Rae, AP; Rotmensch, H; Segal, BL; Sokoloff, NM; Spielman, SR; Webb, CR, 1985) |
| "Multivariate analysis of 11 clinical variables was performed in 104 patients with sustained, symptomatic ventricular tachycardia (VT) or ventricular fibrillation treated with amiodarone to determine variables predictive of subsequent cardiac arrest or sudden death." | 3.67 | Cardiac arrest and sudden death in patients treated with amiodarone for sustained ventricular tachycardia or ventricular fibrillation: risk stratification based on clinical variables. ( Davis, JC; DiCarlo, LA; Evans-Bell, T; Malone, P; Morady, F; Sauve, MJ; Scheinman, MM; Winston, SA, 1985) |
| "Thirteen patients with refractory, recurrent, life-threatening ventricular tachycardia (VT) underwent electrophysiologic testing before and after long-term amiodarone therapy." | 3.67 | Results of late programmed electrical stimulation and long-term electrophysiologic effects of amiodarone therapy in patients with refractory ventricular tachycardia. ( Griffith, LS; Platia, EV; Reid, PR; Veltri, EP, 1985) |
| "In 65 patients a single oral dose of amiodarone (30 mg/kg) produced an antiarrhythmic effect on supraventricular or ventricular arrhythmias within 3 to 8 hours and lasted for 17 to 19 hours." | 3.67 | Suppression of arrhythmias within hours after a single oral dose of amiodarone and relation to plasma and myocardial concentrations. ( Cheymol, G; Coumel, P; Escoubet, B; Jaillon, P; Lagier, G; Leclercq, JF; Maison-Blanche, P; Menasche, P; Piwnica, A; Poirier, JM, 1985) |
| "A dose-dependent cutaneous leukocytoclastic vasculitis developed in a 34 year old man who was given amiodarone for supraventricular tachycardias resistant to other drugs." | 3.67 | Amiodarone-induced vasculitis and polyserositis. ( Bircher, J; Stäubli, M; Zimmermann, A, 1985) |
| " Ventricular tachycardia and fibrillation were resistant to lignocaine and to phenytoin but responded to intravenous amiodarone, with restoration of pacing." | 3.67 | Use of amiodarone and digoxin specific Fab antibodies in digoxin overdosage. ( Holt, DW; Murtagh, JG; Nicholls, DP, 1985) |
| "This study was performed to ascertain whether intravenous amiodarone would revert supraventricular tachycardias to sinus rhythm, and if so, whether this effect depended upon the underlying mechanism of the arrhythmia." | 3.67 | Intravenous amiodarone in the acute termination of supraventricular arrhythmias. ( Crick, JC; Curry, P; Davies, DW; Holt, P, 1985) |
| "A patient with sinuatrial disease and implanted pacemaker was treated with amiodarone (maximum dose 1000 mg, maintenance dose 800 mg daily) for 10 months, for control of supraventricular tachyarrhythmias." | 3.67 | Pneumonitis with pleural and pericardial effusion and neuropathy during amiodarone therapy. ( Clarke, B; Honey, M; Ward, DE, 1985) |
| "Recently a unique clinical entity has been suggested in subjects without apparent heart disease presenting with recurrent ventricular tachycardia (VT) characterized by RBBB + LAH electrocardiographic pattern, relatively slow rate, induction by atrial stimulation, and interruption by verapamil." | 3.67 | [Idiopathic ventricular tachycardia responsive to verapamil. Presentation of 3 cases and review of the literature]. ( Bonso, A; D'Este, D; Delise, P; Di Pede, F; Piccolo, E; Raviele, A, 1985) |
| "We report two patients who developed symptomatic life-threatening ventricular tachyarrhythmias with changing QRS axes (resembling torsades de pointes), during treatment of their supraventricular tachycardias with oral amiodarone." | 3.67 | Life-threatening ventricular arrhythmias provoked by amiodarone treatment. ( Eydt, J; Kumana, CR; Tanser, P, 1985) |
| "The clinical significance of sustained nonclinical ventricular tachycardia (VT) induced during electrophysiologic studies was studied in 10 amiodarone-treated patients." | 3.67 | Clinical significance of nonclinical ventricular tachycardia induced in amiodarone-treated patients. ( Belhassen, B; Keren, G; Laniado, S; Shapira, I, 1985) |
| "In 23 patients with symptomatic severe supraventricular and ventricular tachyarrhythmias the effectiveness and the side effects of a long-term therapy with the class III antiarrhythmic drug Amiodarone (Cordarone) in a dosage of 100-800 mg/die in monotherapy and combination therapy were investigated." | 3.67 | [Long-term therapy with amiodarone in tachyarrhythmias--report on various experiences with special reference to its side effects]. ( Assmann, I, 1985) |
| "The effect of amiodarone on survival was assessed in patients with hypertrophic cardiomyopathy and ventricular tachycardia in a drug trial with historical controls." | 3.67 | Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. ( Goodwin, JF; Krikler, DM; McKenna, WJ; Oakley, CM, 1985) |
| "The role that the new antiarrhythmic agents, such as verapamil and amiodarone, might play in the therapeutic strategy of tachycardia-induced fetal heart failure remains to be determined." | 3.67 | Transplacental treatment of tachycardia-induced fetal heart failure with verapamil and amiodarone: a case report. ( Duperron, L; Gauthier, R; Grignon, A; LeLorier, J; Lemay, M; Rey, E, 1985) |
| "Intravenous amiodarone has a clear anti-arrhythmic effect on induced sustained ventricular tachycardia (VT) in pigs with subacute myocardial infarction." | 3.67 | [Effect of amiodarone on stimulatory convertibility and degeneration into ventricular fibrillation of induced ventricular tachycardias in the pig]. ( Gertsch, M; Hottinger, S; Leupi, F; Mettler, D, 1985) |
| "Fifty-eight patients with symptomatic ventricular tachycardia (VT) or ventricular fibrillation (VF) were treated with amiodarone." | 3.66 | Amiodarone in the management of patients with ventricular tachycardia and ventricular fibrillation. ( Hess, DS; Morady, F; Scheinman, MM, 1983) |
| "Our use of amiodarone in 200 patients during an 8-year period confirms our previous experience which indicated that the drug was close to being the ideal antiarrhythmic agent in children's arrhythmias." | 3.66 | The use of amiodarone in children. ( Coumel, P; Do Ngoc, D; Lucet, V, 1983) |
| "Amiodarone was administered to 80 patients with recurrent cardiac tachyarrhythmias previously resistant to drug treatment." | 3.66 | Adverse reactions during treatment with amiodarone hydrochloride. ( Garan, H; Kelly, E; McGovern, B; Ruskin, JN, 1983) |
| "Amiodarone was used in 40 patients with life-threatening or refractory tachyarrhythmias." | 3.66 | Amiodarone therapy for life threatening or refractory cardiac arrhythmias. ( Anderson, ST; Currie, PJ; Federman, J; Harper, RW; Johns, JA; Pitt, A, 1983) |
| "The antiarrhythmic effects of amiodarone hydrochloride 200 to 600 mg/daily were studied in 25 patients with ventricular tachycardia (VT)." | 3.66 | Long term-treatment of ventricular tachycardia in ambulatory patients with amiodarone. ( Buceta, JE; Dreyer, MP; Milei, J; Piñeiro, DJ; Vazquez Blanco, M, 1983) |
| "Amiodarone was administered to 154 patients who had sustained, symptomatic ventricular tachycardia (VT) (n = 118) or a cardiac arrest (n = 36) and who were refractory to conventional antiarrhythmic drugs." | 3.66 | Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation. ( Bhandari, A; Keung, E; Malone, P; Morady, F; Sauve, MJ; Scheinman, MM; Schwartz, AB; Shen, EN; Sung, RJ, 1983) |
| "Oral amiodarone was administered to ten children aged 3 months to 15 years who had recurrent SVT associated with the Wolff-Parkinson-White syndrome." | 3.66 | Amiodarone in control of sustained tachyarrhythmias in children with Wolff-Parkinson-White syndrome. ( Barzilay, Z; Feigl, A; Frand, M; Shahar, E, 1983) |
| "Twenty-three patients with sustained, recurrent, symptomatic ventricular tachycardia were treated with oral amiodarone." | 3.66 | Long-term management of sustained, recurrent, symptomatic ventricular tachycardia with amiodarone. ( Girotti, LA; Kaski, JC; Messuti, H; Rosenbaum, MB; Rutitzky, B, 1981) |
| "We evaluated the effects of amiodarone in 45 patients with recurrent ventricular tachycardia or ventricular fibrillation." | 3.66 | Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation. ( Heger, JJ; Jackman, WM; Naccarelli, GV; Prystowsky, EN; Rinkenberger, RL; Warfel, KA; Zipes, DP, 1981) |
| "Amiodarone has proved to be a valuable drug in atrial fibrillation associated with the Wolff-Parkinson-White syndrome." | 3.66 | Acceleration of ventricular rate by fibrillation associated with the Wolff-Parkinson-White syndrome. ( Evans, T; Sheinman, BD, 1982) |
| "Amiodarone hydrochloride, used for prophylaxis of recurrent ventricular tachyarrhythmias that are resistant to other agents, may cause toxic pulmonary reactions associated with abnormal chest radiographs." | 3.66 | Lung disease caused by amiodarone, a new antiarrythmic agent. ( Epstein, DM; Gefter, WB; Miller, WT; Pietra, GG, 1983) |
| "Ninety-six patients with life-threatening ventricular arrhythmias refractory to two or more conventional agents were treated with amiodarone and followed for 6 to 40 months (mean, 15 months)." | 3.66 | Amiodarone in refractory life-threatening ventricular arrhythmias. ( Cannom, DS; Feld, G; Hendrickson, J; Intarachot, V; Lopez, B; Nademanee, K; Singh, BN; Weiss, JL, 1983) |
| "Five cases of amiodarone-induced polymorphous ventricular tachycardia (torsade de pointes) are presented." | 3.66 | Amiodarone-induced polymorphous ventricular tachycardia. ( Agmon, J; Arditti, A; Kracoff, O; Lewin, RF; Sclarovsky, S; Strasberg, B, 1983) |
| "Ninety-six patients with recurrent, drug-refractory tachyarrhythmias were treated with amiodarone for 8." | 3.66 | Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias. ( Anderson, KP; Fogoros, RN; Mason, JW; Swerdlow, CD; Winkle, RA, 1983) |
| "A patient with sustained ventricular tachycardia was operated on after an unsuccessful trial of amiodarone." | 3.66 | Should oral amiodarone be used for sustained ventricular tachycardia in patients requiring open-heart surgery? ( Landymore, R; MacKinnon, G; Marble, A, 1983) |
| "Amiodarone was used in 30 patients with tachyarrhythmias refractory to treatment with several antiarrhythmic agents." | 3.66 | Amiodarone in long term management of refractory cardiac tachyarrhythmias. ( Lowe, JB; Lubbe, WF; Mercer, CJ; Roche, AH, 1981) |
| "A 44-year-old woman is described in whom amiodarone, disopyramide, and quinidine, administered alone separately, induced atypical ventricular tachycardia (AVT, torsade de pointes)." | 3.66 | Atypical ventricular tachycardia (torsade de pointes) induced by amiodarone: arrhythmia previously induced by quinidine and disopyramide. ( Benhorin, J; Gottlieb, S; Keren, A; Stern, S; Tzivoni, D, 1982) |
| "Six patients treated with a combination of amiodarone and class I antiarrhythmic agents for a minor arrhythmia developed atypical ventricular tachycardia "en torsades de pointe"." | 3.66 | [Harmful interactions of amiodarone and class I anti-arrhythmia agents]. ( Kappenberger, L; Steinbrunn, W; Tartini, R, 1982) |
| "Amiodarone was utilized in 70 patients with symptomatic, sustained refractory tachyarrhythmias." | 3.66 | Amiodarone therapy in symptomatic, sustained refractory atrial and ventricular tachyarrhythmias. ( Lown, B; Podrid, PJ, 1981) |
| "Amiodarone, 600 mg orally daily, was used in an attempt to control supraventricular tachyarrhythmias in a patient with the sick sinus syndrome." | 3.66 | Amiodarone-induced ventricular fibrillation. ( Adgey, AA; Geddes, JS; Khan, MM; Logan, KR; McComb, JM, 1980) |
| "A combined mexiletine and amiodarone treatment was applied in nine cases with recurrent refractory ventricular tachycardia." | 3.66 | Combined mexiletine and amiodarone treatment of refractory recurrent ventricular tachycardia. ( Demoulin, JC; Kulbertus, HE; Legrand, V; Mary-Rabine, L; Waleffe, A, 1980) |
| "The electrophysiological effects of L 9394 (benzoyl-indolizine), a substance chemically related to amiodarone, but devoid of iodine atoms, were investigated by programmed electrical stimulation of the heart in 12 patients with various forms of tachycardia." | 3.66 | Electrophysiological effects of L 9394 (benzoyl-indolizine) in man. ( Bordalo, A; Bruninx, P; Kulbertus, HE; Waleffe, A; Wellens, HJ, 1979) |
| "Amiodarone hydrochloride was used to treat 19 patients with symptomatic arrhythmias refractory to quinidine sulfate, procainamide hydrochloride, disopyramide phosphate, antazoline hydrochloride, lidocaine hydrochloride, bretylium tosylate, propranolol hydrochloride, phenytoin sodium, and practotol acetanilide given to the limit of tolerance." | 3.66 | Control of refractory cardiac arrhythmias with amiodarone. ( Eydt, JN; Leak, D, 1979) |
| "Five patients with the bradycardia-tachycardia syndrome have been treated successfully with the antiarrhythmic agent amiodarone." | 3.66 | Use of amiodarone in bradycardia-tachycardia syndrome. ( Brown, AK; Newton, P; Primhak, RA, 1978) |
| "A long Q-T interval syndrome is described, followed by "torsade de pointe" and by irriducible ventricular fibrillation that is ascribed to a badly conducted therapy with amiodarone, in a patient affected by mitral valve disease, microcitaemia and hemolitic intercurrent moderate jaundice." | 3.66 | ["T'orsade de pointe" and amiodarone (author's transl)]. ( Guerricchio, G; Scandiffio, T; Veglia, L, 1978) |
| "The effect of amiodarone in the Wolff-Parkinson-White syndrome was studied with programmed electrical stimulation of the heart in 15 patients." | 3.65 | Effect of amiodarone in the Wolff-Parkinson-White syndrome. ( Bär, FW; Dohmen, HJ; Düren, DR; Durrer, D; Lie, KI; Wellens, HJ; Wesdorp, JC, 1976) |
| "AFL accounts for 30% of fetal tachyarrhythmias, 11% to 18% of neonatal tachyarrhythmias, and 8% of supraventricular tachyarrhythmias in children older than 1 year of age." | 2.82 | Atrial Flutter in Pediatric Patients. ( Drago, F; Tamborrino, PP, 2022) |
| "A double-blind, randomized, multicenter, dose-response study of the safety and efficacy of IV amiodarone was conducted in 61 children (30 days to 14." | 2.71 | Intravenous amiodarone for incessant tachyarrhythmias in children: a randomized, double-blind, antiarrhythmic drug trial. ( Acevedo, V; Brown, S; Burriss, SW; Cargo, P; Etheridge, SP; Graepel, J; Koskelo, EK; Marantz, P; Perry, JC; Saul, JP; Scott, WA; Triedman, JK; Wang, R, 2005) |
| "Patients who had cardiac arrest with ventricular fibrillation (or pulseless ventricular tachycardia) and who had not been resuscitated after receiving three or more precordial shocks were randomly assigned to receive 300 mg of intravenous amiodarone (246 patients) or placebo (258 patients)." | 2.69 | Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. ( Cobb, LA; Copass, MK; Cummins, RO; Doherty, AM; Fahrenbruch, CE; Hallstrom, AP; Kudenchuk, PJ; Murray, WA; Olsufka, M; Walsh, T, 1999) |
| "Ventricular fibrillation was induced with AC (applied for 1-2 seconds), and standard epicardial bipolar and epicardial patch electrodes of the AICD were used for pacing and defibrillation, respectively." | 2.67 | Ventricular pacing threshold and time to capture postdefibrillation in patients undergoing implantable cardioverter-defibrillator implantation. ( Aarons, D; Juanteguy, J; Khastgir, T; Lattuca, J; Murphy, J; O'Mara, V; Veltri, EP, 1991) |
| "Amiodarone was given after surgery in a loading bolus of 300 mg for 2 hours followed by 1200 mg every 24 hours for 2 days and 900 mg every 24 hours for the next 2 days." | 2.67 | Electrocardiographic and antiarrhythmic effects of intravenous amiodarone: results of a prospective, placebo-controlled study. ( Dammbacher, T; Fraedrich, G; Hohnloser, SH; Jähnchen, E; Just, H; Meinertz, T; Steiert, K; Zehender, M, 1991) |
| "Amiodarone treatment (loading dose 30 g given over 6 weeks; maintenance dose 400 mg/day) was prospectively evaluated in 50 patients with HC in whom the drug was initiated because of symptoms refractory to conventional drug therapy (calcium antagonists and beta blockers)." | 2.67 | Sudden death during empiric amiodarone therapy in symptomatic hypertrophic cardiomyopathy. ( Bonow, RO; Cannon, RO; Epstein, SE; Fananapazir, L; Leon, MB; Tracy, CM, 1991) |
| " Serial electrophysiologic testing was used in 25 patients with ventricular tachycardia to assess the adequacy of a 1-week oral loading regimen at 1,200 mg/day, to modify maintenance dosing at the conclusion of loading, and to evaluate the appropriateness of maintenance dosing after 2 months of therapy." | 2.66 | Evaluation by serial electrophysiologic studies of an abbreviated oral loading regimen of amiodarone. ( Batsford, WP; Kennedy, EE; McPherson, CA; Rosenfeld, LE, 1985) |
| "Amiodarone is an extremely effective treatment for infants and children with tachyarrhythmias resistant to conventional treatment." | 2.65 | Amiodarone treatment of critical arrhythmias in children and young adults. ( Angell, LK; Garson, A; Gillette, PC; Hesslein, PS; Hittner, HM; Kaldis, LC; McVey, P; Porter, CJ, 1984) |
| "Eight patients with WPW syndrome were catheterised and, during the course of this investigation, the electrophysiological effects of amiodarone were assessed." | 2.64 | [Electrophysiologic effects of amiodarone in Wolf-Parkinson-White syndrome]. ( Delahaye, JP; Huerta, F; Porte, J; Touboul, P, 1976) |
| "Amiodarone is a highly efficacious antiarrhythmic agent for many cardiac arrhythmias, ranging from atrial fibrillation to malignant ventricular tachyarrhythmias, and seems to be superior to other antiarrhythmic agents." | 2.42 | Arrhythmias in the intensive care patient. ( Brandts, B; Trappe, HJ; Weismueller, P, 2003) |
| "Amiodarone is an iodine-rich drug used to treat cardiac dysrhythmias." | 2.42 | Amiodarone-induced neonatal hypothyroidism: a unique form of transient early-onset hypothyroidism. ( Backeljauw, PF; Jackson, WA; Lomenick, JP, 2004) |
| "Cardiac arrhythmias are common in the perioperative period." | 2.41 | Postoperative arrhythmias and conduction disorders. ( Sloan, SB; Weitz, HH, 2001) |
| "Amiodarone is a unique antiarrhythmic agent that is now available in oral and intravenous forms in the United States." | 2.40 | The role of intravenous amiodarone in the management of cardiac arrhythmias. ( Chun, S; Desai, AD; Sung, RJ, 1997) |
| "Torsades de pointes arrhythmia is an undesirable side-effect closely coupled to specific class-III action that may limit their future use." | 2.38 | [New anti-arrhythmia agents]. ( Honerjäger, P; Schmidt, G, 1992) |
| "Amiodarone has a reduced clearance rate, large volume of distribution, low bioavailability and a long half-life that may last 2 months in patients receiving short-term therapy." | 2.37 | Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects. ( Heger, JJ; Prystowsky, EN; Zipes, DP, 1984) |
| " It has an apparent elimination half-life of 15-45 days, which presents unique dosing problems." | 2.36 | Amiodarone for tachyarrhythmias: pharmacology, kinetics, and efficacy. ( Asdourian, GK; Canada, AT; Haffajee, CI; Johnson, B; Lesko, LJ, 1983) |
| "Amiodarone dose was associated to HR decrease but not to MAP or plasma lactate increase." | 1.46 | Effectiveness of heart rate control on hemodynamics in critically ill patients with atrial tachyarrhythmias managed by amiodarone. ( Aissaoui, N; Dureau, P; El-Aissaoui, M; Faisy, C; Funck-Brentano, C; Hulot, JS; Salem, JE; Urien, S, 2017) |
| "Amiodarone induced thyrotoxicosis is a complex condition marked by two different pathophysiological mechanisms with different treatments." | 1.43 | [Iodine excess induced thyroid dysfunction]. ( Egloff, M; Philippe, J, 2016) |
| "Bidirectional ventricular tachycardia (BVT) is an uncommon type of polymorphic ventricular tachycardia (PVT) with alternating polarity of the QRS complex most commonly described digitalis toxicity." | 1.38 | Bidirectional ventricular tachycardia due to coronary allograft vasculopathy a unique presentation. ( Bhavnani, SP; Clyne, CA, 2012) |
| "Ventricular tachycardias have a broad QRS complex (>or=0." | 1.36 | [Life-threatening brady- and tachyarrhythmias]. ( Trappe, HJ, 2010) |
| "Time to persistent arrhythmia recurrence was compared between first and multiple DCCV, and the effect of age, gender, presence of heart disease, left atrial size, fractional shortening, arrhythmia duration, anti-arrhythmic drug therapy (AAD) and other concomitant cardiac medication was evaluated using the Kaplan-Meier method and Cox's Proportional-hazards model." | 1.36 | First time and repeat cardioversion of atrial tachyarrhythmias - a comparison of outcomes. ( Arya, A; Boodhoo, L; Bordoli, G; Cheek, E; Large, J; Lloyd, GW; Mitchell, A; Patel, NR; Pugh, P; Silberbauer, JS; Sulke, AN; Taggu, W; Vrahimides, J, 2010) |
| "Based on this case amiodarone-related pneumonitis will be discussed, which due to a lack of pathognomonic symptoms is often difficult to diagnose and for which there are few treatment options available." | 1.35 | [Amiodarone-induced pneumonitis. Lethal complication in a patient after thoracic surgery]. ( Fisseler-Eckhoff, A; Ghezel-Ahmadi, V; Kürschner, VC; Obenhaus, T; Schirren, J; Schmitz, JE, 2008) |
| "Mapping of arrhythmias was performed with both systems when possible." | 1.34 | Comparison of noncontact and electroanatomic mapping to identify scar and arrhythmia late after the Fontan procedure. ( Abrams, DJ; Cullen, S; Deanfield, JE; Earley, MJ; Gatzoulis, MA; Kistler, PM; Lowe, MD; Mullen, MJ; Schilling, RJ; Sporton, SC; Till, JA; Walker, F, 2007) |
| "Amiodarone-induced pulmonary toxicity (APT) is the most serious side-effect of amiodarone, and its detection and prevention are extremely important." | 1.34 | Incidence and predictors of pulmonary toxicity in Japanese patients receiving low-dose amiodarone. ( Hagiwara, N; Kasanuki, H; Matsuda, N; Shiga, T; Yamada, Y, 2007) |
| "Two patients presented with ventricular tachycardia and one had an atrioventricular re-entrant tachycardia." | 1.33 | Tachycardia-induced elevations in cardiac troponin in the absence of coronary artery disease. ( Cruz, L; Hong, R; Yeo, KK, 2006) |
| "Tachyarrhythmia was evoked in isolated rat right atria by trains of electric stimuli." | 1.32 | Cholinergic-adrenergic antagonism in the induction of tachyarrhythmia by electrical stimulation in isolated rat atria. ( Bassani, JW; Bassani, RA; Zafalon, N, 2004) |
| "The tachyarrhythmias were classified into atrial flutter (n = 8), supraventricular tachycardia (n = 18), arrhythmia absoluta (n = 5), parasystole (n = 1) and brady-tachyarrhythmia (n = 1)." | 1.32 | [Diagnosis and treatment of haemodynamically significant fetal tachycardia--in 33 cases]. ( Hajdú, J; Papp, Z; Pete, B, 2004) |
| " Patients received both amiodarone and warfarin for at least 1 year, and the dosage of warfarin was adjusted as clinically necessary to achieve an international normalized ratio of 2 to 3." | 1.31 | Clinical observations with the amiodarone/warfarin interaction: dosing relationships with long-term therapy. ( Bauman, JL; Sanoski, CA, 2002) |
| "Congestive heart failure was diagnosed in 6 patients (ejection fraction < 25%) and hypertensive heart failure in 3 patients (ejection infarction > 55%)." | 1.31 | [Control of tachycardia with intravenous amiodarone in acute left heart failure]. ( Arabadzisz, H; Beck, K; Marosi, A; Tomcsányi, J; Zsoldos, A, 2001) |
| "Atrial tachyarrhythmias were induced by right atrial burst pacing." | 1.30 | Low energy transvenous cardioversion of short duration atrial tachyarrhythmias in humans using a single lead system. ( Fries, R; Heisel, A; Jung, J; Ozbek, C; Schieffer, H; Sen, S; Stopp, M, 1997) |
| " After restoration of sinus rhythm, several therapeutic protocols were used, often in the same patient: abstention, leading to 5 recurrences in 6 cases; treatment with betablockers in 12 patients with well tolerated or exercise-induced atrial tachycardia with 11 successes; amiodarone, with 4 relapses out of 5 when the dosage was less than 200 mg/m2/day and 13 successes out of 18 when the dosage was 200-250 mg/m2/day." | 1.29 | [Treatment and prognosis of tachyarrhythmia after atrial surgical repair of transposition of great vessels]. ( Aggoun, Y; Bonnet, D; Iserin, L; Kachaner, J; Sidi, D; Villain, E, 1996) |
| "Amiodarone was clinically useful in 32 (68%) patients." | 1.28 | Use of amiodarone for short-term and adjuvant therapy in young patients. ( Benson, DW; Deal, BJ; Pongiglione, G; Strasburger, JF, 1991) |
| "Amiodarone has been used for the last 20 years, initially as antianginal and then as antiarrhythmic agent." | 1.28 | [Optic neuropathy caused by amiodarone]. ( Ferreiro, JL; Isern Longares, JA; Ramón Moya, AF, 1990) |
| "A case of exercise-induced cardiac arrest secondary to catecholamine-sensitive right ventricular tachycardia in the absence of apparent structural heart disease is presented." | 1.28 | Catecholamine-sensitive right ventricular tachycardia in the absence of structural heart disease: a mechanism of exercise-induced cardiac arrest. ( Nadamanee, K; Taylor, R; Wesley, RC, 1991) |
| "To date, there have been three cases of pulmonary fibrosis in patients receiving mexiletine spontaneously reported to the manufacturer." | 1.28 | Possible association of pulmonary fibrosis with mexiletine. ( Bero, CJ; Rihn, TL, 1991) |
| "With amiodarone, VT was no longer inducible or was more difficult to induce in 11 patients (31%), and the drug abolished VT during Holter monitoring in all patients." | 1.28 | Value of electrophysiologic studies in hypertrophic cardiomyopathy treated with amiodarone. ( Epstein, SE; Fananapazir, L, 1991) |
| "Three patients affected by dilated cardiomyopathy complicated by refractory ventricular tachycardia, with a high risk of sudden cardiac death, underwent transcatheter electric fulguration." | 1.28 | [Endocavitary transcatheter electric fulguration as a therapeutic alternative in refractory ventricular tachycardia]. ( Alexidou, G; Ansalone, G; Bisceglie, I; Cacciatore, G; Carelli, M; Di Marcotullio, G; Santini, M; Tubaro, M, 1990) |
| "A patient with preexistent left bundle branch block and spontaneous ventricular tachycardia based upon the bundle branch reentry mechanism underwent electrophysiological testing for the evaluation of sotalol drug efficacy." | 1.28 | Inadvertent catheter-induced right bundle branch block in a patient with preexistent left bundle branch block and recurrent macroreentrant ventricular tachycardia. ( Gössinger, HD; Leitha, T; Mösslacher, H; Siostrzonek, P; Wagner, L, 1989) |
| " The Authors evaluated the prophylactic efficacy of the chronic administration of amiodarone (A) on this arrhythmia and simultaneously the trend of ventricular extrasystole during the antiarrhythmic treatment." | 1.28 | [Amiodarone prophylaxis of ventricular tachycardia in ischemic cardiopathy]. ( Bernasconi, M; Cirino, D; Marzegalli, M; Pogna, M; Potenza, S, 1989) |
| " In 1, with recurrence of MAT, the same intravenous dosage was repeated for 2 consecutive days, with final achievement of stable sinus rhythm." | 1.28 | The effective treatment of multifocal atrial tachycardia with amiodarone. ( Chronopoulos, G; Cokkinos, DV; Halal, G; Ioannou, N; Kouvaras, G, 1989) |
| "Amiodarone was discontinued because of side effects in 14%, 26% and 37% of patients after 1, 3 and 5 years, respectively." | 1.28 | Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation. ( Goldberg, H; Griffin, JC; Helmy, I; Herre, JM; Langberg, JJ; Malone, P; Sauve, MJ; Scheinman, MM, 1989) |
| " Furthermore, amiodarone may interact with beta-blocking agents and some of the calcium antagonists to produce symptomatic sinus bradycardia and sinus arrest, especially in a latent or overt sick sinus syndrome." | 1.27 | Drug interactions with amiodarone. ( Marcus, FI, 1983) |
| " If side effects intervene that may cause continued therapy to be intolerable, changing the antiarrhythmic agent, as opposed to decreasing the dosage to an ineffective range, may be appropriate." | 1.27 | New directions in antiarrhythmic drug therapy. ( Somberg, JC, 1984) |
| "The tachycardia was rapid (240 beats per minute) and required cardioversion." | 1.27 | Rapid ventricular tachycardia due to His-Purkinje reentry. ( Pollak, S; Walter, PF, 1984) |
| "Propafenone was less effective (mean effect 3." | 1.27 | European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias. ( Assayag, P; Coumel, P; Leclercq, JF, 1984) |
| "TWelve patients had overt congestive heart failure." | 1.27 | Intravenous amiodarone in the acute treatment of recurrent symptomatic ventricular tachycardia. ( DiCarlo, L; Morady, F; Scheinman, MM; Shapiro, W; Shen, E; Sung, RJ, 1983) |
| "Thus, the safety of amiodarone in the WPW syndrome should be established by electrophysiologic studies and induction of AF, because amiodarone is not protective in all patients with WPW." | 1.27 | Efficacy of amiodarone in the Wolff-Parkinson-White syndrome with rapid ventricular response via accessory pathway during atrial fibrillation. ( Fromer, MA; Kappenberger, LJ; Shenasa, M; Steinbrunn, W, 1984) |
| " Dosage was adjusted, based on the ambulatory ECG, to maintain arrhythmia suppression at the lowest possible amiodarone dose and, hence, because of the extremely long half-life of amiodarone, patients were rarely in a true steady state." | 1.27 | Amiodarone: correlation of serum concentration with suppression of complex ventricular ectopic activity. ( Blumer, J; Mostow, ND; Noon, DL; Rakita, L; Vrobel, TR, 1984) |
| "Amiodarone is a potent new antiarrhythmic drug that has multiple effects on thyroid function, including inhibition of extrathyroidal triiodothyronine production and rarely, iodine-induced hypothyroidism." | 1.27 | Myxedema coma during long-term amiodarone therapy. ( Cantley, LK; Dalldorf, FG; Foster, JR; Mazonson, PD; Utiger, RD; Williams, ML, 1984) |
| " The latter, however, was taking antiarrhythmic drugs at a dosage less than that proved to be effective during electropharmacological testing." | 1.27 | [Value of a serial electropharmacologic study in survivors of a cardiac arrest secondary to ventricular tachycardia or ventricular fibrillation]. ( Delise, P; Di Pede, F; Piccolo, E; Raviele, A, 1984) |
| "We report a patient with fibrosing alveolitis associated with amiodarone therapy." | 1.27 | Fibrosing alveolitis associated with amiodarone. ( Butland, RJ; Millard, FJ, 1984) |
| " Drug or metabolite concentrations in plasma and RBCs correlated directly with daily dosage of amiodarone." | 1.27 | Plasma and red blood cell concentrations of amiodarone during chronic therapy. ( Heger, JJ; Prystowsky, EN; Solow, EB; Zipes, DP, 1984) |
| "Amiodarone is an investigative antiarrhythmic drug in the United States." | 1.27 | Amiodarone--an investigative drug in the coronary care unit. ( Lemberg, L; Valladares, BK, 1983) |
| "Supraventricular tachycardia is one of the most frequent arrhythmias in childhood." | 1.27 | [Supraventricular tachycardia in children]. ( Attanà, A; Battaglia, T; Caristo, S; Ciconte, V; Fumarulo, A; Martini, B; Paparo, F, 1983) |
| "Amiodarone was added to the treatment regimen of patients receiving D at doses ranging from 0." | 1.27 | [Interaction of amiodarone and digoxin]. ( Nager, F; Nager, G, 1983) |
| "Ventricular tachycardia is detected during electrocardiographic monitoring in 20 to 30% of patients; this arrhythmia is a sensitive but non-specific marker of those patients who are at particular risk of sudden death." | 1.27 | Arrhythmia and prognosis in hypertrophic cardiomyopathy. ( McKenna, WJ, 1983) |
| "Mild pleuroparenchymal fibrosis associated with amiodarone pulmonary toxicity is reported in a 63-year-old white man; partial radiographic resolution and complete symptomatic resolution with decreasing the daily dosage to 200 mg permitted continued anti arrhythmic therapy." | 1.27 | Pulmonary toxicity of amiodarone. ( Gallastegui, J; Leech, JA; Swiryn, S, 1984) |
| "Amiodarone is a new and powerful antiarrhythmic agent currently under investigation in North America." | 1.27 | Acute necrotizing pneumonitis and hyperglycemia after amiodarone therapy. Case report and review of amiodarone-associated pulmonary disease. ( Pollak, PT; Sami, M, 1984) |
| " Pharmacokinetic studies in six patients with a 1 mg intravenous digoxin dose before and during amiodarone therapy increased serum digoxin level at 30 minutes from 8." | 1.27 | Amiodarone-digoxin interaction: clinical significance, time course of development, potential pharmacokinetic mechanisms and therapeutic implications. ( Hendrickson, J; Kannan, R; Kay, I; Nademanee, K; Ookhtens, M; Singh, BN, 1984) |
| "Eleven consecutive patients with idiopathic dilated cardiomyopathy and spontaneous, sustained ventricular tachycardia (VT) of uniform morphology underwent programmed ventricular stimulation and serial antiarrhythmic drug testing." | 1.27 | Sustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy: electrophysiologic testing and lack of response to antiarrhythmic drug therapy. ( Buxton, AE; Doherty, JU; Josephson, ME; Marchlinski, FE; Poll, DS; Waxman, HL, 1984) |
| "The atrial tachyarrhythmias were successfully controlled in 45 of 54 patients (83%) during a mean follow-up of 10." | 1.27 | Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias. ( Alpert, JS; Asdourian, G; Canada, AT; Haffajee, CI; Lesko, LJ; Love, JC, 1983) |
| "Amiodarone was used in the treatment of 21 patients with supraventricular or ventricular arrhythmias which were refractory to conventional antiarrhythmic drugs, individually or in combination." | 1.27 | Amiodarone: an effective alternative for recalcitrant supraventricular and ventricular tachycardias. ( Best, JF; Dunn, M; Lynch, L; Rinkenberger, R, 1986) |
| "9 antiarrhythmic drugs, used alone or in combination, were managed by low doses of beta-blocker agents combined with oral amiodarone (Am), either after loading (1." | 1.27 | Efficacy and safety of low doses of beta-blocker agents combined with amiodarone in refractory ventricular tachycardia. ( Fontaine, G; Frank, R; Grosgogeat, Y; Tonet, J, 1988) |
| "The mechanisms underlying the cause of sudden death have not been clearly elucidated." | 1.27 | [Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences]. ( Kleinebenne, A; McKenna, WJ, 1985) |
| "His bundle tachycardia is a rare arrhythmia in infants and children and is resistant to therapy." | 1.27 | His bundle tachycardia--arrhythmogenic and antiarrhythmic effects of therapy. ( Campbell, RW; Wren, C, 1987) |
| "Sotalol was found to be effective therapy for a subset of patients with ventricular tachycardia unresponsive to type IA drugs." | 1.27 | Usefulness of sotalol for drug-refractory malignant ventricular arrhythmias. ( Gonzalez, R; Griffin, JC; Herre, JM; Sauve, MJ; Scheinman, MM; Sharkey, H, 1988) |
| "The amiodarone group was older, with worse left ventricular function and more peripheral and cerebrovascular disease." | 1.27 | Comparison of survival of amiodarone-treated patients with coronary artery disease and malignant ventricular arrhythmias with that of a control group with coronary artery disease. ( German, LD; Gilbert, MR; Harrell, FE; Kay, GN; Lee, KL; Pressley, JC; Pryor, DB, 1987) |
| "The effects of amiodarone on the pharmacokinetic and electrophysiologic properties of procainamide were examined in eight patients treated for recurrent ventricular arrhythmias who received intravenous procainamide, 6 to 15 mg/kg, at control and after 1 to 2 weeks of oral amiodarone treatment." | 1.27 | Pharmacokinetic and electrophysiologic interactions of amiodarone and procainamide. ( Heger, JJ; Miles, WM; Prystowsky, EN; Windle, J, 1987) |
| "Appearance of optic neuropathy is probably a relative indication for discontinuing the use of the drug, in the hopes of avoiding bilateral involvement or perhaps recovering vision." | 1.27 | Optic neuropathy and amiodarone therapy. ( Feiner, LA; Fraunfelder, FT; Kazmier, FJ; Stricker, BH; Younge, BR, 1987) |
| " There was no significant correlation between serum amiodarone or desethylamiodarone levels and dosage of amiodarone." | 1.27 | Amiodarone efficacy in a young population: relationship to serum amiodarone and desethylamiodarone levels. ( Garson, A; Kannan, R; McVey, P; Miller, S; Singh, BN; Yabek, SM, 1987) |
| "The actuarial risk for sudden death in group B was 31% (95% confidence interval, 11% to 51%) at 1 and 2 years, a value that was significantly higher than that for group A (p less than 0." | 1.27 | The automatic implantable cardioverter-defibrillator in drug-refractory ventricular tachyarrhythmias. ( Elson, JJ; Fiedler, SB; Fogoros, RN, 1987) |
| "Amiodarone was used for recurrent supraventricular tachycardia in four cases and frequent ventricular extra systoles complicating congenital QT prolongation in the remaining case." | 1.27 | Amiodarone-induced torsades de pointes. ( Brown, MA; Lubbe, WF; Norris, RM; Smith, WM, 1986) |
| " Minor reactions were defined as those that required dosage reduction and major reactions as those that required drug discontinuation or permanent pacing for bradycardia." | 1.27 | Adverse reactions to antiarrhythmic drugs during therapy for ventricular arrhythmias. ( Cook, TS; DiMarco, JP; Nygaard, TW; Sellers, TD, 1986) |
| " In 17 of the 29 pts not controlled by this regimen, the dosage of A was increased to 6000-8000 mg week-1; short-term control of VT was achieved in 9/17 (53%) pts, but over a long-term follow-up 5/9 (56%) died and severe side-effects (11% pulmonary fibrosis and 11% hepatitis) occurred in 22%." | 1.27 | Medical and surgical treatment of sustained and recurrent post-infarction ventricular tachycardia. ( Bobba, P; Bressan, MA; Chimienti, M; Martinelli, L; Montemartini, C; Pagnin, A; Previtali, M; Salerno, JA; Vigano, M, 1985) |
| "Amiodarone is an antiarrhythmic agent known to cause prolongation of action potential duration which is reflected in the electrocardiogram as a prolongation of the QT interval." | 1.27 | QT prolongation and the antiarrhythmic efficacy of amiodarone. ( Flowers, D; Keefe, D; Lam, S; Miura, DS; Somberg, JC; Tepper, D; Torres, V; Wynn, J, 1986) |
| "Amiodarone hydrochloride is an antiarrhythmic drug which produces a keratopathy and anterior subcapsular lens opacities that are usually asymptomatic." | 1.27 | Amiodarone keratopathy and lens opacities. ( Dolan, BJ; Flach, AJ; Peterson, JS, 1985) |
| "Amiodarone was given to 17 patients with drug refractory sustained ventricular arrhythmias." | 1.27 | Amiodarone and sustained ventricular arrhythmias: statistical evidence of drug effectiveness. ( Alpert, MA; Flaker, GC; Ruder, MA; Sanfelippo, JF; Tsutakawa, RK; Webel, RR, 1985) |
| "In the patients with a left bundle branch block morphology of VT (7 cases), four showed findings compatible with an arrhythmogenic right ventricular dysplasia or a right ventricular cardiomyopathy." | 1.27 | Morphological findings in apparently idiopathic ventricular tachycardia. An echocardiographic haemodynamic and histologic study. ( Alberti, E; Camerini, F; Morgera, T; Salvi, A; Silvestri, F, 1985) |
| "Hypertrophic cardiomyopathy is a cardiac disorder of unknown aetiology which is characterised by hypertrophy of a non-dilated left ventricle." | 1.27 | Does treatment influence the natural history of patients with hypertrophic cardiomyopathy? ( McKenna, WJ, 1985) |
| "Amiodarone was administered orally at a dose of 500 mg/m2/24 hrs for 5 to 15 days, and then 250 mg/m2/24 hrs for one month in the surgical patient and for 9 to 39 months in the four "idiopathic" cases." | 1.26 | [Treatment of ventricular tachycardia in infancy and childhood with amiodarone]. ( Batisse, A; Fermont, L; Kachaner, J; Sardet, A, 1982) |
| "When amiodarone was stopped in nine patients, the changes in QTc, T4 and rT3 regressed toward normal and arrhythmia recurred in eight 2-20 weeks (mean 7." | 1.26 | Pharmacokinetic significance of serum reverse T3 levels during amiodarone treatment: a potential method for monitoring chronic drug therapy. ( Hendrickson, JA; Hershman, J; Melmed, S; Nademanee, K; Reed, AW; Singh, BN, 1982) |
| "Type 2 tachycardia was of the slow-fast A-V nodal pathway type." | 1.26 | Quintuple pathways participating in three distinct types of atrioventricular reciprocating tachycardia in a patient with Wolff-Parkinson-White syndrome. ( Castellanos, A; Portillo, B; Portillo-Leon, N; Zaman, L, 1982) |
| "Oral amiodarone was given to 135 children (mean age, 10." | 1.26 | Amiodarone in the treatment of cardiac arrhythmias in children: one hundred thirty-five cases. ( Coumel, P; Fidelle, J, 1980) |
| "They give rise to cardiac failure, which is more marked when the rate is high (180-260/mn) and particularly resistant to treatment." | 1.26 | [Congenital bundle-of-his focal tachycardias. Cooperative study of 7 cases]. ( Attuel, P; Batisse, A; Brechenmacher, C; Bretagne, J; Clementy, J; Coumel, P; Fidelle, JE; Gérard, R; Grolleau, R; Huault, G; Kachaner, J; Mouy, A; Nouaille, J; Ribiere, M; Toumieux, MC, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 353 (67.24) | 18.7374 |
| 1990's | 89 (16.95) | 18.2507 |
| 2000's | 43 (8.19) | 29.6817 |
| 2010's | 33 (6.29) | 24.3611 |
| 2020's | 7 (1.33) | 2.80 |
| Authors | Studies |
|---|---|
| Nakamura, K | 1 |
| Neidig, LE | 1 |
| Yang, X | 1 |
| Weber, GJ | 1 |
| El-Nachef, D | 1 |
| Tsuchida, H | 1 |
| Dupras, S | 1 |
| Kalucki, FA | 1 |
| Jayabalu, A | 1 |
| Futakuchi-Tsuchida, A | 1 |
| Nakamura, DS | 1 |
| Marchianò, S | 1 |
| Bertero, A | 1 |
| Robinson, MR | 1 |
| Cain, K | 1 |
| Whittington, D | 1 |
| Tian, R | 1 |
| Reinecke, H | 1 |
| Pabon, L | 1 |
| Knollmann, BC | 1 |
| Kattman, S | 1 |
| Thies, RS | 1 |
| MacLellan, WR | 1 |
| Murry, CE | 1 |
| Cacioppo, F | 1 |
| Schwameis, M | 1 |
| Schuetz, N | 1 |
| Oppenauer, J | 1 |
| Schnaubelt, S | 1 |
| Simon, A | 1 |
| Lutnik, M | 1 |
| Gupta, S | 1 |
| Roth, D | 1 |
| Herkner, H | 1 |
| Spiel, AO | 1 |
| Laggner, AN | 1 |
| Domanovits, H | 1 |
| Niederdoeckl, J | 1 |
| Itoh, T | 2 |
| Ishida, Y | 2 |
| Tomita, H | 2 |
| DeCoy, M | 1 |
| Page-Goertz, C | 1 |
| Nofziger, R | 1 |
| Besunder, J | 1 |
| Raimer, P | 1 |
| Gothard, D | 1 |
| Brown, M | 1 |
| Stewart, R | 1 |
| Ruggles, C | 1 |
| Breedlove, K | 1 |
| Clark, J | 1 |
| Drago, F | 1 |
| Tamborrino, PP | 1 |
| Kataoka, N | 1 |
| Imamura, T | 1 |
| García-García, E | 1 |
| De Ceballos, RD | 1 |
| Salem, JE | 2 |
| Dureau, P | 1 |
| Funck-Brentano, C | 2 |
| Hulot, JS | 2 |
| El-Aissaoui, M | 2 |
| Aissaoui, N | 2 |
| Urien, S | 2 |
| Faisy, C | 2 |
| Stetzenbach, M | 1 |
| Schnorbus, B | 1 |
| Sagoschen, I | 1 |
| Bleser, W | 1 |
| Legner, D | 1 |
| Stürer, A | 1 |
| Affangla, DA | 1 |
| Leye, M | 1 |
| Simo, AW | 1 |
| D'Almeida, F | 1 |
| Sarr, TY | 1 |
| Phiri, A | 1 |
| Kane, A | 1 |
| Maqdasy, S | 1 |
| Benichou, T | 1 |
| Dallel, S | 1 |
| Roche, B | 1 |
| Desbiez, F | 1 |
| Montanier, N | 1 |
| Batisse-Lignier, M | 1 |
| Tauveron, I | 1 |
| Arnouk, S | 1 |
| Aberle, C | 1 |
| Altshuler, D | 1 |
| Merchan, C | 1 |
| Piper, GL | 1 |
| Papadopoulos, J | 1 |
| Plechev, VV | 1 |
| Zagidullin, ShZ | 1 |
| Iunusov, VM | 1 |
| Zubareva, IG | 1 |
| Nikolaeva, IE | 1 |
| Kuck, KH | 2 |
| Wissner, E | 1 |
| Darkner, S | 1 |
| Chen, X | 1 |
| Hansen, J | 1 |
| Pehrson, S | 1 |
| Johannessen, A | 1 |
| Nielsen, JB | 1 |
| Svendsen, JH | 1 |
| Huynh, K | 1 |
| Shah, R | 1 |
| Deam, AG | 1 |
| Nebhani, T | 1 |
| Bakkali, H | 1 |
| Belyamani, L | 1 |
| Alazard, M | 1 |
| Le-Heuzey, JY | 1 |
| Muraro, L | 1 |
| Longo, L | 1 |
| Geraldini, F | 1 |
| Bortot, A | 1 |
| Paoli, A | 1 |
| Boscolo, A | 1 |
| Egloff, M | 1 |
| Philippe, J | 1 |
| Finlay, MC | 1 |
| Specterman, M | 1 |
| Schilling, RJ | 2 |
| Filho, SJ | 1 |
| Dogan, M | 1 |
| Kucuk, U | 1 |
| Yalcin, M | 1 |
| Kardesoglu, E | 1 |
| Ghezel-Ahmadi, V | 1 |
| Kürschner, VC | 1 |
| Fisseler-Eckhoff, A | 1 |
| Schirren, J | 1 |
| Schmitz, JE | 1 |
| Obenhaus, T | 1 |
| Cuneo, BF | 2 |
| Haas, NA | 1 |
| Camphausen, CK | 1 |
| Stiefelhagen, P | 1 |
| Wiegand, G | 1 |
| Haber, HP | 1 |
| Binder, G | 1 |
| Kaulitz, R | 1 |
| Hofbeck, M | 1 |
| Packer, DL | 1 |
| Prutkin, JM | 1 |
| Hellkamp, AS | 1 |
| Mitchell, LB | 3 |
| Bernstein, RC | 1 |
| Wood, F | 1 |
| Boehmer, JP | 1 |
| Carlson, MD | 1 |
| Frantz, RP | 1 |
| McNulty, SE | 1 |
| Rogers, JG | 1 |
| Anderson, J | 1 |
| Johnson, GW | 1 |
| Walsh, MN | 1 |
| Poole, JE | 1 |
| Mark, DB | 1 |
| Lee, KL | 2 |
| Bardy, GH | 1 |
| Eppert, HD | 1 |
| Goddard, KB | 1 |
| Simonian, SM | 1 |
| Lotfipour, S | 1 |
| Wall, C | 1 |
| Langdorf, MI | 1 |
| Trappe, HJ | 2 |
| Arya, A | 1 |
| Silberbauer, JS | 1 |
| Vrahimides, J | 1 |
| Cheek, E | 1 |
| Mitchell, A | 1 |
| Boodhoo, L | 1 |
| Pugh, P | 1 |
| Large, J | 1 |
| Bordoli, G | 1 |
| Taggu, W | 1 |
| Lloyd, GW | 1 |
| Patel, NR | 1 |
| Sulke, AN | 1 |
| Moreno, J | 1 |
| Quintanilla, JG | 1 |
| López-Farré, A | 1 |
| Archondo, T | 1 |
| Cervigón, R | 1 |
| Aragoncillo, P | 1 |
| Usandizaga, E | 1 |
| Silva, J | 1 |
| Rodríguez-Bobada, C | 1 |
| Rojo, JL | 1 |
| Pérez-Castellano, N | 1 |
| Mironov, S | 1 |
| Mont, L | 1 |
| Pérez de Prada, T | 1 |
| Macaya, C | 1 |
| Pérez-Villacastín, J | 1 |
| Dardas, TF | 1 |
| Aaronson, KD | 1 |
| Sohns, C | 1 |
| Zabel, M | 1 |
| Yang, ZF | 1 |
| Li, CZ | 1 |
| Wang, W | 1 |
| Chen, YM | 1 |
| Zhang, Y | 1 |
| Liu, YM | 1 |
| Wang, HW | 1 |
| Werner, CR | 1 |
| Riessen, R | 1 |
| Gregor, M | 1 |
| Bitzer, M | 1 |
| Li, VH | 1 |
| Mallick, A | 1 |
| Concannon, C | 1 |
| Li, VY | 1 |
| Ito, S | 1 |
| Konishi, T | 1 |
| Imazuru, T | 1 |
| Matsuzaki, K | 1 |
| Jikuya, T | 1 |
| Trombert, V | 1 |
| Samaras, N | 1 |
| Vogler, J | 1 |
| Eckardt, L | 1 |
| Bhavnani, SP | 1 |
| Clyne, CA | 1 |
| Dirlik, A | 1 |
| Erinc, R | 1 |
| Ozcan, Z | 1 |
| Atasever, A | 1 |
| Bacakoglu, F | 1 |
| Nalbantgil, S | 1 |
| Ozhan, M | 1 |
| Burak, Z | 1 |
| Shinagawa, K | 1 |
| Shiroshita-Takeshita, A | 1 |
| Schram, G | 1 |
| Nattel, S | 2 |
| Wolbrette, DL | 1 |
| Nelson, JA | 1 |
| Knowlton, KU | 1 |
| Harrigan, R | 1 |
| Pollack, ML | 1 |
| Chan, TC | 1 |
| Hall, CM | 1 |
| McCormick, KP | 1 |
| Brandts, B | 1 |
| Weismueller, P | 1 |
| Burri, S | 1 |
| Hug, MI | 1 |
| Bauersfeld, U | 1 |
| Strasburger, JF | 2 |
| Michon, MM | 1 |
| Gotteiner, NL | 1 |
| Deal, BJ | 3 |
| McGregor, SN | 1 |
| Oudijk, MA | 1 |
| Meijboom, EJ | 1 |
| Feinkind, L | 1 |
| Hussey, M | 1 |
| Parilla, BV | 1 |
| Mazur, AP | 1 |
| Popov, ON | 1 |
| Kuz'mich, IN | 1 |
| Korolev, AE | 1 |
| Lomenick, JP | 1 |
| Jackson, WA | 1 |
| Backeljauw, PF | 1 |
| Zafalon, N | 1 |
| Bassani, JW | 1 |
| Bassani, RA | 1 |
| Pete, B | 1 |
| Hajdú, J | 1 |
| Papp, Z | 1 |
| Saul, JP | 1 |
| Scott, WA | 1 |
| Brown, S | 1 |
| Marantz, P | 1 |
| Acevedo, V | 1 |
| Etheridge, SP | 1 |
| Perry, JC | 2 |
| Triedman, JK | 1 |
| Burriss, SW | 1 |
| Cargo, P | 1 |
| Graepel, J | 1 |
| Koskelo, EK | 1 |
| Wang, R | 2 |
| Pollak, PT | 2 |
| Wee, V | 1 |
| Al-Hazmi, A | 1 |
| Martin, J | 1 |
| Zarnke, KB | 1 |
| Abu-Laban, RB | 1 |
| Yeo, KK | 1 |
| Cruz, L | 1 |
| Hong, R | 1 |
| Sato, K | 2 |
| Shiga, T | 2 |
| Matsuda, N | 2 |
| Onoda, N | 1 |
| Takano, K | 2 |
| Hagiwara, N | 2 |
| Kasanuki, H | 2 |
| Kum, LC | 1 |
| Chan, WW | 1 |
| Hui, HH | 1 |
| Wong, GW | 1 |
| Ho, SS | 1 |
| Sanderson, JE | 1 |
| Yu, CM | 1 |
| Fung, JW | 1 |
| Hsieh, MY | 1 |
| Lee, PC | 1 |
| Hwang, B | 1 |
| Meng, CC | 1 |
| Rejnmark, L | 1 |
| Vestergaard, P | 1 |
| Mosekilde, L | 1 |
| Denne, C | 2 |
| Pföhler, C | 1 |
| Sybrecht, G | 2 |
| Chen, YY | 1 |
| Chen, CY | 1 |
| Leung, KK | 1 |
| Abrams, DJ | 1 |
| Earley, MJ | 1 |
| Sporton, SC | 1 |
| Kistler, PM | 1 |
| Gatzoulis, MA | 1 |
| Mullen, MJ | 1 |
| Till, JA | 1 |
| Cullen, S | 1 |
| Walker, F | 1 |
| Lowe, MD | 1 |
| Deanfield, JE | 1 |
| Jarand, J | 1 |
| Lee, A | 1 |
| Leigh, R | 1 |
| Ozaydín, M | 1 |
| Varol, E | 1 |
| Dogan, A | 1 |
| Aslan, SM | 1 |
| Altínbas, A | 1 |
| Komamura, K | 1 |
| Franklyn, JA | 1 |
| Gammage, MD | 1 |
| Parsai, C | 1 |
| Bonvini, RF | 1 |
| Schnetzler, B | 1 |
| Sunthorn, H | 1 |
| Yamada, Y | 1 |
| Yamazaki, K | 1 |
| Mitsuhashi, T | 1 |
| Yamada, E | 1 |
| Yamada, T | 1 |
| Kosaka, S | 1 |
| Obara, T | 1 |
| Marçon, O | 1 |
| Brembilla-Perrot, B | 1 |
| Barrueto, F | 1 |
| Murr, I | 1 |
| Meltzer, A | 1 |
| Brewer, K | 1 |
| Meggs, W | 1 |
| Negro, R | 1 |
| Aloisi, B | 1 |
| Russo, L | 1 |
| Mazzaglia, G | 1 |
| Liistro, M | 1 |
| Brancati, B | 1 |
| Peters, RW | 1 |
| Inama, G | 4 |
| Guareneiro, M | 1 |
| Disertori, M | 4 |
| Camin, G | 1 |
| Fiorentini, F | 1 |
| Nicasi, L | 1 |
| Furlanello, F | 5 |
| Tartini, R | 2 |
| Kappenberger, L | 2 |
| Steinbrunn, W | 3 |
| Meyer, UA | 1 |
| Pitcher, D | 1 |
| Leather, HM | 1 |
| Storey, GC | 2 |
| Holt, DW | 4 |
| Prystowsky, EN | 13 |
| Marcus, FI | 3 |
| Somberg, JC | 3 |
| Kienzle, MG | 1 |
| Williams, PD | 1 |
| Zygmont, D | 1 |
| Doherty, JU | 3 |
| Josephson, ME | 8 |
| Gasparich, JP | 1 |
| Mason, JT | 1 |
| Greene, HL | 1 |
| Berger, RE | 1 |
| Krieger, JN | 1 |
| Theisen, K | 2 |
| Jahrmärker, H | 1 |
| Zhivoderov, VM | 1 |
| Zakharov, VN | 1 |
| Doshchitsin, VL | 1 |
| Aksenova, TN | 1 |
| Andriukova, EI | 1 |
| Lüderitz, B | 6 |
| Morady, F | 14 |
| Scheinman, MM | 13 |
| Hess, DS | 1 |
| Coumel, P | 10 |
| Lucet, V | 2 |
| Do Ngoc, D | 2 |
| Rotmensch, HH | 3 |
| Swanson, BN | 2 |
| Greenspon, AJ | 5 |
| Shoshani, D | 2 |
| Greenspan, AM | 5 |
| Fisher, JD | 5 |
| Furman, S | 1 |
| Kim, SG | 5 |
| Matos, JA | 1 |
| Waspe, LE | 4 |
| Yee, R | 1 |
| Klein, GJ | 1 |
| Levick, CE | 1 |
| Mizgala, HF | 1 |
| Kerr, CR | 1 |
| Bhandari, AK | 2 |
| Quock, C | 1 |
| Sung, RJ | 6 |
| Wiener, I | 1 |
| Lyons, H | 1 |
| Walter, PF | 1 |
| Pollak, S | 1 |
| Leclercq, JF | 4 |
| Assayag, P | 2 |
| Reddy, CP | 3 |
| Kuo, CS | 3 |
| Jivrajka, V | 1 |
| Waxman, HL | 3 |
| Groh, WC | 1 |
| Marchlinski, FE | 6 |
| Buxton, AE | 7 |
| Sadowski, LM | 1 |
| Horowitz, LN | 6 |
| Kastor, JA | 1 |
| Wilkinson, PR | 1 |
| Rees, JR | 1 |
| Menozzi, C | 2 |
| Lolli, G | 2 |
| Monducci, I | 2 |
| Gheller, G | 1 |
| Brignole, M | 2 |
| Vergoni, W | 1 |
| Barone, A | 1 |
| Cattabiani, ML | 1 |
| Guiducci, U | 1 |
| Canada, AT | 2 |
| Lesko, LJ | 2 |
| Haffajee, CI | 4 |
| Johnson, B | 1 |
| Asdourian, GK | 2 |
| Saksena, S | 4 |
| Rothbart, ST | 3 |
| Cappello, G | 3 |
| Zipes, DP | 11 |
| Heger, JJ | 11 |
| Garson, A | 3 |
| Gillette, PC | 4 |
| McVey, P | 3 |
| Hesslein, PS | 2 |
| Porter, CJ | 2 |
| Angell, LK | 1 |
| Kaldis, LC | 1 |
| Hittner, HM | 1 |
| Miles, WM | 5 |
| Vejby-Christensen, H | 1 |
| Bjerregaard, P | 1 |
| Andreasen, F | 1 |
| Gøtzsche, H | 1 |
| Shen, E | 2 |
| Shapiro, W | 1 |
| DiCarlo, L | 1 |
| Koblic, M | 1 |
| Petri, M | 1 |
| Bell, JA | 1 |
| McGovern, B | 4 |
| Garan, H | 4 |
| Kelly, E | 1 |
| Ruskin, JN | 5 |
| Manz, M | 5 |
| Steinbeck, G | 3 |
| Cassagneau, B | 1 |
| Calazel, J | 1 |
| Puel, J | 1 |
| Massabuau, P | 1 |
| Tournadre, P | 1 |
| Fauvel, JM | 1 |
| Bounhoure, JP | 1 |
| Marin, T | 1 |
| Narula, OS | 1 |
| Laser, J | 1 |
| Ward, DE | 3 |
| Camm, AJ | 2 |
| Dymond, D | 1 |
| Spurrell, RA | 1 |
| Anderson, GJ | 1 |
| Kappenberger, LJ | 1 |
| Fromer, MA | 1 |
| Shenasa, M | 3 |
| Shah, Y | 1 |
| Mostow, ND | 5 |
| Rakita, L | 4 |
| Vrobel, TR | 4 |
| Noon, DL | 2 |
| Blumer, J | 2 |
| Fournier, JP | 1 |
| Palmier, B | 1 |
| Marsan, P | 1 |
| Dorne, R | 1 |
| Garrigue, G | 1 |
| Belhassen, B | 4 |
| Spielman, SR | 6 |
| Vlasses, PH | 2 |
| Mazonson, PD | 1 |
| Williams, ML | 2 |
| Cantley, LK | 1 |
| Dalldorf, FG | 1 |
| Utiger, RD | 1 |
| Foster, JR | 2 |
| Staiger, C | 1 |
| Jauernig, R | 1 |
| de Vries, J | 1 |
| Weber, E | 1 |
| Dick, M | 1 |
| Campbell, RM | 1 |
| Meruane, J | 1 |
| Manzur, F | 1 |
| Saavedra, M | 1 |
| Pinho, C | 1 |
| Bittencourt, LA | 2 |
| Coelho, OR | 1 |
| Jorge, PA | 2 |
| Raviele, A | 4 |
| Di Pede, F | 4 |
| Delise, P | 4 |
| Piccolo, E | 4 |
| Skovlund, E | 1 |
| Haunsø, S | 1 |
| Petersen, A | 2 |
| Andersen, ED | 1 |
| Sørensen, SS | 1 |
| Sander, E | 1 |
| Butland, RJ | 1 |
| Millard, FJ | 1 |
| El Allaf, D | 1 |
| Sprynger, M | 1 |
| Carlier, J | 1 |
| Vergara, G | 3 |
| Guarnerio, M | 3 |
| Bettini, R | 3 |
| Durante, G | 1 |
| Stirpe, E | 2 |
| Ferguson, RK | 1 |
| Solow, EB | 1 |
| Valladares, BK | 1 |
| Lemberg, L | 1 |
| Johns, JA | 1 |
| Harper, RW | 1 |
| Currie, PJ | 1 |
| Federman, J | 1 |
| Anderson, ST | 1 |
| Pitt, A | 1 |
| DiMarco, JP | 6 |
| Derkac, WM | 1 |
| Akins, CW | 1 |
| Daggett, WM | 1 |
| Austen, WG | 1 |
| Buckley, MJ | 1 |
| Vazquez Blanco, M | 1 |
| Milei, J | 1 |
| Piñeiro, DJ | 1 |
| Buceta, JE | 1 |
| Dreyer, MP | 1 |
| Giani, P | 2 |
| Maggioni, AP | 2 |
| Volpi, A | 2 |
| Cavalli, A | 2 |
| Latini, R | 1 |
| Neyroz, P | 1 |
| Riva, E | 1 |
| D'Aranno, V | 1 |
| Ott, D | 1 |
| Zinner, A | 2 |
| Blair, H | 1 |
| Love, JC | 3 |
| Alpert, JS | 3 |
| Sloan, KC | 1 |
| Schwartz, A | 1 |
| Hess, D | 2 |
| Bhandari, A | 3 |
| Sauve, MJ | 5 |
| Malone, P | 3 |
| Shen, EN | 2 |
| Schwartz, AB | 1 |
| Keung, E | 1 |
| Schrijver, G | 1 |
| Allison, SN | 1 |
| Meinders, AE | 1 |
| Chaillet, JL | 1 |
| Shahar, E | 1 |
| Barzilay, Z | 1 |
| Frand, M | 1 |
| Feigl, A | 2 |
| Cortadellas Angel, J | 1 |
| Valle Tudela, V | 1 |
| Cinca Cuscullola, J | 1 |
| Shapira, J | 1 |
| Paredes, A | 1 |
| Ashkenazi, B | 1 |
| Pelleg, A | 1 |
| Miller, HI | 1 |
| Laniado, S | 3 |
| Battaglia, T | 1 |
| Paparo, F | 1 |
| Fumarulo, A | 1 |
| Attanà, A | 1 |
| Ciconte, V | 1 |
| Caristo, S | 1 |
| Martini, B | 1 |
| Nager, G | 1 |
| Nager, F | 1 |
| Glasson, S | 1 |
| Bron, D | 1 |
| Payot, M | 1 |
| Schelling, JL | 1 |
| McKenna, WJ | 4 |
| Fidelle, J | 3 |
| Wellens, HJ | 9 |
| Brugada, P | 7 |
| Abdollah, H | 1 |
| Dassen, WR | 1 |
| Alboni, P | 1 |
| Shantha, N | 1 |
| Pirani, R | 1 |
| Baggioni, F | 1 |
| Scarfo, S | 1 |
| Tomasi, AM | 1 |
| Masoni, A | 1 |
| Gomes, JA | 3 |
| Kang, PS | 3 |
| Hariman, RJ | 4 |
| El-Sherif, N | 2 |
| Lyons, J | 1 |
| Tzivoni, D | 3 |
| Keren, A | 3 |
| Cohen, AM | 1 |
| Loebel, H | 1 |
| Zahavi, I | 1 |
| Chenzbraun, A | 1 |
| Stern, S | 3 |
| Landymore, R | 2 |
| Marble, A | 2 |
| MacKinnon, G | 2 |
| Leadon, R | 1 |
| Gardner, M | 1 |
| Leech, JA | 1 |
| Gallastegui, J | 2 |
| Swiryn, S | 2 |
| Feld, GK | 1 |
| Nademanee, K | 7 |
| Weiss, J | 1 |
| Stevenson, W | 2 |
| Singh, BN | 8 |
| Fogoros, RN | 4 |
| Cinca, J | 1 |
| Valle, V | 1 |
| Figueras, J | 1 |
| Gutierrez, L | 1 |
| Montoyo, J | 1 |
| Rius, J | 1 |
| Santinelli, V | 2 |
| Chiariello, M | 3 |
| Santinelli, C | 1 |
| Condorelli, M | 3 |
| Sami, M | 1 |
| Malacoff, RF | 1 |
| Grant, G | 1 |
| Sellers, TD | 2 |
| Denker, S | 1 |
| Mahmud, R | 1 |
| Lehmann, M | 1 |
| Estrada, A | 1 |
| Akhtar, M | 1 |
| Kannan, R | 3 |
| Hendrickson, J | 3 |
| Ookhtens, M | 1 |
| Kay, I | 1 |
| Heddle, WF | 1 |
| Noon, D | 2 |
| Poll, DS | 1 |
| Forfar, JC | 1 |
| Gribbin, B | 1 |
| Romano, M | 1 |
| Garbarini, U | 1 |
| Cazzani, E | 1 |
| Rasmussen, K | 1 |
| Winkle, R | 1 |
| Ross, D | 1 |
| Griffin, J | 1 |
| Peters, F | 1 |
| Mason, J | 1 |
| Kaski, JC | 1 |
| Girotti, LA | 1 |
| Messuti, H | 1 |
| Rutitzky, B | 1 |
| Rosenbaum, MB | 2 |
| Jackman, WM | 2 |
| Naccarelli, GV | 3 |
| Warfel, KA | 1 |
| Rinkenberger, RL | 2 |
| Garabedian, V | 1 |
| Lagarde, O | 1 |
| Guiraudon, C | 1 |
| Frank, F | 1 |
| Fontaine, G | 3 |
| Richart, JC | 1 |
| Coignard, A | 1 |
| Duret, JC | 1 |
| Mardelle, T | 1 |
| Droniou, J | 1 |
| Mattison, P | 1 |
| Rodger, JC | 1 |
| Sheinman, BD | 1 |
| Evans, T | 1 |
| Batisse, A | 3 |
| Sardet, A | 1 |
| Fermont, L | 1 |
| Kachaner, J | 4 |
| Botvinick, EH | 1 |
| Niessen, S | 1 |
| Gefter, WB | 1 |
| Epstein, DM | 1 |
| Pietra, GG | 1 |
| Miller, WT | 1 |
| Intarachot, V | 1 |
| Lopez, B | 1 |
| Feld, G | 1 |
| Cannom, DS | 1 |
| Weiss, JL | 1 |
| McComb, JM | 2 |
| Khan, MM | 2 |
| Geddes, JS | 2 |
| Sclarovsky, S | 7 |
| Lewin, RF | 2 |
| Kracoff, O | 1 |
| Strasberg, B | 7 |
| Arditti, A | 2 |
| Agmon, J | 5 |
| Asdourian, G | 1 |
| Anderson, KP | 1 |
| Winkle, RA | 3 |
| Swerdlow, CD | 2 |
| Mason, JW | 2 |
| Pickoff, AS | 1 |
| Singh, S | 1 |
| Flinn, CJ | 1 |
| Wolff, GS | 1 |
| Gelband, H | 1 |
| van Zandwijk, N | 1 |
| Darmanata, JI | 1 |
| Düren, DR | 3 |
| Alberts, C | 1 |
| Durrer, D | 2 |
| Wagenvoort, CA | 1 |
| Le Heuzey, JY | 1 |
| Cabanis, C | 2 |
| Lardoux, H | 1 |
| Guize, L | 2 |
| Lairy, G | 1 |
| Maurice, P | 2 |
| Sun, JP | 2 |
| Botti, G | 2 |
| Bonatti, V | 2 |
| Rolli, A | 2 |
| Conte, MR | 1 |
| Gaita, F | 1 |
| Asteggiano, R | 1 |
| Bocchiardo, M | 1 |
| Rosettani, E | 1 |
| Lubbe, WF | 2 |
| Mercer, CJ | 1 |
| Roche, AH | 1 |
| Lowe, JB | 1 |
| Gallagher, JD | 1 |
| Lieberman, RW | 1 |
| Meranze, J | 1 |
| Ellison, N | 1 |
| Fontaine, GH | 1 |
| Frank, R | 3 |
| Grosgogeat, Y | 3 |
| Riccioni, N | 1 |
| Bartolomei, C | 1 |
| Gottlieb, S | 2 |
| Benhorin, J | 2 |
| Griffin, JC | 3 |
| Ross, DL | 1 |
| Keefe, DL | 1 |
| Clusin, WT | 1 |
| Hendrickson, JA | 1 |
| Reed, AW | 1 |
| Melmed, S | 1 |
| Hershman, J | 1 |
| Welch, WJ | 1 |
| Coelho, A | 1 |
| Rosen, KM | 1 |
| Ezri, MD | 2 |
| Huang, SK | 2 |
| Messer, JV | 1 |
| Denes, P | 2 |
| Portillo, B | 1 |
| Portillo-Leon, N | 1 |
| Zaman, L | 1 |
| Castellanos, A | 2 |
| Westveer, DC | 2 |
| Gadowski, GA | 1 |
| Gordon, S | 1 |
| Timmis, GC | 1 |
| Candelpergher, G | 1 |
| Buchberger, R | 1 |
| Suzzi, G | 1 |
| Padrini, R | 1 |
| Costa, C | 1 |
| Guarini, G | 1 |
| Critelli, G | 1 |
| Gallagher, JJ | 1 |
| Perticone, F | 3 |
| Monda, V | 2 |
| Coltorti, F | 1 |
| Podrid, PJ | 2 |
| Lown, B | 1 |
| Curti, HV | 1 |
| Sanches, PC | 1 |
| Manigot, DA | 1 |
| Carvalhal, S | 1 |
| Gavish, D | 1 |
| Levi, J | 1 |
| Friedman, PL | 1 |
| Bär, FW | 2 |
| Chadid, P | 1 |
| Corbalán, R | 1 |
| Fernández, M | 1 |
| Luco, C | 1 |
| Casanegra, P | 1 |
| Vajola, SF | 1 |
| Chiavarelli, V | 1 |
| Milazzotto, F | 1 |
| Logan, KR | 1 |
| Adgey, AA | 1 |
| Waleffe, A | 2 |
| Mary-Rabine, L | 1 |
| Legrand, V | 2 |
| Demoulin, JC | 2 |
| Kulbertus, HE | 2 |
| Moran, JL | 2 |
| Gallagher, J | 1 |
| Peake, SL | 1 |
| Cunningham, DN | 2 |
| Salagaras, M | 1 |
| Leppard, P | 1 |
| Minutiello, L | 1 |
| Andrivet, P | 2 |
| Boubakri, E | 1 |
| Dove, PJ | 1 |
| Mach, V | 2 |
| Vu Ngoc, C | 1 |
| Shukla, R | 1 |
| Jowett, NI | 1 |
| Thompson, DR | 1 |
| Pohl, JE | 1 |
| Trip, MD | 1 |
| Wiersinga, WM | 1 |
| Butler, J | 1 |
| Harriss, DR | 1 |
| Sinclair, M | 1 |
| Westaby, S | 1 |
| Bobrov, VA | 1 |
| Galichanskiĭ, IV | 1 |
| Bobrova, EV | 1 |
| Mikhalkin, IA | 1 |
| Kupnovitskaia, IG | 1 |
| Zalesskiĭ, VN | 1 |
| Faber, TS | 1 |
| Zehender, M | 3 |
| Van de Loo, A | 1 |
| Hohnloser, S | 1 |
| Just, H | 2 |
| Cairns, JA | 1 |
| Connolly, SJ | 1 |
| Roberts, R | 1 |
| Gent, M | 1 |
| Chapman, MJ | 1 |
| O'Fathartaigh, MS | 1 |
| Peisach, AR | 1 |
| Gnoc, CV | 1 |
| Knilans, TK | 1 |
| Marlow, D | 1 |
| Denfield, SW | 1 |
| Fenrich, AL | 1 |
| Friedman, RA | 1 |
| Villain, E | 3 |
| Bonnet, D | 2 |
| Iserin, L | 1 |
| Aggoun, Y | 1 |
| Sidi, D | 3 |
| Böcker, D | 1 |
| Block, M | 1 |
| Borggrefe, M | 3 |
| Breithardt, G | 3 |
| Heisel, A | 1 |
| Jung, J | 1 |
| Fries, R | 1 |
| Stopp, M | 1 |
| Sen, S | 1 |
| Schieffer, H | 1 |
| Ozbek, C | 1 |
| Desai, AD | 1 |
| Chun, S | 1 |
| Daniels, CJ | 1 |
| Schutte, DA | 1 |
| Hammond, S | 1 |
| Franklin, WH | 1 |
| Clemo, HF | 1 |
| Wood, MA | 1 |
| Gilligan, DM | 2 |
| Ellenbogen, KA | 1 |
| Votey, SR | 1 |
| Herbert, ME | 1 |
| Celiker, A | 1 |
| Ceviz, N | 1 |
| Ozme, S | 1 |
| Kudenchuk, PJ | 1 |
| Cobb, LA | 1 |
| Copass, MK | 1 |
| Cummins, RO | 1 |
| Doherty, AM | 1 |
| Fahrenbruch, CE | 1 |
| Hallstrom, AP | 1 |
| Murray, WA | 1 |
| Olsufka, M | 1 |
| Walsh, T | 1 |
| Reiffel, JA | 1 |
| Kowey, PR | 2 |
| Sloan, SB | 1 |
| Weitz, HH | 1 |
| Sanoski, CA | 1 |
| Bauman, JL | 3 |
| Tomcsányi, J | 1 |
| Arabadzisz, H | 1 |
| Zsoldos, A | 1 |
| Marosi, A | 1 |
| Beck, K | 1 |
| Tanttula, K | 1 |
| Pappinen, H | 1 |
| Hämäläinen, P | 1 |
| Donaldson, RM | 1 |
| Brochier, M | 1 |
| Fauchier, JP | 1 |
| Krikler, D | 1 |
| Rosen, MR | 1 |
| Petit, J | 1 |
| Lancelin, B | 1 |
| Lecannelier, E | 1 |
| Charpentier, A | 1 |
| Charlier, R | 1 |
| Bauthier, J | 1 |
| Richard, J | 1 |
| Bordalo, A | 1 |
| Bruninx, P | 1 |
| Leak, D | 2 |
| Eydt, JN | 2 |
| Posse, RA | 1 |
| Zuelgaray, JT | 1 |
| Brown, AK | 1 |
| Primhak, RA | 1 |
| Newton, P | 1 |
| Veglia, L | 1 |
| Scandiffio, T | 1 |
| Guerricchio, G | 1 |
| Modica, G | 1 |
| Di Fazzio, S | 1 |
| Timpanaro, V | 1 |
| Centamore, G | 1 |
| Chiale, PA | 1 |
| Halpern, MS | 1 |
| Nau, GJ | 1 |
| Przybylski, J | 1 |
| Levi, RJ | 1 |
| Lázzari, JO | 1 |
| Elizari, MV | 1 |
| Touboul, P | 1 |
| Porte, J | 1 |
| Huerta, F | 1 |
| Delahaye, JP | 1 |
| Fidelle, JE | 1 |
| Attuel, P | 1 |
| Brechenmacher, C | 1 |
| Bretagne, J | 1 |
| Clementy, J | 1 |
| Gérard, R | 1 |
| Grolleau, R | 1 |
| Huault, G | 1 |
| Mouy, A | 1 |
| Nouaille, J | 1 |
| Ribiere, M | 1 |
| Toumieux, MC | 1 |
| Lie, KI | 1 |
| Wesdorp, JC | 1 |
| Dohmen, HJ | 1 |
| Pistolese, M | 1 |
| Richichi, G | 1 |
| Kaufmann, G | 1 |
| Zdichynec, B | 1 |
| Husson, J | 1 |
| Haverkamp, W | 1 |
| Hindricks, G | 1 |
| Jung, W | 2 |
| Chiamvimonvat, N | 1 |
| Gillis, AM | 1 |
| Wyse, DG | 2 |
| Sheldon, RS | 2 |
| Duff, HJ | 2 |
| Honerjäger, P | 1 |
| Schmidt, G | 2 |
| Handlin, LR | 1 |
| Brodine, WN | 1 |
| Gibbs, H | 1 |
| Vacek, JL | 1 |
| Matsumura, LK | 1 |
| Born, D | 1 |
| Kunii, IS | 1 |
| Franco, DB | 1 |
| Maciel, RM | 1 |
| Zhang, JF | 1 |
| Liu, J | 1 |
| Liu, XZ | 1 |
| Kato, K | 1 |
| Steurer, G | 1 |
| Schmidinger, H | 1 |
| Frey, B | 1 |
| Summitt, J | 1 |
| Kadish, A | 3 |
| Giniger, AG | 1 |
| Retyk, EO | 1 |
| Laiño, RA | 1 |
| Sananes, EG | 1 |
| Lapuente, AR | 1 |
| Denjoy, I | 1 |
| Maisonblanche, P | 1 |
| Cauchemez, B | 1 |
| Chouty, F | 1 |
| Leenhardt, A | 1 |
| Slama, R | 1 |
| Pongiglione, G | 1 |
| Benson, DW | 1 |
| Ventosa, A | 1 |
| Adragão, P | 1 |
| Bonhorst, D | 1 |
| Seabra-Gomes, R | 1 |
| Ferreiro, JL | 1 |
| Isern Longares, JA | 1 |
| Ramón Moya, AF | 1 |
| Kadish, AH | 4 |
| Chen, RF | 1 |
| Schmaltz, S | 4 |
| Goedel-Meinen, L | 1 |
| Hofmann, M | 1 |
| Maier-Rudolph, W | 1 |
| Barthel, P | 1 |
| Schrag, A | 1 |
| Baedeker, W | 1 |
| Blömer, H | 1 |
| Khastgir, T | 1 |
| Lattuca, J | 1 |
| Aarons, D | 1 |
| Murphy, J | 1 |
| O'Mara, V | 1 |
| Juanteguy, J | 2 |
| Veltri, EP | 7 |
| Evans, SJ | 1 |
| Myers, M | 2 |
| Zaher, C | 1 |
| Simonson, J | 1 |
| Nalos, P | 1 |
| Vaughn, C | 1 |
| Oseran, D | 1 |
| Gang, E | 1 |
| Peter, T | 2 |
| Mandel, W | 1 |
| Calkins, H | 2 |
| Sousa, J | 2 |
| el-Atassi, R | 1 |
| Somberg, J | 1 |
| Kreamer, J | 1 |
| Camba, N | 1 |
| Burckhardt, D | 1 |
| Robertson, A | 1 |
| Hoffmann, A | 1 |
| Pfisterer, M | 1 |
| Kerin, NZ | 1 |
| Frumin, H | 1 |
| Faitel, K | 1 |
| Aragon, E | 1 |
| Rubenfire, M | 1 |
| Wesley, RC | 1 |
| Taylor, R | 1 |
| Nadamanee, K | 1 |
| Bero, CJ | 1 |
| Rihn, TL | 1 |
| Haug, SJ | 1 |
| Friedman, AH | 1 |
| Ballas, SL | 1 |
| Morgera, T | 2 |
| Dreas, L | 1 |
| Humar, F | 1 |
| Maras, P | 1 |
| Chersevani, D | 1 |
| Camerini, F | 2 |
| Tan de Guzman, WL | 1 |
| Chenarides, JG | 1 |
| Okike, NO | 1 |
| Vander Salm, TJ | 1 |
| Gasparini, G | 2 |
| Zanocco, A | 2 |
| Bonso, A | 3 |
| D'Este, D | 3 |
| Toivonen, L | 1 |
| Wolfe, CL | 1 |
| Nibley, C | 1 |
| Chatterjee, K | 1 |
| Scheinman, M | 1 |
| Widerhorn, J | 1 |
| Bughi, S | 1 |
| Rahimtoola, SH | 1 |
| Elkayam, U | 1 |
| Missouris, CG | 1 |
| Boyd, MJ | 1 |
| Oakley, CM | 2 |
| Kidwell, GA | 1 |
| Hurley, W | 1 |
| Mannion, J | 1 |
| Shannon, JA | 1 |
| Hammill, SC | 2 |
| Gersh, BJ | 1 |
| Rubin, DA | 1 |
| McAllister, A | 1 |
| Sorbera, C | 1 |
| Kay, RH | 1 |
| Nalos, PC | 2 |
| Ismail, Y | 1 |
| Pappas, JM | 1 |
| Nyitray, W | 1 |
| DonMichael, TA | 1 |
| Hohnloser, SH | 1 |
| Meinertz, T | 1 |
| Dammbacher, T | 1 |
| Steiert, K | 1 |
| Jähnchen, E | 1 |
| Fraedrich, G | 1 |
| Rosalion, A | 1 |
| Snow, NJ | 1 |
| Horrigan, TP | 1 |
| Lawrie, GM | 1 |
| Pacifico, A | 1 |
| Kaushik, R | 1 |
| Nahas, C | 1 |
| Earle, N | 1 |
| Fananapazir, L | 2 |
| Leon, MB | 1 |
| Bonow, RO | 1 |
| Tracy, CM | 1 |
| Cannon, RO | 1 |
| Epstein, SE | 2 |
| Rosenheck, S | 2 |
| deBuitleir, M | 1 |
| Quieffin, J | 1 |
| Brochet, E | 1 |
| Gamerman, G | 1 |
| Antony, I | 1 |
| Valère, PE | 1 |
| Caprioglio, F | 1 |
| Le Bidois, J | 1 |
| Cohen, L | 1 |
| Piéchaud, JF | 1 |
| Jordaens, L | 1 |
| François, B | 1 |
| Clément, DL | 1 |
| Campbell, RW | 2 |
| Dal Forno, P | 1 |
| Cozzi, F | 1 |
| Takanaka, C | 1 |
| Mooss, AN | 1 |
| Mohiuddin, SM | 1 |
| Hee, TT | 1 |
| Esterbrooks, DJ | 1 |
| Hilleman, DE | 1 |
| Rovang, KS | 1 |
| Sketch, MH | 1 |
| Scanavacca, MI | 1 |
| Sosa, EA | 1 |
| Lee, JH | 1 |
| Bellotti, G | 1 |
| Pileggi, F | 1 |
| Castro, I | 1 |
| Rankin, AC | 1 |
| Pringle, SD | 1 |
| Cobbe, SM | 1 |
| Weiss, D | 1 |
| Gang, ES | 1 |
| Oseran, DS | 1 |
| Mandel, WJ | 1 |
| Santini, M | 1 |
| Ansalone, G | 1 |
| Cacciatore, G | 1 |
| Di Marcotullio, G | 1 |
| Carelli, M | 1 |
| Tubaro, M | 1 |
| Alexidou, G | 1 |
| Bisceglie, I | 1 |
| Kusniec, J | 4 |
| Zlotikamien, B | 1 |
| Mager, A | 1 |
| Vaitkus, PT | 1 |
| Johnston, DR | 4 |
| Best, JF | 1 |
| Rinkenberger, R | 1 |
| Lynch, L | 1 |
| Dunn, M | 2 |
| Robbens, EJ | 1 |
| Ruiter, JH | 1 |
| Davies, M | 1 |
| Quantz, M | 1 |
| Krafchek, J | 1 |
| Lin, HT | 1 |
| Beckman, KJ | 1 |
| Nielsen, AP | 1 |
| Magro, SA | 1 |
| Hargis, J | 1 |
| Wyndham, CR | 1 |
| Fiedler, SB | 2 |
| Elson, JJ | 2 |
| Tonet, J | 2 |
| Haberman, RJ | 1 |
| Ladenson, PW | 1 |
| Griffith, LS | 5 |
| Marinchak, RA | 1 |
| O'Connor, KM | 1 |
| Friehling, TD | 1 |
| Greenberg, ML | 1 |
| Lerman, BB | 2 |
| Haines, DE | 2 |
| Baron, JA | 1 |
| Gössinger, HD | 1 |
| Siostrzonek, P | 1 |
| Wagner, L | 1 |
| Leitha, T | 1 |
| Mösslacher, H | 1 |
| Banasiak, W | 1 |
| Telichowski, C | 1 |
| Molenda, W | 1 |
| Petruk, J | 1 |
| Metner, E | 1 |
| Góral, J | 1 |
| Goldberger, J | 1 |
| Goldberger, S | 1 |
| González, R | 3 |
| Fajuri, A | 1 |
| Arriagada, C | 1 |
| Marchesse, M | 1 |
| Serrat, H | 1 |
| Kenny, D | 1 |
| Paul, V | 1 |
| Griffith, M | 1 |
| Roden, DM | 1 |
| Woosley, RL | 1 |
| Aonuma, K | 1 |
| Rozanski, JJ | 1 |
| Barold, SS | 1 |
| DeWitt, PL | 1 |
| Gosselin, AJ | 1 |
| Lister, JW | 1 |
| Kleinebenne, A | 1 |
| Rudnick, L | 1 |
| Ovsyscher, IA | 1 |
| Schützenberger, W | 1 |
| Leisch, F | 1 |
| Kerschner, K | 1 |
| Harringer, W | 1 |
| Herbinger, W | 1 |
| Lazzara, R | 1 |
| Jorens, PG | 1 |
| van den Heuvel, PA | 1 |
| Ranquin, RE | 1 |
| van den Branden, FA | 1 |
| Parizel, GA | 1 |
| Manolis, AS | 2 |
| Uricchio, F | 1 |
| Estes, NA | 2 |
| Woelfel, A | 1 |
| Cascio, WE | 1 |
| Simpson, RJ | 1 |
| Gettes, LS | 1 |
| Hargrove, WC | 1 |
| Miller, JM | 2 |
| Chinaglia, A | 1 |
| Cibinel, GA | 1 |
| Uslenghi, E | 1 |
| Mangiardi, L | 1 |
| Bernasconi, M | 1 |
| Pogna, M | 1 |
| Potenza, S | 1 |
| Marzegalli, M | 1 |
| Cirino, D | 1 |
| Mattioni, TA | 1 |
| Zheutlin, TA | 1 |
| Sarmiento, JJ | 1 |
| Parker, M | 1 |
| Lesch, M | 1 |
| Kehoe, RF | 1 |
| Bonnyns, M | 1 |
| Sterling, I | 1 |
| Renard, M | 1 |
| Bernard, R | 1 |
| Demaret, B | 1 |
| Bourdoux, P | 1 |
| Ochi, RP | 1 |
| Goldenberg, IF | 1 |
| Almquist, A | 1 |
| Pritzker, M | 1 |
| Milstein, S | 1 |
| Pedersen, W | 1 |
| Gobel, FL | 1 |
| Benditt, DG | 1 |
| Kouvaras, G | 1 |
| Cokkinos, DV | 1 |
| Halal, G | 1 |
| Chronopoulos, G | 1 |
| Ioannou, N | 1 |
| Rechavia, E | 3 |
| Anderson, JL | 2 |
| Martino, E | 1 |
| Aghini-Lombardi, F | 1 |
| Mariotti, S | 1 |
| Bartalena, L | 1 |
| Braverman, L | 1 |
| Pinchera, A | 1 |
| Herre, JM | 3 |
| Helmy, I | 1 |
| Langberg, JJ | 1 |
| Goldberg, H | 1 |
| Pines, A | 1 |
| Dake, MD | 1 |
| Madison, JM | 1 |
| Montgomery, CK | 1 |
| Shellito, JE | 1 |
| Hinchcliffe, WA | 1 |
| Winkler, ML | 1 |
| Bainton, DF | 1 |
| Palakurthy, PR | 1 |
| Iyer, V | 1 |
| Meckler, RJ | 1 |
| Foster, CJ | 1 |
| Love, HG | 1 |
| Huang, W | 1 |
| Wren, C | 1 |
| Kreeger, RW | 1 |
| Rao, RH | 1 |
| Buckell, HM | 1 |
| Rege, VP | 1 |
| Spathis, GS | 1 |
| Sagie, A | 2 |
| Capparelli, EV | 1 |
| Kluger, J | 1 |
| Regnier, JC | 1 |
| Chow, MS | 1 |
| Saoudi, N | 1 |
| Berland, J | 1 |
| Cribier, A | 1 |
| Letac, B | 1 |
| Bassevich, R | 1 |
| Klainman, E | 1 |
| Sharkey, H | 1 |
| Mercadal, E | 1 |
| Alburquerque, J | 1 |
| Martínez, A | 1 |
| Garrett, SN | 1 |
| Waterhouse, WJ | 1 |
| Parmley, VC | 1 |
| De Paola, AA | 1 |
| Brady, P | 1 |
| Morganroth, J | 2 |
| Kay, HR | 4 |
| Tordjman, T | 1 |
| Mack, KD | 1 |
| Volosin, KJ | 1 |
| Greenberg, RM | 1 |
| Jefferies, L | 1 |
| Klein, RC | 1 |
| Machell, C | 1 |
| Rushforth, N | 1 |
| Standefur, J | 1 |
| Trohman, RG | 1 |
| Castellanos, D | 1 |
| Kessler, KM | 1 |
| Klein, LS | 1 |
| Fineberg, N | 1 |
| Kammerling, JM | 1 |
| Chang, MS | 1 |
| Borbola, J | 1 |
| Trampisch, HJ | 1 |
| Gallastegui, JL | 1 |
| Bellocci, F | 1 |
| Santarelli, P | 1 |
| Montenero, S | 1 |
| Nobile, A | 1 |
| Spampinato, A | 1 |
| Nava, S | 1 |
| Zecchi, P | 1 |
| Manzoli, U | 1 |
| Manyari, DE | 1 |
| Ardura, J | 1 |
| Hermoso, F | 1 |
| Bermejo, J | 1 |
| Rae, AP | 3 |
| Kutalek, SP | 1 |
| Kay, GN | 1 |
| Pryor, DB | 1 |
| Harrell, FE | 1 |
| Pressley, JC | 1 |
| Gilbert, MR | 1 |
| German, LD | 1 |
| Koblin, DD | 1 |
| Romanoff, ME | 1 |
| Martin, DE | 1 |
| Hensley, FA | 1 |
| Larach, DR | 1 |
| Stauffer, RA | 1 |
| Luck, JC | 1 |
| Rey, E | 2 |
| Bachrach, LK | 1 |
| Burrow, GN | 1 |
| Goldstein, GD | 1 |
| Windle, J | 1 |
| Felder, SD | 3 |
| Figura, I | 3 |
| Mercando, AD | 1 |
| Feiner, LA | 1 |
| Younge, BR | 1 |
| Kazmier, FJ | 1 |
| Stricker, BH | 1 |
| Fraunfelder, FT | 1 |
| Schmitt, C | 1 |
| Brachmann, J | 1 |
| Waldecker, B | 2 |
| Rizos, I | 1 |
| Senges, J | 1 |
| Kübler, W | 1 |
| Yabek, SM | 1 |
| Miller, S | 1 |
| Leroy, G | 1 |
| Haiat, R | 1 |
| Barthelemy, M | 1 |
| Lionnet, F | 1 |
| Yazaki, Y | 1 |
| Gold, RL | 1 |
| Bishop, RL | 1 |
| Cuda, G | 1 |
| Spadea, F | 2 |
| Pintaudi, C | 2 |
| Tropea, R | 2 |
| Zhu, J | 1 |
| Guarnieri, T | 2 |
| Levine, JH | 1 |
| Watkins, L | 1 |
| Mower, MM | 1 |
| Mirowski, M | 1 |
| Kracoff, OH | 1 |
| Ovsyshcher, I | 1 |
| Gueron, M | 1 |
| Berk, SI | 1 |
| Langenberg, PW | 1 |
| Beckman, K | 1 |
| Brownstein, S | 1 |
| Columbro, C | 1 |
| Bova, G | 1 |
| Gonska, BD | 1 |
| Bethge, KP | 1 |
| Wagner, H | 1 |
| Bosse, K | 1 |
| Köbberling, J | 1 |
| Quentin, CD | 1 |
| Kreuzer, H | 1 |
| Feigl, D | 1 |
| Reinwein, D | 1 |
| Brown, MA | 1 |
| Smith, WM | 1 |
| Norris, RM | 1 |
| Nygaard, TW | 1 |
| Cook, TS | 1 |
| Lukl, J | 1 |
| Cernosek, B | 1 |
| Rezácová, M | 1 |
| Heinc, P | 1 |
| Nguyen, PT | 1 |
| Seger, J | 1 |
| Ericson, T | 1 |
| Mogensen, L | 1 |
| Leman, RB | 1 |
| Zinner, AJ | 1 |
| Bucknall, CA | 1 |
| Keeton, BR | 1 |
| Curry, PV | 1 |
| Tynan, MJ | 1 |
| Sutherland, GR | 1 |
| Jackson, LK | 1 |
| Vassallo, JA | 1 |
| Flores, BT | 1 |
| Platia, EV | 3 |
| Reid, PR | 3 |
| Moro, C | 1 |
| Romero, J | 1 |
| Corres Peiretti, MA | 1 |
| DiCarlo, LA | 3 |
| de Buitleir, M | 2 |
| Baerman, JM | 2 |
| Schurig, L | 1 |
| Annesley, T | 1 |
| Lavery, D | 1 |
| Arnoux, P | 1 |
| Seyral, P | 1 |
| Llurens, M | 1 |
| Djiane, P | 1 |
| Potier, A | 1 |
| Unal, D | 1 |
| Cano, JP | 1 |
| Serradimigni, A | 1 |
| Rouault, F | 1 |
| Mechlis, S | 1 |
| Lubin, E | 1 |
| Laor, J | 1 |
| Margaliot, M | 1 |
| Salerno, JA | 1 |
| Bressan, MA | 1 |
| Vigano, M | 1 |
| Chimienti, M | 1 |
| Previtali, M | 1 |
| Martinelli, L | 1 |
| Pagnin, A | 1 |
| Montemartini, C | 1 |
| Bobba, P | 1 |
| Klein, H | 1 |
| Liu, PH | 1 |
| Lin, CC | 1 |
| Ko, GC | 1 |
| Wang, DJ | 1 |
| Shieh, SM | 1 |
| Sung, PK | 1 |
| Paciotti, MV | 1 |
| Kennedy, EE | 1 |
| Rosenfeld, LE | 1 |
| McPherson, CA | 1 |
| Batsford, WP | 1 |
| Fossati, C | 1 |
| Roy, D | 1 |
| Fineberg, NS | 1 |
| Duncan, G | 1 |
| Dorian, P | 1 |
| Torres, V | 1 |
| Tepper, D | 1 |
| Flowers, D | 1 |
| Wynn, J | 1 |
| Lam, S | 1 |
| Keefe, D | 1 |
| Miura, DS | 1 |
| Krol, RB | 1 |
| Rinder, HM | 1 |
| Wexler, R | 1 |
| Skale, BT | 1 |
| Facchini, M | 1 |
| Den Dulk, K | 1 |
| Buchanan, D | 1 |
| Crawford, F | 1 |
| Zeevi, B | 1 |
| Berant, M | 1 |
| Blieden, LC | 1 |
| Ruffy, R | 1 |
| Lal, R | 1 |
| Kouchoukos, NT | 1 |
| Kim, SS | 1 |
| Sokoloff, NM | 2 |
| Brady, PM | 1 |
| Rumessen, JJ | 1 |
| Kelly, RP | 1 |
| Kuchar, DL | 1 |
| Thorburn, CW | 1 |
| Chowdry, IH | 1 |
| Webb, CR | 1 |
| Rotmensch, H | 1 |
| Segal, BL | 1 |
| Davis, JC | 1 |
| Evans-Bell, T | 1 |
| Winston, SA | 1 |
| Varma, RR | 1 |
| Troup, PJ | 1 |
| Komorowski, RA | 1 |
| Sarna, T | 1 |
| Escoubet, B | 1 |
| Poirier, JM | 1 |
| Maison-Blanche, P | 1 |
| Jaillon, P | 1 |
| Menasche, P | 1 |
| Cheymol, G | 1 |
| Piwnica, A | 1 |
| Lagier, G | 1 |
| Stäubli, M | 1 |
| Zimmermann, A | 1 |
| Bircher, J | 1 |
| Nicholls, DP | 1 |
| Murtagh, JG | 1 |
| Holt, P | 1 |
| Crick, JC | 2 |
| Davies, DW | 1 |
| Curry, P | 1 |
| Clarke, B | 1 |
| Honey, M | 1 |
| Xu, ML | 1 |
| Kumana, CR | 1 |
| Tanser, P | 1 |
| Eydt, J | 1 |
| Dolan, BJ | 1 |
| Flach, AJ | 1 |
| Peterson, JS | 1 |
| Flaker, GC | 1 |
| Alpert, MA | 1 |
| Webel, RR | 1 |
| Ruder, MA | 1 |
| Sanfelippo, JF | 1 |
| Tsutakawa, RK | 1 |
| Shapira, I | 1 |
| Keren, G | 1 |
| Salvi, A | 1 |
| Alberti, E | 1 |
| Silvestri, F | 1 |
| Assmann, I | 1 |
| Krikler, DM | 1 |
| Goodwin, JF | 1 |
| Cavallini, B | 1 |
| Beccari, G | 1 |
| Piancastelli, M | 1 |
| Spinolo, L | 1 |
| Duperron, L | 1 |
| Gauthier, R | 1 |
| Lemay, M | 1 |
| Grignon, A | 1 |
| LeLorier, J | 1 |
| Turakhia, DP | 1 |
| Gandhi, MJ | 1 |
| Adinolfi, L | 1 |
| Bonaduce, D | 1 |
| Dote, I | 1 |
| Golia, B | 1 |
| Masullo, LA | 1 |
| Sparvieri, F | 1 |
| Mariotti, W | 1 |
| Mariani, A | 1 |
| Pierantozzi, A | 1 |
| Hottinger, S | 1 |
| Mettler, D | 1 |
| Leupi, F | 1 |
| Gertsch, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Modeling of Amiodarone Effect on Heart Rate Control in Critically Ill Patients With Atrial Tachyarrhythmias[NCT03413150] | 80 participants (Actual) | Observational | 2007-01-31 | Completed | |||
| Insertable Cardiac Monitor-Guided Early Intervention to Reduce Atrial Fibrillation Burden Following Catheter Ablation (ICM REDUCE-AF)[NCT04922281] | Phase 4 | 120 participants (Anticipated) | Interventional | 2022-02-28 | Recruiting | ||
| [NCT00000609] | Phase 3 | 0 participants | Interventional | 1997-05-31 | Completed | ||
| Acute Mechanical Response to Anti-arrhythmic Drug Therapy[NCT02575534] | 0 participants (Actual) | Interventional | 2015-10-31 | Withdrawn (stopped due to No enrollment in study.) | |||
| Pragmatic Randomized Clinical Trial of Early Dronedarone Versus Usual Care to Change and Improve Outcomes in Persons With First-Detected Atrial Fibrillation[NCT05130268] | Phase 4 | 3,000 participants (Anticipated) | Interventional | 2021-10-29 | Active, not recruiting | ||
| Safety Assessment for Sotalol Protocol in Outpatient Unit[NCT05418036] | Phase 4 | 110 participants (Anticipated) | Interventional | 2020-10-26 | Recruiting | ||
| aMsa and amiOdarone Study in cArdiaC Arrest[NCT04997980] | 500 participants (Anticipated) | Observational | 2015-01-01 | Recruiting | |||
| "Population Pharmacokinetics and Pharmacodynamics of Amiodarone in Children: PK-AMIO"[NCT03842020] | 57 participants (Actual) | Interventional | 2019-02-13 | Completed | |||
| Cognitive Changes After Surgery in the Elderly: Does Minimally Invasive Surgery Influence the Incidence of Postoperative Cognitive Changes Compared to Open Colon Surgery?[NCT01623297] | 52 participants (Anticipated) | Observational | 2012-01-31 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
41 reviews available for amiodarone and Tachycardia
| Article | Year |
|---|---|
Atrial Flutter in Pediatric Patients.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Flutter; Child; Child, Preschool; D | 2022 |
Issues in amiodarone-induced thyrotoxicosis: Update and review of the literature.
Topics: Amiodarone; Anti-Arrhythmia Agents; Humans; Recurrence; Risk Factors; Tachycardia; Thioamides; Thyro | 2019 |
[Tetraplegia revealing a severe pneumococcal meningomyelitis: about a case and literature review].
Topics: Amiodarone; Autoimmunity; Blepharoptosis; Ceftriaxone; Cerebrospinal Fluid; Delayed Diagnosis; Dexam | 2015 |
Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Emergency Servi | 2010 |
[Current role of amiodarone in antiarrhythmic therapy].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Comple | 2010 |
Pharmacology of myocardial calcium-handling.
Topics: Acetanilides; Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Calcium; Calcium Chan | 2012 |
Risk of proarrhythmia with class III antiarrhythmic agents: sex-based differences and other issues.
Topics: Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Female; Heart Conduction System; Humans; Hy | 2003 |
Arrhythmias in the intensive care patient.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; | 2003 |
Amiodarone-induced neonatal hypothyroidism: a unique form of transient early-onset hypothyroidism.
Topics: Amiodarone; Anti-Arrhythmia Agents; Congenital Hypothyroidism; Female; Fetal Diseases; Humans; Hypot | 2004 |
[Tachycardia-induced cardiomyopathy].
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter A | 2007 |
[Long-term drug therapy of reciprocating supraventricular tachycardia: re-examination of a selected series of cases, using computerized programs].
Topics: Acebutolol; Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents | 1980 |
Pharmacologic therapy of tachyarrhythmias in patients with Wolff-Parkinson-White syndrome.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Ajmaline; Amiodarone; Anilides; Aprindine; Atr | 1983 |
Antiarrhythmic drug therapy for sustained ventricular tachycardia.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Benzeneacetami | 1984 |
[Medical treatment of extrasystole and tachycardia (author's transl)].
Topics: Action Potentials; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Bretylium Compounds; Calcium; Cardi | 1980 |
Amiodarone for tachyarrhythmias: pharmacology, kinetics, and efficacy.
Topics: Amiodarone; Animals; Benzofurans; Humans; Kinetics; Tachycardia; Tissue Distribution | 1983 |
Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects.
Topics: Administration, Oral; Amiodarone; Animals; Arrhythmias, Cardiac; Atrioventricular Node; Benzofurans; | 1984 |
Clinical pharmacology of amiodarone.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Benzofurans; Drug Interactions; Heart Ventricles; Humans; | 1984 |
Clinical use and pharmacology of amiodarone.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Autonomic Ne | 1984 |
[Control of recurrent ventricular tachycardia in a case of mitral valve prolapse and arterial hypertension, using the combination of disopyramide and amiodarone].
Topics: Amiodarone; Benzofurans; Disopyramide; Drug Therapy, Combination; Female; Heart Ventricles; Humans; | 1982 |
Clinical pharmacology and therapeutic applications of the antiarrhythmic agent amiodarone.
Topics: Acute Disease; Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atria | 1981 |
Defibrillators are superior to antiarrhythmic drugs in the treatment of ventricular tachyarrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Humans; Randomized Controlled Trial | 1997 |
The role of intravenous amiodarone in the management of cardiac arrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Clinical Trials as Topic; Drug Interactions; Heart Conduction Sy | 1997 |
Postoperative arrhythmias and conduction disorders.
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Surgical Procedures; | 2001 |
How to evaluate class III antiarrhythmic drug efficacy clinically: the benefits and shortcomings of the invasive approach.
Topics: Amiodarone; Anti-Arrhythmia Agents; Drug Evaluation; Electric Stimulation; Electrocardiography, Ambu | 1992 |
[New anti-arrhythmia agents].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardio | 1992 |
Amiodarone therapy guided by electrophysiologic testing: an update.
Topics: Amiodarone; Arrhythmias, Cardiac; Electric Countershock; Electric Stimulation; Electrophysiology; Hu | 1991 |
Fetal and neonatal adverse effects profile of amiodarone treatment during pregnancy.
Topics: Adult; Amiodarone; Female; Fetal Diseases; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infan | 1991 |
[Incessant idiopathic ventricular tachycardia in infants].
Topics: Amiodarone; Cardiomyopathies; Child, Preschool; Electrocardiography; Female; Flecainide; Follow-Up S | 1990 |
Is drug treatment of tachyarrhythmias a science or a lottery?
Topics: Amiodarone; Cardiomyopathy, Hypertrophic; Flecainide; Humans; Propafenone; Tachycardia | 1990 |
Amiodarone: value of programmed electrical stimulation and Holter monitoring.
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Benzofurans; Cardiac Pacing, Artificial; Clin | 1986 |
Amiodarone and torsade de pointes.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Humans; Long QT Syndr | 1989 |
Amiodarone induced torsades de pointe. Report of three cases and review of literature.
Topics: Aged; Aged, 80 and over; Amiodarone; Atrial Fibrillation; Drug Interactions; Electrocardiography; Fe | 1989 |
Rationale of combination antiarrhythmic drug therapy.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Bretylium Compounds; Digitalis Glyc | 1985 |
Amiodarone in pregnancy. Case report and review of the literature.
Topics: Adult; Amiodarone; Electrocardiography; Female; Fetal Heart; Humans; Pregnancy; Pregnancy Complicati | 1988 |
[Hemodynamics in ventricular arrhythmias and in their treatment].
Topics: Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Heart Ventricles; Hemodynamics; Humans; Tac | 1988 |
Indications for the use of amiodarone: a personal perspective.
Topics: Amiodarone; Arrhythmias, Cardiac; Humans; Tachycardia; Ventricular Fibrillation | 1987 |
Practical follow-up guidelines for patients treated with amiodarone.
Topics: Amiodarone; Follow-Up Studies; Humans; Tachycardia; Ventricular Fibrillation | 1987 |
New antiarrhythmic drugs: tocainide, mexiletine, flecainide, encainide, and amiodarone.
Topics: Administration, Oral; Amiodarone; Anilides; Anti-Arrhythmia Agents; Drug Interactions; Encainide; Fl | 1987 |
Atypical pulmonary and neurologic complications of amiodarone in the same patient. Report of a case and review of the literature.
Topics: Aged; Amiodarone; Autonomic Nervous System Diseases; Diagnosis, Differential; Female; Humans; Hypote | 1987 |
[Pharmacologic interaction of amiodarone with other drugs].
Topics: Amiodarone; Benzofurans; Digoxin; Drug Interactions; Humans; Kinetics; Quinidine; Tachycardia | 1985 |
Pharmacologic therapy for survivors of sudden death based on programmed stimulation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Death, Sudden; Heart; Heart Arrest; | 1985 |
35 trials available for amiodarone and Tachycardia
| Article | Year |
|---|---|
Recurrence of arrhythmia following short-term oral AMIOdarone after CATheter ablation for atrial fibrillation: a double-blind, randomized, placebo-controlled study (AMIO-CAT trial).
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Combined Modality | 2014 |
Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cause of Death; Combined Modality Therapy; Death, Sudden, Cardia | 2009 |
Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cause of Death; Combined Modality Therapy; Death, Sudden, Cardia | 2009 |
Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cause of Death; Combined Modality Therapy; Death, Sudden, Cardia | 2009 |
Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cause of Death; Combined Modality Therapy; Death, Sudden, Cardia | 2009 |
Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cause of Death; Combined Modality Therapy; Death, Sudden, Cardia | 2009 |
Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cause of Death; Combined Modality Therapy; Death, Sudden, Cardia | 2009 |
Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cause of Death; Combined Modality Therapy; Death, Sudden, Cardia | 2009 |
Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cause of Death; Combined Modality Therapy; Death, Sudden, Cardia | 2009 |
Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cause of Death; Combined Modality Therapy; Death, Sudden, Cardia | 2009 |
Technetium-99m-DTPA aerosol scintigraphy in amiodarone induced pulmonary toxicity in comparison with Ga-67 scintigraphy.
Topics: Administration, Inhalation; Aerosols; Aged; Amiodarone; Citrates; Female; Gallium; Humans; Lung; Lun | 2002 |
Intravenous amiodarone for incessant tachyarrhythmias in children: a randomized, double-blind, antiarrhythmic drug trial.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Blood Pressure; Child; Child, Preschool; Dose-Respon | 2005 |
Chronic effects of amiodarone in patients with refractory ventricular tachycardia.
Topics: Administration, Oral; Adult; Aged; Amiodarone; Atrioventricular Node; Benzofurans; Clinical Trials a | 1983 |
Amiodarone treatment of critical arrhythmias in children and young adults.
Topics: Adolescent; Adult; Amiodarone; Atrial Flutter; Benzofurans; Child; Child, Preschool; Clinical Trials | 1984 |
[Clinical experience with amiodarone in the treatment of supraventricular and ventricular tachyarrhythmia].
Topics: Adult; Aged; Amiodarone; Benzofurans; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; T | 1984 |
[Long-term drug therapy in ventricular cardiac arrhythmias. Is an improvement of the prognosis possible?].
Topics: Adult; Aged; Amiodarone; Aprindine; Arrhythmias, Cardiac; Disopyramide; Humans; Long-Term Care; Mexi | 1983 |
[Value of provocation tests in the evaluation of the treatment of ventricular tachycardias with amiodarone].
Topics: Adult; Aged; Amiodarone; Benzofurans; Clinical Trials as Topic; Disopyramide; Drug Therapy, Combinat | 1984 |
Antiarrhythmic efficacy of amiodarone in recurrent ventricular tachycardia evaluated by multiple electrophysiological and ambulatory ECG recordings.
Topics: Adult; Aged; Amiodarone; Benzofurans; Clinical Trials as Topic; Electrocardiography; Electrophysiolo | 1982 |
Treatment of the bradycardia-tachycardia syndrome with low doses of amiodarone.
Topics: Aged; Amiodarone; Benzofurans; Bradycardia; Clinical Trials as Topic; Female; Humans; Male; Middle A | 1981 |
Parenteral magnesium sulfate versus amiodarone in the therapy of atrial tachyarrhythmias: a prospective, randomized study.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; APACHE; Female; Humans; Infusions, Pare | 1995 |
A clinical study of amiodarone as a single oral dose in patients with recent-onset atrial tachyarrhythmia.
Topics: Administration, Oral; Aged; Amiodarone; Atrial Fibrillation; Atrial Flutter; Female; Follow-Up Studi | 1994 |
Amiodarone prophylaxis for tachycardias after coronary artery surgery: a randomised, double blind, placebo controlled trial.
Topics: Adult; Aged; Amiodarone; Cardiac Surgical Procedures; Double-Blind Method; Electrocardiography, Ambu | 1993 |
Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT): rationale and protocol. CAMIAT Investigators.
Topics: Amiodarone; Canada; Humans; Myocardial Infarction; Pilot Projects; Proportional Hazards Models; Rese | 1993 |
Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Double-Blind Method; Electr | 1999 |
Clinical efficacy of amiodarone as an antiarrhythmic agent.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Clinical Trials as Topic; Cornea; Drug Evaluation; He | 1976 |
[Electrophysiologic effects of amiodarone in Wolf-Parkinson-White syndrome].
Topics: Action Potentials; Adult; Amiodarone; Anti-Arrhythmia Agents; Benzofurans; Bundle of His; Clinical T | 1976 |
Efficacy and safety of amiodarone in treatment of refractory atrial and ventricular tachyarrhythmias.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Atrial Fibrillation; Electrocardiography; Female; Humans | 1992 |
A comparison of standard and high-dose regimens for the initiation of amiodarone therapy.
Topics: Aged; Amiodarone; Cardiac Pacing, Artificial; Drug Administration Schedule; Female; Heart Conduction | 1992 |
Magnitude and time course of beta-adrenergic antagonism during oral amiodarone therapy.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Amiodarone; Cardiac Complexes, Premature; D | 1990 |
Ventricular pacing threshold and time to capture postdefibrillation in patients undergoing implantable cardioverter-defibrillator implantation.
Topics: Amiodarone; Cardiac Pacing, Artificial; Electric Countershock; Electrocardiography; Female; Humans; | 1991 |
The efficacy of amiodarone in the treatment of refractory nonsustained ventricular tachycardia.
Topics: Administration, Oral; Amiodarone; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Humans | 1991 |
Effects of long-term amiodarone therapy on the defibrillation threshold and the rate of shocks of the implantable cardioverter-defibrillator.
Topics: Amiodarone; Death, Sudden; Electric Countershock; Female; Follow-Up Studies; Humans; Male; Middle Ag | 1991 |
[Treatment of malignant ventricular tachyarrhythmia with amiodarone: comparison of empirical administration and administration guided by Holter or ventricular stimulation. Results of the parallel test].
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Cardiac Pacing, Artificial; Electrocardiography, Ambulat | 1991 |
Electrocardiographic and antiarrhythmic effects of intravenous amiodarone: results of a prospective, placebo-controlled study.
Topics: Aged; Amiodarone; Analysis of Variance; Arrhythmias, Cardiac; Atrial Fibrillation; Chi-Square Distri | 1991 |
Sudden death during empiric amiodarone therapy in symptomatic hypertrophic cardiomyopathy.
Topics: Adult; Amiodarone; Cardiomyopathy, Hypertrophic; Death, Sudden; Electrocardiography, Ambulatory; Fem | 1991 |
Efficacy and tolerance of high-dose intravenous amiodarone for recurrent, refractory ventricular tachycardia.
Topics: Administration, Oral; Aged; Amiodarone; Clinical Trials as Topic; Drug Tolerance; Electrocardiograph | 1990 |
Amiodarone: value of programmed electrical stimulation and Holter monitoring.
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Benzofurans; Cardiac Pacing, Artificial; Clin | 1986 |
[Characteristics of the effectiveness of long-term treatment of ventricular arrhythmia with amiodarone hydrochloride after its intravenous administration].
Topics: Administration, Oral; Amiodarone; Cardiac Complexes, Premature; Electrocardiography, Ambulatory; Hea | 1988 |
Adjuvant xamoterol or metoprolol in patients with malignant ventricular arrhythmia resistant to amiodarone.
Topics: Adrenergic beta-Agonists; Adult; Aged; Amiodarone; Drug Resistance; Drug Therapy, Combination; Elect | 1989 |
Development of congestive heart failure and alterations in left ventricular function in patients with sustained ventricular tachyarrhythmias treated with amiodarone.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Clinical Trials as Topic; Female; Heart; Heart Failure; | 1987 |
Electrophysiologic assessment of antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with dilated cardiomyopathy.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Cardiomyopathy, Dilated | 1987 |
Amiodarone versus amiodarone and a type IA agent for treatment of patients with rapid ventricular tachycardia.
Topics: Adult; Aged; Amiodarone; Death, Sudden; Drug Evaluation; Drug Therapy, Combination; Female; Follow-U | 1986 |
Evaluation by serial electrophysiologic studies of an abbreviated oral loading regimen of amiodarone.
Topics: Administration, Oral; Adult; Aged; Amiodarone; Benzofurans; Clinical Trials as Topic; Drug Administr | 1985 |
450 other studies available for amiodarone and Tachycardia
| Article | Year |
|---|---|
Pharmacologic therapy for engraftment arrhythmia induced by transplantation of human cardiomyocytes.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cell Line; Cell- and Tissue-Based | 2021 |
Cardioversion of Post-Ablation Atrial Tachyarrhythmia with Ibutilide and Amiodarone: A Registry-Based Cohort Study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cohort Studies; Electric Co | 2022 |
Question: Incessant wide QRS complex tachycardia refractory to amiodarone.
Topics: Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Humans; Tachycardia | 2022 |
Answer: Incessant wide QRS complex tachycardia refractory to amiodarone.
Topics: Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Humans; Tachycardia | 2022 |
Hemodynamic profile effects of PM101 amiodarone formulation in patients with post-operative tachyarrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Child; Female; Heart Rate; Humans; Infant, Newborn; Male; Retros | 2023 |
Implication to Prevent Tachyarrhythmia by Amiodarone Therapy During Durable Left Ventricular Assist Device Supports.
Topics: Amiodarone; Anti-Arrhythmia Agents; Heart Failure; Heart-Assist Devices; Humans; Tachycardia | 2023 |
Acquired Hypothyroidism in a Newborn Treated with Amiodarone in the First Week of Life.
Topics: Amiodarone; Anti-Arrhythmia Agents; Fetal Diseases; Humans; Hypothyroidism; Infant, Newborn; Prenata | 2017 |
Effectiveness of heart rate control on hemodynamics in critically ill patients with atrial tachyarrhythmias managed by amiodarone.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Cohort Studies; Critical Illness; Femal | 2017 |
[Acute Monkshood Intoxication Requiring Acute Resuscitation in Suicidal Intent].
Topics: Aconitine; Aconitum; Amiodarone; Anti-Arrhythmia Agents; Female; Glasgow Coma Scale; Humans; Middle | 2017 |
[Poorly tolerated broad QRS complex tachycardia in a newborn].
Topics: Amiodarone; Anti-Arrhythmia Agents; Combined Modality Therapy; Echocardiography, Doppler; Electric C | 2017 |
Clinical effects of intravenous to oral amiodarone transition strategies in critically ill adult patients.
Topics: Administration, Oral; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillati | 2019 |
[Prophylactic use of VFS in patients with coronary artery disease in the perioperative coronary artery bypass grafting].
Topics: Aconitine; Amiodarone; Anti-Arrhythmia Agents; Chemoprevention; Comparative Effectiveness Research; | 2013 |
Why amiodarone failed to lower the rate of recurrence six months after catheter ablation for atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Female; Humans; Male; Ta | 2014 |
Arrhythmias: Amiodarone fails to lower AF recurrence in AMIO-CAT trial.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Female; Humans; Male; Ta | 2014 |
Wide complex tachycardia in a patient with a family history of sudden death.
Topics: Amiodarone; Anti-Arrhythmia Agents; Death, Sudden; Electrocardiography; Humans; Hypotension; Male; M | 2015 |
Modeling of Amiodarone Effect on Heart Rate Control in Critically Ill Patients with Atrial Tachyarrhythmias.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cohort Studies; Cr | 2016 |
Intralipid in acute caffeine intoxication: a case report.
Topics: Advanced Cardiac Life Support; Amiodarone; Antidotes; Caffeine; Drug Overdose; Emulsions; Epinephrin | 2016 |
[Iodine excess induced thyroid dysfunction].
Topics: Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Contrast Media; Humans; Hyperthyroidism; Hyp | 2016 |
A dolus of i.v. amiodarone.
Topics: Amiodarone; Humans; Procainamide; Tachycardia | 2017 |
ECG of the Month.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Dog Diseases; Dogs; Electrocardiography; Male; Tachycar | 2016 |
New Recommendation for Amiodarone in Treatment of Symptomatic Arrhythmias Associated With Atrioventricular Bypass Tracts.
Topics: Amiodarone; Arrhythmias, Cardiac; Electrocardiography; Humans; Tachycardia | 2017 |
[Amiodarone-induced pneumonitis. Lethal complication in a patient after thoracic surgery].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; F | 2008 |
Treatment of fetal tachycardia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiac Electrophysiology; Digoxin; Female; Fetal Diseases; Huma | 2008 |
Impact of early and standardized treatment with amiodarone on therapeutic success and outcome in pediatric patients with postoperative tachyarrhythmia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Blood Pressure; Central Venous Pressure; Critical Care; Heart De | 2008 |
[Cardiac symptoms in endocrinologic disorders. Heart illness caused by the thyroid gland].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Arrhythmias, Cardiac; Atrial Fi | 2009 |
Tital page - ultrasound findings in newborns with amiodarone-induced hypothyroidism.
Topics: Amiodarone; Anti-Arrhythmia Agents; Follow-Up Studies; Humans; Hypothyroidism; Infant, Newborn; Infa | 2009 |
Administration of amiodarone during resuscitation of ventricular arrhythmias.
Topics: Advanced Cardiac Life Support; Amiodarone; Anti-Arrhythmia Agents; Drug Administration Schedule; Dru | 2010 |
[Life-threatening brady- and tachyarrhythmias].
Topics: Adenosine; Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Atropine; Brad | 2010 |
First time and repeat cardioversion of atrial tachyarrhythmias - a comparison of outcomes.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Electric Countershock; Female; Humans; Male; Recurrence; R | 2010 |
Skeletal myoblast implants induce minor propagation delays, but do not promote arrhythmias in the normal swine heart.
Topics: Action Potentials; Amiodarone; Animals; Female; Heart Ventricles; Myoblasts, Skeletal; Myocardial In | 2010 |
Letter by Dardas and Aaronson regarding article, "Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial".
Topics: Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable; Equipment F | 2010 |
Electrophysiological mechanisms of sophocarpine as a potential antiarrhythmic agent.
Topics: Action Potentials; Alkaloids; Amiodarone; Animals; Anti-Arrhythmia Agents; Cells, Cultured; Electrop | 2011 |
[Unexpected complication following esophageal variceal hemorrhage - Case 2/2011].
Topics: Amiodarone; Anti-Bacterial Agents; Ciprofloxacin; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inh | 2011 |
Wide complex tachycardia causing congestive heart failure.
Topics: Amiodarone; Anti-Arrhythmia Agents; Bundle-Branch Block; Catheter Ablation; Cyclohexane Monoterpenes | 2011 |
[A different person in 2 minutes].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Antisocial Personality Disorder; Attitude of Health Perso | 2011 |
[Comparative study between landiolol and amiodarone for therapeutic efficacy after open heart surgery].
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiac Surgical Procedures; | 2011 |
[Practical problem on ECG in elderly patient. Case #18].
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Diagnosis, Differential; Electrocardiography; | 2011 |
Bidirectional ventricular tachycardia due to coronary allograft vasculopathy a unique presentation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Coronary Artery Disease; Defibrillators, Implantable; Drug-Eluti | 2012 |
Effects of antiarrhythmic drugs on fibrillation in the remodeled atrium: insights into the mechanism of the superior efficacy of amiodarone.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channels, L-Type; Dogs; El | 2003 |
Electrocardiographic manifestations: wide complex tachycardia due to accessory pathway.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Electric Countershock; Electrocardiography; Female; Heart | 2003 |
Amiodarone and breast feeding.
Topics: Amiodarone; Anti-Arrhythmia Agents; Breast Feeding; Fetal Diseases; Humans; Infant, Newborn; Milk, H | 2003 |
Efficacy and safety of intravenous amiodarone for incessant tachycardias in infants.
Topics: Age Factors; Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Infant; Infant, Newborn; Infusions, | 2003 |
Amiodarone therapy for drug-refractory fetal tachycardia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Flutter; Digoxin; Electrocardiography; Female; Fetal Dise | 2004 |
[Life threatening tachyarrhythmias in perioperative period].
Topics: Aged; Amiodarone; Electrocardiography; Humans; Middle Aged; Postoperative Period; Risk Factors; Tach | 2003 |
Cholinergic-adrenergic antagonism in the induction of tachyarrhythmia by electrical stimulation in isolated rat atria.
Topics: 1-Methyl-3-isobutylxanthine; Amiodarone; Animals; Anti-Arrhythmia Agents; Carbachol; Cholinergic Ago | 2004 |
[Diagnosis and treatment of haemodynamically significant fetal tachycardia--in 33 cases].
Topics: Amiodarone; Anti-Arrhythmia Agents; Digoxin; Electric Countershock; Female; Fetal Diseases; Follow-U | 2004 |
The use of amiodarone for in-hospital cardiac arrest at two tertiary care centres.
Topics: Amiodarone; Anti-Arrhythmia Agents; Canada; Emergency Medical Services; Heart Arrest; Hospitals; Hum | 2006 |
Amiodarone and apparently unimproved survival from in-hospital cardiac arrest: association, causation or a mix of both?
Topics: Amiodarone; Anti-Arrhythmia Agents; Canada; Emergency Medical Services; Heart Arrest; Hospitals; Hum | 2006 |
Tachycardia-induced elevations in cardiac troponin in the absence of coronary artery disease.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Catheter Abla | 2006 |
Mild and short recurrence of type II amiodarone-induced thyrotoxicosis in three patients receiving amiodarone continuously for more than 10 years.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Autoantibodies; Humans; Immunoglobulins, Thyroid-Stimulati | 2006 |
Prevalence of amiodarone-related hepatotoxicity in 720 Chinese patients with or without baseline liver dysfunction.
Topics: Alanine Transaminase; Algorithms; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Fl | 2006 |
Multifocal atrial tachycardia in 2 children.
Topics: Amiodarone; Child, Preschool; Electrocardiography; Heart Rate; Humans; Infant; Male; Tachycardia | 2006 |
Fracture risk in patients treated with amiodarone or digoxin for cardiac arrhythmias: a nation-wide case-control study.
Topics: Adult; Age Factors; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillat | 2007 |
[Phototoxic skin changes caused by amiodarone].
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Cheek; Dermatitis, Phototoxic; Diagnosis, Dif | 2007 |
Acute pancreatitis and amiodarone: a case report.
Topics: Acute Disease; Aged; Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Pancreatitis; Propafenone; | 2007 |
Comparison of noncontact and electroanatomic mapping to identify scar and arrhythmia late after the Fontan procedure.
Topics: Adolescent; Adult; Aging; Amiodarone; Arrhythmias, Cardiac; Atrial Function, Right; Cardiac Catheter | 2007 |
Amiodaronoma: an unusual form of amiodarone-induced pulmonary toxicity.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Diagnosis, Differential; Female; Humans; Lung Diseases; Lu | 2007 |
Multiple tachycardia forms occurring in a patient with Wolff-Parkinson-White syndrome and acute myocardial infarction.
Topics: Acute Disease; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiotonic Agents; Dopamine; Drug Therapy, | 2007 |
[Face color reveals what tablets he takes].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Dermatitis, Phototoxic; Diagnosis, Differential; Facial De | 2007 |
Treatment of amiodarone-associated thyrotoxicosis.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Carbimazole; Hormone Replacement Therapy; Humans; Hypothyr | 2007 |
Cardiac transplantation in a patient with emotionally triggered implantable cardioverter defibrillator storms.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anxiety; Bradycardia; Defibrillators, Implantable; Electric | 2007 |
Incidence and predictors of pulmonary toxicity in Japanese patients receiving low-dose amiodarone.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Dose-Response Relationship, Drug; Female; Humans; I | 2007 |
Amiodarone reversibly decreases sodium-iodide symporter mRNA expression at therapeutic concentrations and induces antioxidant responses at supraphysiological concentrations in cultured human thyroid follicles.
Topics: Amiodarone; Anti-Arrhythmia Agents; Antioxidants; Cells, Cultured; Dose-Response Relationship, Drug; | 2007 |
[Bi-tachycardia and ischemic cardiopathy (following myocardial infarction)].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Echocardiography; Electrophysiology; Female; Humans | 2007 |
Effects of amiodarone in a swine model of nortriptyline [corrected] toxicity.
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Antidepressive Agents, Tricyclic; Bl | 2006 |
[Long-term use of amiodarone in the treatment of ventricular pre-excitation with tachyarrhythmia attacks].
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Benzofurans; Drug Therapy, Combination; Humans; Q | 1981 |
[Treatment of supraventricular tachycardia].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter | 1981 |
Dangerous interaction between amiodarone and quinidine.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Interactions; Drug Therapy, Combination; Electro | 1982 |
Amiodarone in pregnancy.
Topics: Adult; Amiodarone; Benzofurans; Female; Fetus; Heart Atria; Humans; Infant, Newborn; Pregnancy; Preg | 1983 |
Drug interactions with amiodarone.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Benzofurans; Blo | 1983 |
New directions in antiarrhythmic drug therapy.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Benz | 1984 |
Non-infectious epididymitis associated with amiodarone therapy.
Topics: Adult; Amiodarone; Benzofurans; Epididymitis; Humans; Male; Middle Aged; Tachycardia | 1984 |
[Anti-arrhythmic effectiveness of ethmozine, cordaron and rhythmodan in treating ischemic heart disease].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Benzofurans; Cardiac Complexes | 1981 |
[Drug therapy of arrhythmia in coronary cardiopathy].
Topics: Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Cardiac Comp | 1983 |
Amiodarone in the management of patients with ventricular tachycardia and ventricular fibrillation.
Topics: Amiodarone; Benzofurans; Cardiac Pacing, Artificial; Electrocardiography; Female; Heart Rate; Heart | 1983 |
The use of amiodarone in children.
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Benzofurans; Bundle-Branch Bl | 1983 |
Amiodarone: individualizing dosage with serum concentrations.
Topics: Amiodarone; Animals; Benzofurans; Biological Availability; Cardiac Pacing, Artificial; Chromatograph | 1983 |
DDD/DDT pacemakers in the treatment of ventricular tachycardia.
Topics: Action Potentials; Amiodarone; Heart Rate; Humans; Male; Middle Aged; Muscle Contraction; Pacemaker, | 1984 |
Wide QRS tachycardia: multiple mechanisms in a patient after myocardial infarction.
Topics: Adult; Amiodarone; Cardiac Pacing, Artificial; Drug Therapy, Combination; Electrocardiography; Heart | 1984 |
Failure to pace following high dose antiarrhythmic therapy--reversal with isoproterenol.
Topics: Amiodarone; Anti-Arrhythmia Agents; Disopyramide; Drug Therapy, Combination; Electrocardiography; Hu | 1984 |
Polymorphous ventricular tachycardia associated with a marked prolongation of the Q-T interval induced by amiodarone.
Topics: Aged; Amiodarone; Benzofurans; Electrocardiography; Heart Ventricles; Humans; Male; Tachycardia | 1984 |
Amiodarone for refractory automatic atrial tachycardia: observations on the electrophysiological actions of amiodarone.
Topics: Amiodarone; Atrioventricular Node; Benzofurans; Cardiac Pacing, Artificial; Electrocardiography; Hea | 1984 |
Rapid ventricular tachycardia due to His-Purkinje reentry.
Topics: Adult; Aged; Amiodarone; Bundle of His; Cardiac Pacing, Artificial; Electrocardiography; Heart Condu | 1984 |
European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillati | 1984 |
Effect of amiodarone on electric induction, morphology, and rate of ventricular tachycardia and its relation to clinical efficacy.
Topics: Adult; Aged; Amiodarone; Benzofurans; Cardiac Pacing, Artificial; Electrocardiography; Electrophysio | 1984 |
Amiodarone for control of sustained ventricular tachyarrhythmia: clinical and electrophysiologic effects in 51 patients.
Topics: Adolescent; Adult; Aged; Amiodarone; Benzofurans; Cardiac Pacing, Artificial; Chemical and Drug Indu | 1982 |
Amiodarone: prolonged elimination following cessation of chronic therapy.
Topics: Amiodarone; Benzofurans; Half-Life; Humans; Male; Middle Aged; Peripheral Nervous System Diseases; T | 1984 |
[Our experience in the electric therapy of sustained ventricular tachycardia and in the provocation test. Subsequent pharmacologic implications].
Topics: Adolescent; Adult; Aged; Amiodarone; Child; Electric Stimulation Therapy; Electrocardiography; Femal | 1984 |
Intravenous amiodarone in the acute treatment of recurrent symptomatic ventricular tachycardia.
Topics: Adult; Aged; Amiodarone; Benzofurans; Female; Heart Block; Heart Failure; Humans; Infusions, Parente | 1983 |
New drugs: antiarrhythmic drugs.
Topics: Amiodarone; Benzofurans; Humans; Infusions, Parenteral; Tachycardia | 1983 |
Adverse reactions during treatment with amiodarone hydrochloride.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Digoxin; Drug Interactions; Female; Huma | 1983 |
Intractable tachycardia and a dead battery.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Benzeneacetamides; Electric Countershock; Electric Injurie | 1984 |
Drug therapy of cardiac arrhythmias.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Biological Availabili | 1983 |
Suppression of long-standing incessant ventricular tachycardia by amiodarone.
Topics: Adult; Amiodarone; Benzofurans; Cardiomegaly; Electrocardiography; Humans; Male; Radiography; Tachyc | 1980 |
Antiarrhythmic actions of amiodarone.
Topics: Adult; Amiodarone; Animals; Arrhythmias, Cardiac; Benzofurans; Corneal Diseases; Dose-Response Relat | 1982 |
Efficacy of amiodarone in the Wolff-Parkinson-White syndrome with rapid ventricular response via accessory pathway during atrial fibrillation.
Topics: Adolescent; Adult; Amiodarone; Atrial Fibrillation; Benzofurans; Cardiac Pacing, Artificial; Electro | 1984 |
Clinical efficacy and electropharmacology of continuous intravenous amiodarone infusion and chronic oral amiodarone in refractory ventricular tachycardia.
Topics: Administration, Oral; Aged; Amiodarone; Benzofurans; Cardiac Pacing, Artificial; Electrocardiography | 1984 |
Amiodarone: correlation of serum concentration with suppression of complex ventricular ectopic activity.
Topics: Amiodarone; Benzofurans; Electrocardiography; Female; Heart Ventricles; Humans; Male; Middle Aged; R | 1984 |
[Pulmonary fibrosis during treatment involving amiodarone].
Topics: Aged; Amiodarone; Benzofurans; Humans; Male; Pulmonary Fibrosis; Tachycardia | 1984 |
Steady-state serum amiodarone concentrations: relationships with antiarrhythmic efficacy and toxicity.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Dose-Response Relationship, Drug; Female | 1984 |
Myxedema coma during long-term amiodarone therapy.
Topics: Aged; Amiodarone; Benzofurans; Coma; Humans; Male; Myxedema; Tachycardia; Thyroid Gland; Thyrotropin | 1984 |
Influence of amiodarone on antipyrine pharmacokinetics in three patients with ventricular tachycardia.
Topics: Amiodarone; Antipyrine; Benzofurans; Drug Interactions; Heart Ventricles; Humans; Kinetics; Tachycar | 1984 |
Advances in the management of cardiac arrhythmias in children.
Topics: Adolescent; Adult; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Pa | 1984 |
[Torsade de pointes or atypical ventricular tachycardia in a patient with Chagas' cardiomyopathy].
Topics: Aged; Amiodarone; Chagas Cardiomyopathy; Drug Therapy, Combination; Echocardiography; Electrocardiog | 1984 |
[Torsade de pointes induced by anti-arrhythmia agents. Report of 2 cases].
Topics: Aged; Amiodarone; Benzofurans; Electrocardiography; Female; Humans; Male; Middle Aged; Procainamide; | 1984 |
[Value of a serial electropharmacologic study in survivors of a cardiac arrest secondary to ventricular tachycardia or ventricular fibrillation].
Topics: Adult; Aged; Amiodarone; Death, Sudden; Disopyramide; Drug Therapy, Combination; Electrocardiography | 1984 |
[Amiodarone-induced alveolitis].
Topics: Aged; Amiodarone; Benzofurans; Humans; Male; Pneumonia; Pulmonary Alveoli; Radiography; Tachycardia | 1984 |
[Amiodarone in antiarrhythmic therapy].
Topics: Adolescent; Adult; Aged; Amiodarone; Benzofurans; Child; Child, Preschool; Female; Follow-Up Studies | 1984 |
Fibrosing alveolitis associated with amiodarone.
Topics: Aged; Amiodarone; Benzofurans; Humans; Male; Pulmonary Fibrosis; Tachycardia; Time Factors | 1984 |
Potentiation of the action of oral anticoagulants by amiodarone.
Topics: Acenocoumarol; Amiodarone; Anti-Arrhythmia Agents; Benzofurans; Drug Synergism; Female; Humans; Midd | 1984 |
[Sustained ventricular tachycardia: induced polymorphism. Clinical and electrophysiological aspects; therapeutic implications].
Topics: Adult; Aged; Ajmaline; Amiodarone; Electric Stimulation; Electrocardiography; Electrophysiology; Fem | 1984 |
Amiodarone: a new drug for the treatment of cardiac arrhythmias.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Humans; Tachycardia | 1984 |
Plasma and red blood cell concentrations of amiodarone during chronic therapy.
Topics: Amiodarone; Anorexia; Benzofurans; Erectile Dysfunction; Erythrocytes; Humans; Male; Nausea; Saliva; | 1984 |
Amiodarone--an investigative drug in the coronary care unit.
Topics: Amiodarone; Benzofurans; Heart Ventricles; Humans; Male; Middle Aged; Tachycardia | 1983 |
Amiodarone therapy for life threatening or refractory cardiac arrhythmias.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Kinetics; Ma | 1983 |
Electrophysiologic studies before and after myocardial revascularization in patients with life-threatening ventricular arrhythmias.
Topics: Aged; Amiodarone; Cardiac Pacing, Artificial; Coronary Artery Bypass; Digoxin; Electrophysiology; Fe | 1983 |
Long term-treatment of ventricular tachycardia in ambulatory patients with amiodarone.
Topics: Adult; Aged; Amiodarone; Benzofurans; Electrocardiography; Female; Heart Ventricles; Humans; Male; M | 1983 |
Blood levels and electrophysiological effects of intravenous amiodarone in patients with junctional reciprocating tachycardia. Preliminary observations.
Topics: Adult; Aged; Amiodarone; Atrioventricular Node; Benzofurans; Cardiac Catheterization; Electrophysiol | 1984 |
Junctional automatic ectopic tachycardia: new proposed treatment by transcatheter His bundle ablation.
Topics: Amiodarone; Benzofurans; Bundle of His; Cardiac Catheterization; Electrocardiography; Heart Conducti | 1983 |
Efficacy and safety of long-term amiodarone in treatment of cardiac arrhythmias: dosage experience.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Blood Coagulation Disorders; | 1983 |
Long-term follow-up of patients with recurrent unexplained syncope evaluated by electrophysiologic testing.
Topics: Amiodarone; Electrophysiology; Female; Follow-Up Studies; Humans; Male; Mitral Valve Prolapse; Pacem | 1983 |
Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation.
Topics: Aged; Amiodarone; Anorexia; Ataxia; Benzofurans; Female; Heart Arrest; Humans; Lung Diseases; Male; | 1983 |
[Interstitial and alveolar lung changes following treatment with amiodarone].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Benzofurans; Female; Humans; Myocardial Infarction; Pulmon | 1983 |
Amiodarone in control of sustained tachyarrhythmias in children with Wolff-Parkinson-White syndrome.
Topics: Administration, Oral; Adolescent; Amiodarone; Benzofurans; Child; Child, Preschool; Electrocardiogra | 1983 |
Amiodarone therapy in children: a cautionary comment.
Topics: Adolescent; Amiodarone; Benzofurans; Child; Child, Preschool; Humans; Infant; Tachycardia; Wolff-Par | 1983 |
[Immediate effects of intravenous amiodarone on supraventricular tachyarrhythmias].
Topics: Adolescent; Adult; Aged; Amiodarone; Benzofurans; Child; Drug Evaluation; Female; Humans; Injections | 1983 |
[Role of electrophysiologic studies in selecting preventive therapy in recurrent, sustained ventricular tachycardia].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Drug Therapy, Combination; Electrocardiography; Fem | 1983 |
[Supraventricular tachycardia in children].
Topics: Adenosine Triphosphate; Amiodarone; Cardiac Pacing, Artificial; Child; Digitalis Glycosides; Heart D | 1983 |
[Interaction of amiodarone and digoxin].
Topics: Adult; Aged; Amiodarone; Benzofurans; Digoxin; Drug Interactions; Female; Humans; Male; Middle Aged; | 1983 |
[Monitoring amiodarone].
Topics: Aged; Amiodarone; Benzofurans; Child; Female; Humans; Male; Middle Aged; Tachycardia | 1983 |
Arrhythmia and prognosis in hypertrophic cardiomyopathy.
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiomyopathy, Hypertrophic; Death, Sudden; | 1983 |
Problems of antiarrhythmic treatment in children.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Child; Electrocardiography; Humans; Propaf | 1983 |
A comparison of the electrophysiologic effects of intravenous and oral amiodarone in the same patient.
Topics: Administration, Oral; Adolescent; Adult; Amiodarone; Benzofurans; Cardiac Pacing, Artificial; Child; | 1984 |
Effects of amiodarone on supraventricular tachycardia involving bypass tracts.
Topics: Adolescent; Adult; Aged; Amiodarone; Atrioventricular Node; Benzofurans; Child; Electrocardiography; | 1984 |
Electrophysiologic effects and mechanisms of termination of supraventricular tachycardia by intravenous amiodarone.
Topics: Aged; Amiodarone; Benzofurans; Cardiac Catheterization; Depression, Chemical; Electrocardiography; H | 1984 |
Magnesium therapy for torsades de pointes.
Topics: Aged; Amiodarone; Electrocardiography; Female; Humans; Imipramine; Magnesium Sulfate; Male; Middle A | 1984 |
Effects of oral amiodarone on left ventricular function in dogs: clinical implications for patients with life-threatening ventricular tachycardia.
Topics: Administration, Oral; Amiodarone; Animals; Benzofurans; Cardiopulmonary Bypass; Dogs; Heart; Heart F | 1984 |
Pulmonary toxicity of amiodarone.
Topics: Amiodarone; Benzofurans; Humans; Lung Diseases; Male; Middle Aged; Tachycardia | 1984 |
Electrophysiologic basis for the suppression by amiodarone of orthodromic supraventricular tachycardias complicating pre-excitation syndromes.
Topics: Adult; Aged; Amiodarone; Benzofurans; Digoxin; Electrocardiography; Heart Conduction System; Humans; | 1984 |
Amiodarone-induced refractoriness to cardioversion.
Topics: Amiodarone; Benzofurans; Electric Countershock; Heart Ventricles; Humans; Male; Middle Aged; Tachyca | 1984 |
Shortening of ventriculoatrial conduction in patients with left-sided Kent bundles.
Topics: Adult; Amiodarone; Electrocardiography; Female; Heart Conduction System; Humans; Male; Middle Aged; | 1984 |
Effects of intravenous amiodarone in patients with inducible repetitive ventricular responses and ventricular tachycardia.
Topics: Aged; Amiodarone; Benzofurans; Blood Pressure; Bundle of His; Electric Stimulation; Electrocardiogra | 1984 |
Ventricular tachyarrhythmias complicating amiodarone therapy in the presence of hypokalemia.
Topics: Amiodarone; Benzofurans; Female; Humans; Hypokalemia; Middle Aged; Tachycardia | 1984 |
Acute necrotizing pneumonitis and hyperglycemia after amiodarone therapy. Case report and review of amiodarone-associated pulmonary disease.
Topics: Acute Disease; Aged; Amiodarone; Benzofurans; Humans; Hyperglycemia; Lung; Male; Necrosis; Pneumonia | 1984 |
Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone.
Topics: Aged; Amiodarone; Benzofurans; Cardiac Pacing, Artificial; Death, Sudden; Electrocardiography; Femal | 1984 |
Effect of amiodarone on retrograde conduction and refractoriness of the His-Purkinje system in man.
Topics: Adult; Aged; Amiodarone; Benzofurans; Bundle of His; Electrocardiography; Heart Conduction System; H | 1984 |
Effect of amiodarone on conduction and refractoriness of the His-Purkinje system in the human heart.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Bundle of His; Cardiac Pacing, Artificia | 1984 |
Amiodarone-digoxin interaction: clinical significance, time course of development, potential pharmacokinetic mechanisms and therapeutic implications.
Topics: Adult; Aged; Amiodarone; Benzofurans; Digoxin; Drug Interactions; Drug Therapy, Combination; Female; | 1984 |
Multiple circus movement tachycardias with multiple accessory pathways.
Topics: Amiodarone; Atrioventricular Node; Cardiac Pacing, Artificial; Child; Electrocardiography; Female; H | 1984 |
Amiodarone: intravenous loading for rapid suppression of complex ventricular arrhythmias.
Topics: Administration, Oral; Adult; Aged; Amiodarone; Benzofurans; Female; Heart Ventricles; Humans; Infusi | 1984 |
Sustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy: electrophysiologic testing and lack of response to antiarrhythmic drug therapy.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Death, Sudden; Electric St | 1984 |
Torsade de pointes after amiodarone withdrawal; effects of mild hypokalaemia on repolarization.
Topics: Amiodarone; Benzofurans; Bradycardia; Cardiac Pacing, Artificial; Electrocardiography; Female; Human | 1984 |
[33-year-old patient with severe ventricular heart rhythm disorders].
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Cardiomyopathies; Electroencephalography; Heart Failure; He | 1982 |
Long-term management of sustained, recurrent, symptomatic ventricular tachycardia with amiodarone.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Benzofurans; Corneal Diseases; Humans; Long-Term Ca | 1981 |
Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation.
Topics: Adult; Aged; Amiodarone; Benzofurans; Drug Evaluation; Electric Stimulation; Electrophysiology; Fema | 1981 |
[Malignant ventricular tachyarrythmia due to atrial fibrillation in the Wolff-Parkinson-White syndrome. Section of the Kent bundle apropos of 2 cases].
Topics: Adult; Amiodarone; Atrial Fibrillation; Electrocardiography; Electrophysiology; Heart Conduction Sys | 1981 |
Drug conversion of nonsustained ventricular tachycardia to sustained ventricular tachycardia during serial electrophysiologic studies: identification of drugs that exacerbate tachycardia and potential mechanisms.
Topics: Adult; Aged; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Cardiac Catheterization; Disop | 1982 |
Sinus arrest during treatment with amiodarone.
Topics: Aged; Amiodarone; Benzofurans; Cardiac Pacing, Artificial; Heart Arrest; Humans; Male; Middle Aged; | 1982 |
Rapid control of recurrent ventricular tachycardia with oral amiodarone.
Topics: Administration, Oral; Adult; Aged; Amiodarone; Benzofurans; Female; Humans; Male; Recurrence; Tachyc | 1982 |
Acceleration of ventricular rate by fibrillation associated with the Wolff-Parkinson-White syndrome.
Topics: Aged; Amiodarone; Atrial Fibrillation; Benzofurans; Electrocardiography; Humans; Male; Tachycardia; | 1982 |
[Amiodarone in ventricular tachycardias].
Topics: Adult; Aged; Amiodarone; Benzofurans; Chronic Disease; Female; Heart Ventricles; Humans; Male; Middl | 1982 |
[Treatment of ventricular tachycardia in infancy and childhood with amiodarone].
Topics: Amiodarone; Benzofurans; Child; Electrocardiography; Female; Follow-Up Studies; Humans; Infant; Male | 1982 |
Electrophysiologic mechanism of exercise-induced sustained ventricular tachycardia.
Topics: Adolescent; Adult; Aged; Amiodarone; Cardiomyopathies; Catecholamines; Coronary Disease; Electrophys | 1983 |
[Tachyarrhythmias. Recent aspects of drug treatment].
Topics: Amiodarone; Benzofurans; Electrocardiography; Heart Ventricles; Humans; Tachycardia | 1983 |
Lung disease caused by amiodarone, a new antiarrythmic agent.
Topics: Adult; Aged; Amiodarone; Benzofurans; Biopsy; Humans; Lung; Lung Diseases; Male; Middle Aged; Radiog | 1983 |
Amiodarone in refractory life-threatening ventricular arrhythmias.
Topics: Acute Disease; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Electrocardiography; Fema | 1983 |
Amiodarone and ventricular tachycardia.
Topics: Amiodarone; Benzofurans; Heart Ventricles; Humans; Tachycardia | 1983 |
Amiodarone and ventricular tachycardia.
Topics: Amiodarone; Benzofurans; Digoxin; Drug Interactions; Humans; Tachycardia | 1983 |
Evaluation of antiarrhythmic efficacy of amiodarone in VT.
Topics: Amiodarone; Benzofurans; Cardiac Pacing, Artificial; Electrophysiology; Humans; Tachycardia | 1983 |
Amiodarone-induced polymorphous ventricular tachycardia.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiac Pacing, Artificial; Electrocardiography | 1983 |
Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiac Pacing, Artificial; Chromatograp | 1983 |
Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Male; Middle Aged; Tachy | 1983 |
The efficacy of amiodarone for ventricular arrhythmias can be predicted with clinical electrophysiological studies.
Topics: Adult; Aged; Amiodarone; Benzofurans; Electrophysiology; Female; Heart Ventricles; Humans; Male; Mid | 1983 |
The efficacy of amiodarone for ventricular arrhythmias cannot be predicted with clinical electrophysiological studies.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Electrophysiology; Heart Ventricles; Humans; Tachycar | 1983 |
Should oral amiodarone be used for sustained ventricular tachycardia in patients requiring open-heart surgery?
Topics: Amiodarone; Animals; Benzofurans; Cardiac Output; Cardiac Output, Low; Cardiac Surgical Procedures; | 1983 |
Use of amiodarone in the therapy of primary ventricular arrhythmias in children.
Topics: Adolescent; Age Factors; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Corneal Diseases; Dru | 1983 |
Amiodarone pneumonitis.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Humans; Male; Middle Aged; Pneumonia; Tachycardia | 1983 |
[Supraventricular tachycardias induced by swallowing].
Topics: Adult; Amiodarone; Cardiac Catheterization; Deglutition; Drug Therapy, Combination; Electrocardiogra | 1983 |
[Clinical experience in the treatment of tachyarrhythmias with amiodarone].
Topics: Adult; Aged; Amiodarone; Benzofurans; Electrocardiography; Female; Heart Conduction System; Humans; | 1983 |
[Validity and limits of invasive pharmacological tests in the treatment of malignant ventricular hyperkinetic arrhythmias].
Topics: Adult; Aged; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Evaluation; Fe | 1983 |
[Amiodarone in the bradycardia-tachycardia syndrome. 2-year follow-up].
Topics: Adult; Aged; Amiodarone; Benzofurans; Bradycardia; Female; Follow-Up Studies; Humans; Male; Middle A | 1982 |
Amiodarone in long term management of refractory cardiac tachyarrhythmias.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Benzofurans; Female; Heart Atria | 1981 |
Amiodarone-induced complications during coronary artery surgery.
Topics: Amiodarone; Benzofurans; Coronary Artery Bypass; Heart Block; Humans; Male; Middle Aged; Postoperati | 1981 |
Atypical ventricular tachycardia (torsade de pointes) induced by amiodarone: arrhythmia previously induced by quinidine and disopyramide.
Topics: Adult; Amiodarone; Atrial Fibrillation; Benzofurans; Disopyramide; Dose-Response Relationship, Drug; | 1982 |
Programmed ventricular stimulation in predicting vulnerability to ventricular arrhythmias and their response to antiarrhythmic therapy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Electrocardiog | 1982 |
Antiarrhythmic efficacy and electrophysiologic actions of amiodarone in patients with life-threatening ventricular arrhythmias: potent suppression of spontaneously occurring tachyarrhythmias versus inconsistent abolition of induced ventricular tachycardia
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Electrocardiogra | 1982 |
Pharmacokinetic significance of serum reverse T3 levels during amiodarone treatment: a potential method for monitoring chronic drug therapy.
Topics: Adult; Aged; Amiodarone; Atrial Flutter; Benzofurans; Electrocardiography; Heart Ventricles; Humans; | 1982 |
Sustained macroreentrant ventricular tachycardia.
Topics: Aged; Amiodarone; Disopyramide; Electrocardiography; Heart Conduction System; Humans; Male; Procaina | 1982 |
Electrophysiologic observations of concealed ventricular depolarizations due to amiodarone.
Topics: Amiodarone; Anti-Arrhythmia Agents; Benzofurans; Electrophysiology; Exercise Test; Humans; Male; Mid | 1982 |
Quintuple pathways participating in three distinct types of atrioventricular reciprocating tachycardia in a patient with Wolff-Parkinson-White syndrome.
Topics: Aged; Amiodarone; Atrioventricular Node; Electrocardiography; Electrophysiology; Heart Conduction Sy | 1982 |
Amiodarone-induced ventricular tachycardia.
Topics: Amiodarone; Benzofurans; Electrocardiography; Humans; Male; Middle Aged; Tachycardia; Tachycardia, P | 1982 |
[Trans-placental passage of amiodarone: electrocardiographic evidence and pharmacological findings in a newborn infant].
Topics: Adult; Amiodarone; Benzofurans; Female; Fetus; Humans; Infant, Newborn; Maternal-Fetal Exchange; Pre | 1982 |
[Amiodarone in long-term prevention of hyperkinetic cardiac disorders. Clinical experiments].
Topics: Administration, Oral; Adult; Aged; Amiodarone; Benzofurans; Drug Administration Schedule; Female; Hu | 1982 |
[Harmful interactions of amiodarone and class I anti-arrhythmia agents].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Drug Interaction | 1982 |
[Closed chest interruption of A-V conduction in the treatment of refractory supraventricular tachyarrhythmias. A clinical contribution].
Topics: Amiodarone; Atrial Fibrillation; Atrial Flutter; Cardiac Pacing, Artificial; Digitalis Glycosides; E | 1982 |
Amiodarone therapy in symptomatic, sustained refractory atrial and ventricular tachyarrhythmias.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Male; Middle | 1981 |
[Ventricular tachycardia caused by the use of amiodarone. Report of a case].
Topics: Amiodarone; Benzofurans; Chagas Cardiomyopathy; Electrocardiography; Humans; Male; Middle Aged; Phys | 1981 |
Etiology, warning signs and therapy of torsade de pointes. A study of 10 patients.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Disopyramide; Electrocardiography; Female; Heart Ve | 1981 |
Initiation of ventricular tachycardia by interpolated ventricular premature depolarizations.
Topics: Amiodarone; Cardiac Pacing, Artificial; Electrocardiography; Electrophysiology; Heart Conduction Sys | 1981 |
Amiodarone for ventricular arrhythmias.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Corneal Diseases; Heart; Heart Ventricles; Huma | 1981 |
[Longterm effects of amiodarone in supraventricular tachyarrhythmias (author's transl)].
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Female; Humans; Longi | 1981 |
[Pharmacological therapy and prevention of recurrent ventricular tachycardia].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Bunaftine; Disopyramide; Humans; Male; Middle Aged; | 1981 |
Amiodarone-induced ventricular fibrillation.
Topics: Amiodarone; Benzofurans; Bradycardia; Cardiac Pacing, Artificial; Electric Countershock; Electrocard | 1980 |
Combined mexiletine and amiodarone treatment of refractory recurrent ventricular tachycardia.
Topics: Adult; Amiodarone; Benzofurans; Drug Therapy, Combination; Electric Stimulation; Follow-Up Studies; | 1980 |
Amiodarone in the treatment of cardiac arrhythmias in children: one hundred thirty-five cases.
Topics: Adolescent; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Child, Preschool; Drug Tolerance; | 1980 |
[Noninvasive cardioversion of atrial tachycardia using dual-chamber definitive stimulator].
Topics: Aged; Aged, 80 and over; Amiodarone; Cardiac Pacing, Artificial; Echocardiography; Electrocardiograp | 1994 |
Side effects with amiodarone therapy.
Topics: Aged; Amiodarone; Drug Administration Schedule; Drug Eruptions; Female; Humans; Male; Middle Aged; N | 1994 |
Two cases of amiodarone-induced thyrotoxicosis successfully treated with a short course of antithyroid drugs while amiodarone was continued.
Topics: Adolescent; Amiodarone; Carbimazole; Humans; Male; Middle Aged; Perchlorates; Potassium Compounds; T | 1994 |
[The optimization of the anti-arrhythmia effect of kordaron and novocainamide by laser biostimulation therapy in a combined program for treating refractory tachyarrhythmias].
Topics: Acupuncture Points; Amiodarone; Blood; Combined Modality Therapy; Evaluation Studies as Topic; Heart | 1993 |
Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiomyopathy, Dilated; Drug Combinati | 1994 |
Management of atrial tachyarrhythmias in the critically ill: a comparison of intravenous procainamide and amiodarone.
Topics: Aged; Amiodarone; Atrial Fibrillation; Atrial Flutter; Blood Pressure; Female; Heart Rate; Humans; I | 1993 |
A clinical study of intravenous cibenzoline in selected patients with recent-onset atrial tachyarrhythmia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Female; Humans; Imidazoles; | 1993 |
Intravenous amiodarone for life-threatening tachyarrhythmias in children and young adults.
Topics: Adolescent; Adult; Amiodarone; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; Infant, | 1993 |
[Treatment and prognosis of tachyarrhythmia after atrial surgical repair of transposition of great vessels].
Topics: Adolescent; Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Card | 1996 |
Low energy transvenous cardioversion of short duration atrial tachyarrhythmias in humans using a single lead system.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cardiac Pacing | 1997 |
[Modern therapy of tachycardiac heart arrhythmias].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Atrial Fibrillation; Atrial Flutter; Humans; | 1995 |
Amiodarone as treatment for atrial tachycardias after surgery.
Topics: Administration, Oral; Adolescent; Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Flutter; Cathete | 1997 |
Acute pulmonary toxicity in an infant from intravenous amiodarone.
Topics: Acute Disease; Amiodarone; Bronchoalveolar Lavage Fluid; Dobutamine; Humans; Infant; Infant, Newborn | 1997 |
Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias.
Topics: Aged; Amiodarone; Critical Illness; Female; Heart Rate; Humans; Infusions, Intravenous; Male; Middle | 1998 |
Intravenous amiodarone for treating acute life threatening arrhythmias.
Topics: Acute Disease; Amiodarone; Anti-Arrhythmia Agents; Humans; Injections, Intravenous; Tachycardia; Ven | 1998 |
Effectiveness and safety of intravenous amiodarone in drug-resistant tachyarrhythmias of children.
Topics: Amiodarone; Anti-Arrhythmia Agents; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Infa | 1998 |
Generic antiarrhythmics are not therapeutically equivalent for the treatment of tachyarrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Health Care Surveys; Humans; Tachycardia; Therapeutic Equivalenc | 2000 |
Clinical observations with the amiodarone/warfarin interaction: dosing relationships with long-term therapy.
Topics: Aged; Amiodarone; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Fe | 2002 |
[Control of tachycardia with intravenous amiodarone in acute left heart failure].
Topics: Acute Disease; Aged; Amiodarone; Anti-Arrhythmia Agents; Female; Heart Failure; Humans; Infusions, I | 2001 |
[Pain attacks causing muscle cramps].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Coronary Artery Disease; Defibrillators, Implantable; Elec | 1999 |
[Drug therapy of tachyarrhythmias (author's transl)].
Topics: Action Potentials; Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Aprind | 1978 |
The treatment of supraventricular arrhythmias.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Arrhyt | 1979 |
["Torsades de pointe" and reentry induced by anti-arrhythmia agents].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Flutte | 1978 |
Newer antiarrhythmic drugs.
Topics: Administration, Oral; Adult; Amiodarone; Animals; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Ca | 1978 |
[Hisian tachycardia in an adult with corrected transposition of great vessels].
Topics: Adult; Amiodarone; Bundle of His; Electrocardiography; Female; Heart Conduction System; Humans; Tach | 1979 |
A potentially antianginal benzo [b]thiophene with an amiodarone-like haemodynamic profile.
Topics: Adrenergic beta-Antagonists; Amiodarone; Angina Pectoris; Animals; Benzofurans; Blood Pressure; Card | 1975 |
Electrophysiological effects of L 9394 (benzoyl-indolizine) in man.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Electrocardiography; Female; Heart Conduction System; Human | 1979 |
Control of refractory cardiac arrhythmias with amiodarone.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Male; Middle Aged; Recur | 1979 |
Use of amiodarone in bradycardia-tachycardia syndrome.
Topics: Amiodarone; Benzofurans; Bradycardia; Humans; Tachycardia | 1979 |
[The place of amiodarone in 1979 in the therapeutic arsenal of a cardiac intensive care unit].
Topics: Amiodarone; Angina Pectoris; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Benzofurans; | 1979 |
Use of amiodarone in bradycardia-tachycardia syndrome.
Topics: Aged; Amiodarone; Benzofurans; Bradycardia; Corneal Diseases; Female; Humans; Male; Middle Aged; Syn | 1978 |
["T'orsade de pointe" and amiodarone (author's transl)].
Topics: Amiodarone; Benzofurans; Female; Humans; Middle Aged; Mitral Valve Insufficiency; Syncope; Tachycard | 1978 |
[Use of amiodarone in atrial tachyarrhythmias associated with sinus bradycardia. Evaluation of the results by means of continuous monitoring].
Topics: Aged; Amiodarone; Benzofurans; Bradycardia; Electrocardiography; Exercise Test; Humans; Male; Middle | 1977 |
[Congenital bundle-of-his focal tachycardias. Cooperative study of 7 cases].
Topics: Amiodarone; Bundle of His; Digitalis Glycosides; Female; Heart Failure; Humans; Infant; Infant, Newb | 1976 |
Effect of amiodarone in the Wolff-Parkinson-White syndrome.
Topics: Adolescent; Adult; Amiodarone; Atrial Fibrillation; Atrioventricular Node; Benzofurans; Electrocardi | 1976 |
[Persistent atrial ectopic supraventricular tachycardia. Report of a case of a child with persistent regression of the arrhythmia after treatment with amiodarone per os (author's transl)]U.
Topics: Administration, Oral; Amiodarone; Benzofurans; Child; Humans; Male; Remission, Spontaneous; Tachycar | 1976 |
[Drug therapy of tachycardial arrhythmias].
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Digitalis Glycosides; Drug Therapy, Combina | 1976 |
[New drugs used in the treatment of tachyarrhythmias].
Topics: Amiodarone; Benzofurans; Humans; Tachycardia | 1976 |
[Amiodarone, an anti-arrhythmic agent (apropos of a case of ventricular recurrent tachycardia in a coronary patient)].
Topics: Amiodarone; Benzofurans; Coronary Disease; Electrocardiography; Heart Ventricles; Humans; Male; Midd | 1975 |
[Combination anti-arrhythmic drug therapy].
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Drug Therapy, Combination; Electro | 1992 |
Use-dependent electrophysiologic effects of amiodarone in coronary artery disease and inducible ventricular tachycardia.
Topics: Amiodarone; Cardiac Pacing, Artificial; Coronary Disease; Electrocardiography; Female; Heart Conduct | 1992 |
Slowing of ventricular tachycardia as a possible endpoint for serial drug testing at electrophysiological study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Death, Sudden, Cardiac; Female; Hear | 1992 |
Outcome of thyroid function in newborns from mothers treated with amiodarone.
Topics: Adult; Amiodarone; Female; Humans; Hypothyroidism; Infant, Newborn; Maternal-Fetal Exchange; Pregnan | 1992 |
Stabilization of cardiac rhythm in subsequently fatal ventricular tachycardia and fibrillation by calcitonin gene-related peptide.
Topics: Amiodarone; Calcitonin Gene-Related Peptide; Electric Countershock; Electrocardiography, Ambulatory; | 1992 |
Antiadrenergic cardiovascular adverse effects of high-dose amiodarone loading regimen.
Topics: Administration, Oral; Amiodarone; Cardiac Output, Low; Catecholamines; Humans; Male; Middle Aged; My | 1992 |
Hemodynamic effects of amiodarone during acute and chronic treatment in patients with recurrent sustained ventricular tachycardia.
Topics: Aged; Amiodarone; Cardiac Output; Dose-Response Relationship, Drug; Electrocardiography; Female; Hem | 1992 |
Ventricular tachycardia in Chagas' disease.
Topics: Adult; Aged; Amiodarone; Chagas Cardiomyopathy; Echocardiography; Electric Stimulation; Electrophysi | 1992 |
Long-term follow-up after sustained monomorphic ventricular tachycardia: Causes, pump failure, and empiric antiarrhythmic therapy that modify survival.
Topics: Actuarial Analysis; Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Female; F | 1991 |
Use of amiodarone for short-term and adjuvant therapy in young patients.
Topics: Administration, Oral; Adolescent; Adrenergic beta-Antagonists; Adult; Amiodarone; Arrhythmias, Cardi | 1991 |
[Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Electrocardiography, Am | 1990 |
[Optic neuropathy caused by amiodarone].
Topics: Amiodarone; Animals; Cardiac Complexes, Premature; Demyelinating Diseases; Humans; Male; Middle Aged | 1990 |
[Effect of amiodarone on signal-averaged and long-term ECG].
Topics: Aged; Aged, 80 and over; Amiodarone; Cardiac Complexes, Premature; Cardiac Pacing, Artificial; Cardi | 1991 |
High dose oral amiodarone loading: electrophysiologic effects and clinical tolerance.
Topics: Administration, Oral; Amiodarone; Dose-Response Relationship, Drug; Drug Evaluation; Drug Tolerance; | 1992 |
Reversal of antiarrhythmic drug effects by epinephrine: quinidine versus amiodarone.
Topics: Amiodarone; Cardiac Pacing, Artificial; Electrocardiography; Electrophysiology; Epinephrine; Female; | 1992 |
Epinephrine infusions during antiarrhythmic drug evaluations: toward a better understanding of drug activity.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Epinephrine; Humans; Quinidine; Tach | 1992 |
Long-term treatment of ventricular tachycardia with amiodarone in presence of severe left ventricular dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Cardiomyopathies; Coronary Disease; Death, Sudden, Cardi | 1991 |
Survival of patients with nonsustained ventricular tachycardia and impaired left ventricular function treated with low-dose amiodarone.
Topics: Aged; Amiodarone; Death, Sudden, Cardiac; Female; Heart Ventricles; Humans; Male; Middle Aged; Survi | 1991 |
Catecholamine-sensitive right ventricular tachycardia in the absence of structural heart disease: a mechanism of exercise-induced cardiac arrest.
Topics: Adult; Amiodarone; Basketball; Bundle of His; Bundle-Branch Block; Cardiac Pacing, Artificial; Catec | 1991 |
Possible association of pulmonary fibrosis with mexiletine.
Topics: Aged; Amiodarone; Humans; Male; Mexiletine; Pulmonary Fibrosis; Tachycardia; Tomography, X-Ray Compu | 1991 |
Identification of amiodarone in corneal deposits.
Topics: Aged; Amiodarone; Cornea; Electron Probe Microanalysis; Epithelium; Humans; Inclusion Bodies; Male; | 1991 |
The use of associated propafenone in patients with amiodarone-resistant ventricular tachycardia.
Topics: Adult; Aged; Amiodarone; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combinatio | 1991 |
A prospective comparison of class IA, B, and C antiarrhythmic agents in combination with amiodarone in patients with inducible, sustained ventricular tachycardia.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Drug Therapy, Combination; Electrocardiography; Encain | 1991 |
Polymorphous ventricular tachycardia associated with acute myocardial infarction.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Coronary Angiography; Electrocardiograp | 1991 |
Sudden death due to ventricular tachycardia during amiodarone therapy in familial hypertrophic cardiomyopathy.
Topics: Amiodarone; Atrial Fibrillation; Cardiomyopathy, Hypertrophic; Death, Sudden; Electrocardiography, A | 1991 |
Amiodarone-related postoperative adult respiratory distress syndrome.
Topics: Aged; Amiodarone; Endocardium; Female; Humans; Incidence; Male; Middle Aged; Pacemaker, Artificial; | 1991 |
Predictive value of early electrophysiologic testing in determining long-term outcome with amiodarone treatment in patients with sustained ventricular tachycardia.
Topics: Adult; Aged; Amiodarone; Electrophysiology; Evaluation Studies as Topic; Female; Follow-Up Studies; | 1991 |
Subacute pulmonary toxicity from amiodarone.
Topics: Aged; Amiodarone; Humans; Lung Diseases; Male; Tachycardia | 1991 |
Intravenous amiodarone for short-term treatment of refractory ventricular tachycardia or fibrillation.
Topics: Aged; Amiodarone; Death, Sudden, Cardiac; Drug Evaluation; Electrocardiography; Female; Humans; Infu | 1991 |
Invasive electrophysiologic studies as predictor of sudden death and for treatment of patients with aborted sudden death.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Child; Death, Sudden; Electric Cou | 1990 |
Amiodarone versus bretylium for suppression of reperfusion arrhythmias in dogs.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Blood Pressure; Bretylium Compounds; Dogs; Drug Evaluatio | 1991 |
Factors predictive of results of direct ablative operations for drug-refractory ventricular tachycardia. Analysis of 80 patients.
Topics: Adult; Aged; Amiodarone; Analysis of Variance; Cardiopulmonary Bypass; Electrophysiology; Female; He | 1991 |
Value of electrophysiologic studies in hypertrophic cardiomyopathy treated with amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Cardiomyopathy, Hypertrophic; Death, S | 1991 |
Comparison of the results of electrophysiologic testing after short-term and long-term treatment with amiodarone in patients with ventricular tachycardia.
Topics: Aged; Amiodarone; Blood Pressure; Cardiac Pacing, Artificial; Electrophysiology; Female; Humans; Mal | 1991 |
[Ventricular arrhythmia following thioridazine poisoning].
Topics: Amiodarone; Female; Humans; Middle Aged; Tachycardia; Thioridazine; Torsades de Pointes; Ventricular | 1991 |
The amiodarone--class I agent combination increases refractoriness, conduction, and the number of electrophysiologic studies. But does it increase survival rate?
Topics: Amiodarone; Anti-Arrhythmia Agents; Death, Sudden; Drug Synergism; Drug Therapy, Combination; Tachyc | 1991 |
[Empiric treatment with amiodarone in patients with sustained ventricular tachyarrhythmia. Results of a long-term follow-up].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Female; Follow-Up Studies; Heart Ventricles; | 1990 |
Effects of encainide and amiodarone on the adaptation of ventricular refractoriness to an increase in rate.
Topics: Adaptation, Physiological; Amiodarone; Anilides; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; | 1990 |
[Tachycardia with wide ventricular complexes and alternating QRS complexes and RR intervals].
Topics: Amiodarone; Cardiac Pacing, Artificial; Electric Countershock; Electrocardiography; Humans; Male; Me | 1990 |
Arrhythmogenic effects of antiarrhythmic drugs.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Female; Flecainide; Humans; Male; Middle Aged; Prop | 1990 |
Barium-induced nondriven action potentials as a model of triggered potentials from early afterdepolarizations: significance of slow channel activity and differing effects of quinidine and amiodarone.
Topics: Action Potentials; Amiodarone; Animals; Barium; Calcium Channels; Dogs; Female; Heart Conduction Sys | 1990 |
Rapid control of refractory atrial tachyarrhythmias with high-dose oral amiodarone.
Topics: Administration, Oral; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Drug Ev | 1990 |
[Empiric therapy with amiodarone in patients with chronic Chagas cardiomyopathy and sustained ventricular tachycardia].
Topics: Adult; Aged; Amiodarone; Chagas Cardiomyopathy; Chronic Disease; Female; Heart Rate; Humans; Male; M | 1990 |
[Therapeutic decision in sustained ventricular tachycardia in patients with cardiomyopathy].
Topics: Amiodarone; Heart Rate; Humans; Tachycardia | 1990 |
Acute treatment of torsades de pointes with amiodarone: proarrhythmic and antiarrhythmic association of QT prolongation.
Topics: Amiodarone; Arrhythmias, Cardiac; Electrocardiography; Humans; Long QT Syndrome; Male; Middle Aged; | 1990 |
Benefit and risks of long-term amiodarone therapy for sustained ventricular tachycardia/fibrillation: minimum of three-year follow-up in 145 patients.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Dose-Response Relationship, Drug | 1990 |
[Endocavitary transcatheter electric fulguration as a therapeutic alternative in refractory ventricular tachycardia].
Topics: Adult; Aged; Amiodarone; Cardiomyopathy, Dilated; Catheterization; Electrosurgery; Follow-Up Studies | 1990 |
Long-term follow-up of postmyocardial infarction patients with ventricular tachycardia or ventricular fibrillation treated with amiodarone.
Topics: Aged; Amiodarone; Cardiac Pacing, Artificial; Female; Follow-Up Studies; Heart; Humans; Life Tables; | 1990 |
Cycle-length response of ventricular tachycardia associated with coronary artery disease to procainamide and amiodarone.
Topics: Amiodarone; Cardiac Pacing, Artificial; Coronary Disease; Electrophysiology; Female; Heart; Humans; | 1990 |
Monophasic action potential studies in human subjects with prolonged ventricular repolarization and long QT syndromes.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Bradycardia; Cardiac Complexes, Premature | 1985 |
Amiodarone: an effective alternative for recalcitrant supraventricular and ventricular tachycardias.
Topics: Amiodarone; Atrial Fibrillation; Benzofurans; Cardiac Complexes, Premature; Cardiomyopathy, Dilated; | 1986 |
Noninvasive serial electrophysiological testing using an implanted pacemaker for management of recurrent ventricular tachycardia.
Topics: Aged; Amiodarone; Electrophysiology; Heart Ventricles; Humans; Male; Mexiletine; Pacemaker, Artifici | 1986 |
Atrial pacing via unilateral persistent left superior vena cava.
Topics: Aged; Amiodarone; Bundle-Branch Block; Cardiac Pacing, Artificial; Electrodes, Implanted; Electrophy | 1986 |
The antiarrhythmic efficacy of amiodarone and desethylamiodarone, alone and in combination, in dogs with acute myocardial infarction.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Dogs; Dose-Response Relatio | 1988 |
Cumulative effects of amiodarone on inducibility of ventricular tachycardia: implications for electrophysiological testing.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Cardiac Pacing, Artificial; Female; Humans; Male; Middle | 1988 |
Empiric amiodarone versus "ineffective" drug therapy in patients with refractory ventricular tachyarrhythmias.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Male; Middle Aged; Prognosis; Tachycardia | 1988 |
Efficacy and safety of low doses of beta-blocker agents combined with amiodarone in refractory ventricular tachycardia.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Cardiac Pacing, Artificial; Drug Therapy, Comb | 1988 |
Serum reverse T3 and amiodarone efficacy.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Cardiac Complexes, Premature; Electrocardiography; Femal | 1989 |
Acute electrophysiologic effects and antiarrhythmic/antifibrillatory activity of intravenous amiodarone in a chronic feline infarction model.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Cats; Chronic Disease; Electric Stimulation; Electrophy | 1989 |
Stability of electrophysiological parameters after acute amiodarone loading: implications for patient management.
Topics: Aged; Amiodarone; Analysis of Variance; Coronary Disease; Dose-Response Relationship, Drug; Electrop | 1989 |
Inadvertent catheter-induced right bundle branch block in a patient with preexistent left bundle branch block and recurrent macroreentrant ventricular tachycardia.
Topics: Aged; Amiodarone; Bundle-Branch Block; Cardiac Catheterization; Electric Stimulation; Electrocardiog | 1989 |
Iatrogenic thyroid dysfunction.
Topics: Amiodarone; Humans; Hyperthyroidism; Male; Middle Aged; Propylthiouracil; Tachycardia; Thyroid Funct | 1989 |
[Idiopathic recurrent ventricular tachycardia: role of verapamil in its treatment].
Topics: Adolescent; Amiodarone; Electrocardiography; Heart Rate; Heart Ventricles; Humans; Middle Aged; Recu | 1989 |
Amiodarone prophylaxis in hypertrophic obstructive cardiomyopathy.
Topics: Amiodarone; Cardiomyopathy, Hypertrophic; Humans; Tachycardia | 1989 |
Characteristics, prognosis and treatment of the ventricular arrhythmias of right ventricular dysplasia.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardio | 1989 |
[Efficacy of the combination of low doses of beta-blockers and amiodarone in the treatment of refractory ventricular tachycardia].
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Chronic Disease; Drug Evaluation; | 1989 |
QT prolongation and arrhythmia suppression.
Topics: Acecainide; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Deafness; Death, Sudden; Elect | 1985 |
Externally activated antitachycardia pacemaker with noninvasive electrophysiologic re-testing capability.
Topics: Aged; Amiodarone; Atrioventricular Node; Combined Modality Therapy; Electrocardiography; Female; Fol | 1985 |
[Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac Complexes, Pr | 1985 |
Polymorphous ventricular tachycardia (PVT)
Topics: Amiodarone; Benzofurans; Electrocardiography; Humans; Hypokalemia; Tachycardia | 1985 |
Clinical efficacy of intravenous amiodarone in the short term treatment of recurrent sustained ventricular tachycardia and ventricular fibrillation.
Topics: Amiodarone; Electrocardiography; Female; Heart Ventricles; Humans; Infusions, Intravenous; Male; Mid | 1989 |
Prognostic value of early electrophysiologic studies for ventricular tachycardia recurrence in patients with coronary artery disease treated with amiodarone.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Coronary Disease; Electric Stimulation; Electrocardiogra | 1989 |
Intravenous amiodarone during prolonged resuscitation from cardiac arrest.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Female; Heart Arrest; Humans; Infusions, Intravenous; In | 1989 |
Risk stratification and management of patients with recurrent ventricular tachycardia and other malignant ventricular arrhythmias.
Topics: Actuarial Analysis; Amiodarone; Cardiac Surgical Procedures; Electric Countershock; Endocardium; Fem | 1989 |
[Torsade de pointes following intravenous infusion of amiodarone].
Topics: Aged; Amiodarone; Electrocardiography; Female; Humans; Infusions, Intravenous; Lidocaine; Tachycardi | 1989 |
[Amiodarone prophylaxis of ventricular tachycardia in ischemic cardiopathy].
Topics: Aged; Aged, 80 and over; Amiodarone; Coronary Disease; Death, Sudden; Electrocardiography; Female; H | 1989 |
Amiodarone in patients with previous drug-mediated torsade de pointes. Long-term safety and efficacy.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac | 1989 |
Dexamethasone treatment of amiodarone-induced thyrotoxicosis (AIT) with or without persistent administration of the drug.
Topics: Amiodarone; Dexamethasone; Humans; Male; Middle Aged; Propylthiouracil; Tachycardia; Thyrotoxicosis | 1989 |
Intravenous amiodarone for the rapid treatment of life-threatening ventricular arrhythmias in critically ill patients with coronary artery disease.
Topics: Amiodarone; Coronary Disease; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middl | 1989 |
The effective treatment of multifocal atrial tachycardia with amiodarone.
Topics: Administration, Oral; Aged; Aged, 80 and over; Amiodarone; Electrocardiography; Female; Heart Atria; | 1989 |
Amiodarone-induced polymorphous ventricular tachycardia.
Topics: Aged; Amiodarone; Cardiac Pacing, Artificial; Humans; Male; Tachycardia | 1989 |
Amiodarone: a common source of iodine-induced thyrotoxicosis.
Topics: Adult; Aged; Amiodarone; Drug Therapy, Combination; Female; Humans; Immunoglobulin G; Immunoglobulin | 1987 |
Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation.
Topics: Aged; Amiodarone; Electrophysiology; Female; Follow-Up Studies; Humans; Male; Middle Aged; Recurrenc | 1989 |
Failure of corticosteroid therapy to prevent induction of ventricular tachycardia in sarcoidosis.
Topics: Adult; Amiodarone; Cardiac Pacing, Artificial; Cardiomyopathies; Disopyramide; Drug Therapy, Combina | 1989 |
Electron microscopic demonstration of lysosomal inclusion bodies in lung, liver, lymph nodes, and blood leukocytes of patients with amiodarone pulmonary toxicity.
Topics: Amiodarone; Benzofurans; Biopsy, Needle; Follow-Up Studies; Humans; Inclusion Bodies; Leukocytes; Li | 1985 |
Unusual neurotoxicity associated with amiodarone therapy.
Topics: Aged; Amiodarone; Brain Diseases; Brain Stem; Female; Humans; Jaw; Male; Middle Aged; Movement Disor | 1987 |
Clinical experience with amiodarone for treatment of recurrent ventricular tachycardia and ventricular fibrillation.
Topics: Aged; Amiodarone; Benzofurans; Electrophysiology; Female; Heart; Humans; Lung; Male; Middle Aged; Ta | 1986 |
Amiodarone in the treatment and control of tachyarrhythmias.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Female; Humans; Male; Middle Aged; Tachycardia; Tachycar | 1986 |
His bundle tachycardia--arrhythmogenic and antiarrhythmic effects of therapy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Bundle of His; Electrocardiography; Flecainide; Humans; Infant, | 1987 |
Thyrotropin hyperresponsiveness to TRH despite hyperthyroxinemia in amiodarone-treated subjects.
Topics: Amiodarone; Female; Humans; Male; Tachycardia; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine | 1987 |
Rapid suppression of flecainide-induced incessant ventricular tachycardia with high-dose intravenous amiodarone.
Topics: Amiodarone; Flecainide; Humans; Male; Middle Aged; Tachycardia | 1988 |
Clinical and electrophysiologic effects of flecainide in patients with refractory ventricular tachycardia.
Topics: Aged; Amiodarone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrophysiology; Fe | 1988 |
[Bundle branch reentry tachycardia: a possible mechanism of flecainide proarrhythmia effect].
Topics: Amiodarone; Atrial Fibrillation; Cardiomyopathy, Alcoholic; Drug Therapy, Combination; Electrocardio | 1988 |
Unstable angina with tachycardia: clinical and therapeutic implications.
Topics: Aged; Amiodarone; Angina Pectoris; Angina, Unstable; Electrocardiography; Female; Heart Rate; Humans | 1988 |
Usefulness of sotalol for drug-refractory malignant ventricular arrhythmias.
Topics: Adult; Aged; Amiodarone; Female; Follow-Up Studies; Humans; Male; Middle Aged; Sotalol; Tachycardia; | 1988 |
[Torsade de pointes: clinical experience of 9 patients].
Topics: Adult; Aged; Amiodarone; Coronary Disease; Electrocardiography; Female; Humans; Hypokalemia; Isoprot | 1988 |
Long-term results of amiodarone therapy.
Topics: Adult; Aged; Amiodarone; Atrial Fibrillation; Follow-Up Studies; Heart Arrest; Humans; Middle Aged; | 1987 |
Case history roundtable discussion. Ventricular tachycardia.
Topics: Adult; Aged; Amiodarone; Electrophysiology; Female; Humans; Male; Middle Aged; Monitoring, Physiolog | 1987 |
Amiodarone keratopathy in the donor cornea.
Topics: Aged; Amiodarone; Cornea; Corneal Diseases; Corneal Transplantation; Humans; Male; Middle Aged; Tach | 1988 |
Amiodarone therapy: role of early and late electrophysiologic studies.
Topics: Adult; Aged; Amiodarone; Cardiac Pacing, Artificial; Electrophysiology; Female; Follow-Up Studies; H | 1988 |
Efficacy of intravenous amiodarone as short-term treatment for refractory ventricular tachycardia.
Topics: Adult; Aged; Amiodarone; Electrocardiography; Heart Ventricles; Hemodynamics; Humans; Infusions, Int | 1988 |
Amiodarone-induced delirium.
Topics: Aged; Amiodarone; Delirium; Heart Ventricles; Humans; Male; Tachycardia | 1988 |
Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrop
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Coronary Disea | 1988 |
Oral amiodarone loading therapy. I. The effect on serial signal-averaged electrocardiographic recordings and the QTc in patients with ventricular tachyarrhythmias.
Topics: Administration, Oral; Amiodarone; Electrocardiography; Female; Humans; Male; Middle Aged; Prospectiv | 1988 |
Reappraisal of criteria for assessing drug efficacy in patients with ventricular tachyarrhythmias: complete versus partial suppression of inducible arrhythmias.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Electrocardiography; Electrop | 1988 |
Worsening of ventricular tachycardia by amiodarone.
Topics: Aged; Amiodarone; Humans; Male; Middle Aged; Tachycardia | 1988 |
[The value of electrophysiological studies in the treatment of ventricular tachycardias with amiodarone alone or in combination with class-I anti-arrhythmia drugs].
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Drug | 1988 |
Right and left ventricular function during chronic amiodarone therapy.
Topics: Aged; Amiodarone; Electrocardiography; Electrophysiology; Exercise Test; Female; Humans; Male; Middl | 1988 |
[Amiodarone in children. Impact on growth].
Topics: Amiodarone; Child; Child, Preschool; Female; Growth; Humans; Infant; Infant, Newborn; Male; Tachycar | 1987 |
Comparison of survival of amiodarone-treated patients with coronary artery disease and malignant ventricular arrhythmias with that of a control group with coronary artery disease.
Topics: Aged; Amiodarone; Coronary Disease; Female; Heart Ventricles; Humans; Male; Middle Aged; Prognosis; | 1987 |
Anesthetic management of the parturient receiving amiodarone.
Topics: Adult; Amiodarone; Anesthesia, Epidural; Drug Interactions; Female; Fentanyl; Hemodynamics; Humans; | 1987 |
Effects of amiodarone during pregnancy.
Topics: Adult; Amiodarone; Female; Heart Ventricles; Humans; Infant, Newborn; Iodine; Maternal-Fetal Exchang | 1987 |
A case of the blues.
Topics: Aged; Amiodarone; Heart Ventricles; Humans; Male; Pigmentation Disorders; Tachycardia; Time Factors | 1987 |
Pharmacokinetic and electrophysiologic interactions of amiodarone and procainamide.
Topics: Aged; Amiodarone; Drug Interactions; Electrocardiography; Female; Heart; Heart Ventricles; Humans; I | 1987 |
Prognostic value of the changes in the mode of ventricular tachycardia induction during therapy with amiodarone or amiodarone and a class 1A antiarrhythmic agent.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Drug Therapy, Combination; Ele | 1987 |
Should electrophysiologic studies be performed to assess drug efficacy in patients receiving amiodarone?
Topics: Amiodarone; Cardiac Pacing, Artificial; Electrophysiology; Forecasting; Half-Life; Humans; Tachycard | 1987 |
Optic neuropathy and amiodarone therapy.
Topics: Aged; Amiodarone; Female; Humans; Male; Middle Aged; Optic Nerve Diseases; Tachycardia; Vision Tests | 1987 |
Amiodarone in patients with recurrent sustained ventricular tachyarrhythmias: results of programmed electrical stimulation and long-term clinical outcome in chronic treatment.
Topics: Amiodarone; Cardiac Pacing, Artificial; Death, Sudden; Electrocardiography; Female; Follow-Up Studie | 1987 |
Amiodarone efficacy in a young population: relationship to serum amiodarone and desethylamiodarone levels.
Topics: Adolescent; Adult; Amiodarone; Child; Child, Preschool; Heart Ventricles; Humans; Infant; Tachycardi | 1987 |
Torsade de pointes during loading with amiodarone.
Topics: Administration, Oral; Amiodarone; Atrial Flutter; Cardiac Pacing, Artificial; Dose-Response Relation | 1987 |
Amiodarone.
Topics: Amiodarone; Electrocardiography; Humans; Male; Middle Aged; Monitoring, Physiologic; Tachycardia | 1987 |
Electrophysiologic predictors of long-term clinical outcome with amiodarone for refractory ventricular tachycardia secondary to coronary artery disease.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Cardiac Pacing, Artificial; Female; Follow-Up Studies; H | 1987 |
Malignant ventricular arrhythmia in the Wolff-Parkinson-White syndrome during amiodarone treatment.
Topics: Adult; Amiodarone; Atrioventricular Node; Cardiac Pacing, Artificial; Electrophysiology; Heart Condu | 1987 |
Predictors of efficacy of amiodarone and characteristics of recurrence of arrhythmia in patients with sustained ventricular tachycardia and coronary artery disease.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Coronary Disease; Female; Follow | 1987 |
The automatic implantable cardioverter-defibrillator in drug-refractory ventricular tachyarrhythmias.
Topics: Aged; Amiodarone; Combined Modality Therapy; Death, Sudden; Drug Resistance; Electric Countershock; | 1987 |
Success of chronic defibrillation and the role of antiarrhythmic drugs with the automatic implantable cardioverter/defibrillator.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Combined Modality Therapy; Electric Countershock; Electroc | 1987 |
Malignant course of a benign anomaly: myocardial bridging.
Topics: Adult; Amiodarone; Cardiomyopathies; Coronary Angiography; Diltiazem; Electrocardiography; Electroph | 1987 |
Amiodarone for sustained ventricular tachycardia: efficacy, safety, and factors influencing long-term outcome.
Topics: Adolescent; Adult; Aged; Amiodarone; Chronic Disease; Female; Follow-Up Studies; Heart Function Test | 1987 |
Usefulness of electrophysiologic studies in predicting drug efficacy in patients receiving amiodarone.
Topics: Amiodarone; Cardiac Pacing, Artificial; Humans; Tachycardia; Ventricular Fibrillation | 1987 |
[Importance of retrograde occult conduction on the modulation of the ventricular response in the cardiac pre-excitation syndrome].
Topics: Adult; Amiodarone; Electric Countershock; Electric Stimulation; Heart Conduction System; Humans; Mal | 1987 |
[Amiodarone therapy--behavior of serum and fatty tissue concentrations].
Topics: Adipose Tissue; Adult; Aged; Amiodarone; Benzofurans; Biotransformation; Dose-Response Relationship, | 1986 |
Postexercise ventricular tachycardia in children.
Topics: Adolescent; Amiodarone; Female; Heart Rate; Humans; Male; Physical Exertion; Tachycardia | 1986 |
[Thyroid function disorder caused by amiodarone].
Topics: Amiodarone; Benzofurans; Humans; Hyperthyroidism; Tachycardia | 1986 |
Amiodarone-induced torsades de pointes.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Benzofurans; Dru | 1986 |
Adverse reactions to antiarrhythmic drugs during therapy for ventricular arrhythmias.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Female; Heart Ventricles; Humans; Male; Mexiletine; Middle | 1986 |
[Amiodarone in the treatment of severe supraventricular tachycardias].
Topics: Aged; Amiodarone; Benzofurans; Electrocardiography; Female; Humans; Male; Middle Aged; Tachycardia | 1986 |
Polymorphous ventricular tachycardia: clinical characterization, therapy, and the QT interval.
Topics: Adolescent; Adult; Aged; Amiodarone; Electrocardiography; Female; Follow-Up Studies; Humans; Male; M | 1986 |
[Intravenous amiodarone in life-threatening ventricular arrhythmias].
Topics: Amiodarone; Benzofurans; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; | 1986 |
Resolution of congestive cardiomyopathy caused by supraventricular tachycardia using amiodarone.
Topics: Adult; Amiodarone; Benzofurans; Cardiomyopathy, Dilated; Female; Humans; Tachycardia | 1986 |
Intravenous and oral amiodarone for arrhythmias in children.
Topics: Administration, Oral; Adolescent; Amiodarone; Arrhythmias, Cardiac; Atrial Flutter; Child; Child, Pr | 1986 |
Sustained and nonsustained ventricular tachycardia: genesis, significance, and management.
Topics: Aged; Amiodarone; Electric Countershock; Electrocardiography; Exercise Test; Humans; Male; Pacemaker | 1986 |
The use of ambulatory monitoring in the prognostic evaluation of patients with sustained ventricular tachycardia treated with amiodarone.
Topics: Amiodarone; Electrocardiography; Evaluation Studies as Topic; Female; Follow-Up Studies; Heart Ventr | 1986 |
Amiodarone: correlation of early and late electrophysiologic studies with outcome.
Topics: Adult; Aged; Amiodarone; Cardiac Pacing, Artificial; Drug Evaluation; Electrocardiography; Female; F | 1986 |
Amiodarone and hypokalemia. A dangerous combination.
Topics: Amiodarone; Female; Humans; Hypokalemia; Middle Aged; Tachycardia | 1986 |
Value of Holter monitoring in predicting long-term efficacy and inefficacy of amiodarone used alone and in combination with class 1A antiarrhythmic agents in patients with ventricular tachycardia.
Topics: Actuarial Analysis; Aged; Amiodarone; Anti-Arrhythmia Agents; Drug Therapy, Combination; Electrocard | 1987 |
Effects of chronic amiodarone therapy on ventricular tachycardia induced by programmed ventricular stimulation.
Topics: Aged; Amiodarone; Electric Stimulation; Electrophysiology; Female; Humans; Male; Middle Aged; Prospe | 1987 |
Management of refractory sustained ventricular tachycardia with amiodarone: a reappraisal.
Topics: Administration, Oral; Aged; Ambulatory Care; Amiodarone; Electrocardiography; Female; Humans; Male; | 1987 |
Comparison of programmed stimulation and Holter monitoring for predicting long-term efficacy and inefficacy of amiodarone used alone or in combination with a class 1A antiarrhythmic agent in patients with ventricular tachyarrhythmia.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Cardiomyopathy, Hypertrophic; | 1987 |
Amiodarone and digoxin for refractory fetal tachycardia.
Topics: Adult; Amiodarone; Digoxin; Female; Fetal Diseases; Humans; Pregnancy; Tachycardia | 1987 |
Amiodarone-induced thyroid gland dysfunction.
Topics: Amiodarone; Female; Humans; Hypothyroidism; Iodine; Male; Tachycardia; Thyroid Diseases; Thyroid Gla | 1987 |
Medical and surgical treatment of sustained and recurrent post-infarction ventricular tachycardia.
Topics: Adult; Aged; Amiodarone; Benzofurans; Combined Modality Therapy; Endocardium; Female; Humans; Male; | 1985 |
[Value and limitations of electropharmacological tests in the selection of anti-arrhythmic therapy in malignant ventricular tachyarrhythmia].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Electric Stimulation; Electrocardiography; Electrophysiol | 1985 |
Selection of antiarrhythmic drugs based on electrophysiologic studies.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Electrocardiography; Electrophysiolo | 1985 |
Electrophysiologic effects of amiodarone in tachyarrhythmias.
Topics: Adult; Amiodarone; Atrial Fibrillation; Benzofurans; Electrocardiography; Female; Heart; Humans; Mal | 1985 |
Asystole during treatment with amiodarone in a patient with persistent atrial tachycardia.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Digoxin; Drug Therapy, | 1985 |
[Medical treatment and long-term development of permanent reciprocal tachycardia in children. Apropos of 10 cases followed for 11 years].
Topics: Amiodarone; Child; Child, Preschool; Digoxin; Drug Therapy, Combination; Electrocardiography; Female | 1985 |
Amiodarone in the treatment of life-threatening ventricular tachycardia: role of Holter monitoring in predicting long-term clinical efficacy.
Topics: Adult; Aged; Amiodarone; Benzofurans; Electrocardiography; Humans; Long-Term Care; Monitoring, Physi | 1985 |
Amiodarone: risk factors for recurrence of symptomatic ventricular tachycardia identified at electrophysiologic study.
Topics: Amiodarone; Benzofurans; Electrocardiography; Electrophysiology; Female; Humans; Long-Term Care; Mal | 1985 |
Syncope, tachycardia, and exertional dyspnea.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiac Catheterization; Coronary Disease; Dyspnea; Elect | 1985 |
QT prolongation and the antiarrhythmic efficacy of amiodarone.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiac Pacing, Artificial; Electrocardiography | 1986 |
Acute and chronic effects of amiodarone on ventricular refractoriness, intraventricular conduction and ventricular tachycardia induction.
Topics: Administration, Oral; Aged; Amiodarone; Benzofurans; Cardiac Pacing, Artificial; Electric Stimulatio | 1986 |
Amiodarone hepatotoxicity.
Topics: Aged; Amiodarone; Benzofurans; Humans; Liver Cirrhosis; Male; Tachycardia | 1986 |
Survivors of cardiac arrest: prevention of recurrence by drug therapy as predicted by electrophysiologic testing or electrocardiographic monitoring.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Coronary Di | 1986 |
Effects of isoproterenol and amiodarone and the role of exercise in initiation of circus movement tachycardia in the accessory atrioventricular pathway.
Topics: Adult; Amiodarone; Atrioventricular Node; Benzofurans; Female; Heart Conduction System; Humans; Isop | 1986 |
Importance of modes of electrical termination of ventricular tachycardia for the selection of implantable antitachycardia devices.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Coronary Disease; Humans; Male; Middle | 1986 |
Role of electrophysiologic studies in identifying arrhythmogenic properties of antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electric Stimulation; Electrophysiology; H | 1986 |
Transient exacerbation followed by control of ventricular tachycardia with amiodarone.
Topics: Amiodarone; Benzofurans; Electrocardiography; Heart Ventricles; Humans; Male; Middle Aged; Tachycard | 1986 |
An unusual ventricular tachycardia responsive to verapamil.
Topics: Adult; Amiodarone; Bundle-Branch Block; Electrocardiography; Heart Ventricles; Humans; Lidocaine; Ma | 1986 |
Ventricular tachydysrhythmias in near-miss sudden infant death syndrome.
Topics: Amiodarone; Heart Ventricles; Humans; Infant, Newborn; Infusions, Parenteral; Male; Procainamide; Pr | 1986 |
Treatment of multifocal atrial tachycardia with amiodarone in a child with congenital heart disease.
Topics: Amiodarone; Benzofurans; Child, Preschool; Electrocardiography; Heart Defects, Congenital; Heart Fai | 1986 |
Amiodarone for refractory cardiac arrhythmias: 10-year study.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Coro | 1986 |
Combined bipolar dual chamber pacing and automatic implantable cardioverter/defibrillator.
Topics: Aged; Amiodarone; Bradycardia; Cardiac Pacing, Artificial; Electric Countershock; Electrodes, Implan | 1986 |
Utility of ambulatory electrocardiographic monitoring for predicting recurrence of sustained ventricular tachyarrhythmias in patients receiving amiodarone.
Topics: Aged; Ambulatory Care; Amiodarone; Benzofurans; Electrocardiography; Female; Heart Ventricles; Human | 1986 |
Hepatotoxicity of amiodarone.
Topics: Aged; Amiodarone; Benzofurans; Cholestasis, Intrahepatic; Humans; Liver Function Tests; Male; Tachyc | 1986 |
Subvalvular mitral calcium as a cause of surgically correctable ventricular tachycardia.
Topics: Amiodarone; Calcinosis; Cardiac Catheterization; Female; Heart Ventricles; Humans; Middle Aged; Mitr | 1986 |
Sustained symptomatic sinus node reentrant tachycardia: incidence, clinical significance, electrophysiologic observations and the effects of antiarrhythmic agents.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Electrophysiology; Humans; Mal | 1985 |
Usefulness of electrophysiologic testing in evaluation of amiodarone therapy for sustained ventricular tachyarrhythmias associated with coronary heart disease.
Topics: Adult; Aged; Amiodarone; Benzofurans; Coronary Disease; Electrophysiology; Female; Humans; Male; Mid | 1985 |
Cardiac arrest and sudden death in patients treated with amiodarone for sustained ventricular tachycardia or ventricular fibrillation: risk stratification based on clinical variables.
Topics: Aged; Amiodarone; Analysis of Variance; Benzofurans; Death, Sudden; Female; Heart Arrest; Humans; Ma | 1985 |
Results of late programmed electrical stimulation and long-term electrophysiologic effects of amiodarone therapy in patients with refractory ventricular tachycardia.
Topics: Amiodarone; Benzofurans; Cardiac Pacing, Artificial; Electric Stimulation; Electrophysiology; Female | 1985 |
Clinical and morphologic effects of amiodarone on the liver.
Topics: Adult; Amiodarone; Benzofurans; Humans; Liver; Lysosomes; Male; Middle Aged; Tachycardia | 1985 |
Suppression of arrhythmias within hours after a single oral dose of amiodarone and relation to plasma and myocardial concentrations.
Topics: Administration, Oral; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrioventr | 1985 |
Amiodarone-induced vasculitis and polyserositis.
Topics: Adult; Amiodarone; Benzofurans; Humans; Male; Necrosis; Photosensitivity Disorders; Serositis; Tachy | 1985 |
Use of amiodarone and digoxin specific Fab antibodies in digoxin overdosage.
Topics: Amiodarone; Benzofurans; Digoxin; Electrocardiography; Humans; Immunoglobulin Fab Fragments; Male; M | 1985 |
Intravenous amiodarone in the acute termination of supraventricular arrhythmias.
Topics: Adolescent; Adult; Aged; Amiodarone; Atrial Fibrillation; Atrioventricular Node; Benzofurans; Cardia | 1985 |
Pneumonitis with pleural and pericardial effusion and neuropathy during amiodarone therapy.
Topics: Adult; Amiodarone; Atrial Fibrillation; Atrial Flutter; Benzofurans; Combined Modality Therapy; Exer | 1985 |
[ECG observations on terminating tachyarrhythmia by intravenous amiodarone].
Topics: Adolescent; Adult; Aged; Amiodarone; Benzofurans; Electrocardiography; Female; Humans; Injections, I | 1985 |
Chronic amiodarone therapy and hypokalemia.
Topics: Amiodarone; Benzofurans; Humans; Hypokalemia; Tachycardia | 1985 |
[Idiopathic ventricular tachycardia responsive to verapamil. Presentation of 3 cases and review of the literature].
Topics: Adolescent; Adult; Aged; Ajmaline; Amiodarone; Bundle-Branch Block; Female; Humans; Male; Tachycardi | 1985 |
[Sustained ventricular tachycardia in postinfarct ischemic heart disease: spontaneous polymorphism. Clinical, therapeutic and prognostic aspects].
Topics: Adult; Aged; Amiodarone; Coronary Disease; Electrocardiography; Female; Heart Ventricles; Humans; Ma | 1985 |
Life-threatening ventricular arrhythmias provoked by amiodarone treatment.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Benzofurans; Digoxin; Electrocardiograp | 1985 |
Amiodarone keratopathy and lens opacities.
Topics: Adult; Aged; Amiodarone; Benzofurans; Cataract; Corneal Opacity; Follow-Up Studies; Humans; Middle A | 1985 |
Incessant atrioventricular nodal reciprocating tachycardia successfully treated with intravenous amiodarone.
Topics: Aged; Amiodarone; Atrioventricular Node; Benzofurans; Humans; Injections, Intravenous; Male; Tachyca | 1985 |
Amiodarone and sustained ventricular arrhythmias: statistical evidence of drug effectiveness.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Benzofurans; Cardiomyopathies; Coronary Disease; Drug Resi | 1985 |
Clinical significance of nonclinical ventricular tachycardia induced in amiodarone-treated patients.
Topics: Adult; Aged; Amiodarone; Benzofurans; Cardiac Pacing, Artificial; Electrocardiography; Electrophysio | 1985 |
Morphological findings in apparently idiopathic ventricular tachycardia. An echocardiographic haemodynamic and histologic study.
Topics: Adult; Aged; Amiodarone; Biopsy; Bundle-Branch Block; Cardiomyopathies; Drug Therapy, Combination; E | 1985 |
[Long-term therapy with amiodarone in tachyarrhythmias--report on various experiences with special reference to its side effects].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Benzofurans; Bradycardia; Drug Therapy, Combination; Elec | 1985 |
Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia.
Topics: Amiodarone; Benzofurans; Cardiomyopathy, Hypertrophic; Electrocardiography; Female; Heart Ventricles | 1985 |
Does treatment influence the natural history of patients with hypertrophic cardiomyopathy?
Topics: Amiodarone; Cardiomyopathy, Hypertrophic; Humans; Tachycardia | 1985 |
[Amiodarone-induced polyneuritis].
Topics: Aged; Amiodarone; Benzofurans; Humans; Male; Polyneuropathies; Tachycardia | 1985 |
Transplacental treatment of tachycardia-induced fetal heart failure with verapamil and amiodarone: a case report.
Topics: Adult; Amiodarone; Benzofurans; Female; Fetal Diseases; Fetal Heart; Heart Failure; Heart Rate; Huma | 1985 |
Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia.
Topics: Amiodarone; Benzofurans; Cardiomyopathy, Hypertrophic; Humans; Tachycardia | 1985 |
Repetitive ventricular tachycardia.
Topics: Adult; Amiodarone; Electrocardiography; Female; Humans; Mitral Valve Prolapse; Tachycardia | 1985 |
Effects of oral amiodarone on rate-dependent changes in refractoriness in patients with Wolff-Parkinson-White syndrome.
Topics: Administration, Oral; Amiodarone; Benzofurans; Cardiac Pacing, Artificial; Electrophysiology; Heart | 1985 |
[Ventricular tachycardia].
Topics: Amiodarone; Aprindine; Digitalis Glycosides; Electrocardiography; Heart Aneurysm; Heart Ventricles; | 1985 |
[Intravenous amiodarone in the therapy of supraventricular tachyarrhythmia].
Topics: Adolescent; Adult; Aged; Amiodarone; Benzofurans; Female; Follow-Up Studies; Humans; Infusions, Pare | 1985 |
[Effect of amiodarone on stimulatory convertibility and degeneration into ventricular fibrillation of induced ventricular tachycardias in the pig].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Benzofurans; Female; Swine; Tachycardia; Ventricular Fi | 1985 |